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Abstract 
Radiotherapy is one of the basic methods for cancer treatments. This extremely 
valuable and effective technique deliver high therapeutic doses of ionising radiations to the 
malignant cells to shrink tumours and kill cancer cells in a way that is safer and more reliable. 
The source of this ionising radiation is typically high energy photon or electron beams, which 
are potentially carcinogenic and/or deadly to all cells at high dosage. Therefore, the major 
obstacle of planning and delivery of radiotherapy is the preservation of healthy surrounding 
tissues by limiting the delivered radiation dose to the tolerance levels of normal tissues while 
still ensuring the effective targeting of tumour volumes to eradicate it.   
Developments in the field of nanotechnology have potentially provided effective 
radiotherapy techniques through the use of high and medium atomic number (Z) 
nanostructure materials as radiosensitisation agents. The high Z nanoparticles (NPs) such as 
gold, bismuth compound, iodine and gadolinium have already been successfully utilised as 
radiosensitiser agents when applied to tumours for in vitro, in vivo and even in some 
preclinical trials. However, the high and medium Z materials are more toxic than low Z 
elements, therefore investigation of radiosensitasation induced by low Z elements have 
become more attractive. Several studies have been conducted to test the low Z nanoparticles 
as dose enhancing agents. Most of these studies were in the field of UV and X-rays of 
kilovoltage energy ranges. This thesis’ research extends thier application to include the most 
common form of radiotherapy i.e. using megavoltage range of X-rays. The aims of this thesis 
are focused on investigations of employing low Z materials and particularly anatase titanium 
dioxide nanoparticles (TiO2 NPs) as potential radiosensitisation agent and as imaging agent 
too. 
This research was conducted by two main ways, one by using phantoms (PRESAGE® 
dosimeters) and the other by in vitro using two types of cell lines, cultured human 
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keratinocyte (HaCaT) and prostate cancer (DU145) cells, and both methods were aimed at 
determining the effects on NPs on the radiation dose enhancement at both low (kilovoltage) 
and high (megavoltage) radiotherapy X-ray beams. Furthermore, TiO2 NPs were activated via 
proton beam to investigate for their suitability as diagnostic agent hence this nano-compound 
qualifies to be true theranostic agent. 
Several characteristics of TiO2 NPs, which make them ideally suited for application in 
radiotherapy, are investigated throughout this research. Anatase TiO2 NPs were synthesised, 
characterised and functionalised to allow dispersion in culture medium for in vitro studies 
and halocarbons (PRESAGE® chemical compositions) for phantom based studies. The 
fabricated PRESAGE® dosimeters/phantoms were scanned to obtain the physical and 
radiological properties and further to determine the radiation dose enhancement induced by 
TiO2 NPs. Clonogenic and cell viability assays were employed to determine cells survival 
curves from which the dose enhancement levels “radiosensitisation” are deduced. The dose 
enhancement produced experimentally by 0.5, 1 and 4 mM TiO2 NPs concentrations for 
phantom and in vitro studies irradiated with 1-8 Gy ranges of radiation doses was quantified 
for kilovoltage and megavoltage energies of external X-ray radiation sources. Furthermore, 
the TiO2 NPs were activated via proton beam and the energy spectrums were acquired using 
Germanium detectors. The radiolabeled anatase TiO2 NPs were imaged using positron 
emission tomography (PET) scanner. 
One aspect of this research was to demonstrate that the TiO2 NPs were typically 
synthesised to achieve highly pure and uniform anatase nanocrystalline structure. This form 
of NPs creates more free radicals and effectively generates more reactive oxygen species 
(ROS) since it has larger surface to volume ratio. These features combined have a high 
impact in damaging DNA molecule of biological system during irradiation. 
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In phantom studies, the radiation modifying effects of incorporating of PEG 
functionalised anatase TiO2 NPs in the formulation of the water equivalent 3D PRESAGE
® 
dosimeter were explored. The dose enhancement factors (DEFs) were quantified and then the 
results were validated with the biological studies. The results clearly demonstrates that the 
sensitivity of the dosimeter increases to the radiation doses with the concentration of the TiO2 
NPs incorporated in the composition of the PRESAGE® dosimeter. Furthermore, the 
measured DEF was significant at 80 kV compared to the negligible dose enhancement 
detected at 6 MV X-ray energy beams. 
The In vitro studies, TiO2 NPs proved to be cytocompatible to cells, even at very high 
concentrations. The DEFs were deduced from the data analysed in the form of cell survival 
curves. The result indicates that radiosensitisation induced by TiO2 NPs was significant at 
kilovoltage range of energy which the maximal dose enhancement was observed at 80 kV. 
Furthermore, significant radiosensitisation was observed for in vitro study at megavoltage 
energy beam. Higher radiosensitisation were obtained for low energy x-rays compared to the 
high energy ones. Generally, with the inclusion of TiO2 NPs in the target, same fraction of 
cells were destroyed with lower radiation doses compared to the case of absence of TiO2 NPs. 
This means if the TiO2 NPs are added to the biological target, a reduction of external dose of 
an order of magnitude can be achieved to deliver the same local control as without the 
inclusion of TiO2 NPs for treatments with kilovoltage and megavoltage X-rays beams. This 
reduction of delivered radiation dose to the target results in reducing the dose to the 
surrounding normal tissues during treatment that is the primary concern in all radiotherapy 
treatment procedures. Hence, TiO2 NPs are considered to be an efficient dose enhancer agent 
and have a great potential value for future clinical radiotherapy applications. 
In addition, the radiobiological effect of amino functionalised anatase TiO2 NPs on 
HaCaT and DU145 cell lines were investigated. The linear (α) and the quadratic (β) 
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radiobiological-parameters were extracted from the cell survival curves in order to describe 
the DNA damage by radiation. The results clearly demonstrate that α value significantly 
increases with the inclusion of TiO2 NPs while β values do not show any predictable trend. 
This increase in α value indicates that the probability of double strand DNA breakage 
increases with the presence of NPs in the target. Accordingly, the DEF results for in vitro and 
phantom based studies showed good agreement with the hypothesis of α value increases as a 
consequence of inclusion TiO2 NPs in the target. 
There are measurable differences in the level of produced DEF between biological 
and phantom based studies at MV energy. The PRESAGE® dosimeters showed lower 
enhancements in radiosensitivity than cell in culture studies. This is due to PRESAGE® 
dosimeters is only able to detect the free electron generated as a result of photoelectric effect, 
Compton scatter and/or Auger effect and not being suited to detect the generated ROS 
(Biochemical effects) due to a lack of free water molecules in its structure, whereas cells can 
be affected by many other biochemical factors, such as the generated ROS which is added to 
the stress caused by generated electron free radicals, and this result in higher radiosensitivity. 
Therefore, the ROS generated from amino functionalised anatase TiO2 NPs upon exposed to 
radiotherapy X-ray energy beam was investigated. Aqueous solutions without and with the 
presence of TiO2 NPs was exposed to 6 MV beam. The result clearly shows that the level of 
generated ROS was proportionally dependent on the TiO2 NPs concentration. This explains 
that biochemical effects need to be considered as a key factor for enhancing the cellular 
radiosensitivity with the presence of nanoparticles, which would be an important 
consideration for in vitro and in vivo radiosensitivity measurements. 
Finally, the TiO2 NPs are proposed as a reliable potential candidate for producing 
nuclear medical radioisotopes via proton activation. The results demonstrate that intense peak 
was observed at 511 keV which correspond to the γ-ray resulted from electron-positron 
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annihilation. This γ-ray peak is the most important radioisotope for potential nuclear 
medicine imaging applications using PET. Recently, several innovative for new 
radiopharmaceutical evolution potentially suggest β- and α emitters. Therefore, the produced 
47Sc radionuclide is a promising therapeutic agent for preparing radiolabeled antibodies due 
to its favorable β- emission energy (162 keV) which decays to stable 47Ti (100% β- emission 
), and to its moderate half-life (T1/2 = 3.35 d). 
To conclude, this research shows that TiO2 NPs improve the efficiency of dose 
delivery, which has implications for future radiotherapy treatments. The TiO2 NPs can also 
be used as a potential imaging agents hence with these findings renders these NPs as 
theranostic agents with dual effects (i.e. imaging and dose enhancer agent) simultaneously if 
it is in the targets. 
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Thesis Outline 
This thesis is mainly divided into three main sections for validation the radiation dose 
enhancement induced by TiO2 NPs and this include: Section A: Synthesis and 
characterisation of TiO2 NPs, Section B: Phantom studies using PRESAGE
® dosimeters, 
Section C: Cell culture studies. Furthermore, it presents one of the potential applications of 
PRESAGE® dosimetry in radiotherapy. Finally, it reports the potential use of TiO2 NPs 
activated via proton beam as imaging agent in nuclear medicine applications.  
 
Chapter 1: Is an introduction to basic radiation physics, detailed description of the 
interaction of radiation with matter, radiobiology, introduction to TiO2 NPs, and to 3D 
PRESAGE® dosimetry in radiotherapy.   
 
Chapter 2: Contains detailed description of nanotechnology in radiotherapy, and a review of 
previous and current work on radiation dose enhancement using high and low atomic number 
(Z) materials such as gold, bismuth compound, and titanium dioxide nanoparticles. This 
chapter also provide analysis of the radiation attenuation and absorption coefficient and 
theoretically calculate the effects of radiation dose enhancement with the presence nano-sized 
materials. Finally, the objectives of the thesis are also explained. 
 
Chapter 3: The methodology of the thesis is described and is divided into three sections. 
Section A: synthesis of anatase TiO2 NPs for in vitro and phantom based studies and then 
characterise them. Section B: PRESAGE® dosimetry studies and this include fabrication and 
characterisation of PRESAGE® dosimetry, irradiation of PRESAGE® dosimeters with 
different X-rays modalities, and scanning techniques and procedures of this type of 
phantoms. Section C: describes the general protocols for radiobiological studies using cell 
culture. The protocols specify the correct preparation of anatase TiO2 NPs for in vitro studies, 
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cell culture protocol, cell irradiation methodology with conventional clinical X-rays 
radiotherapy beams, cell survival curves measurements employ colorimetric (MTS) and 
clonogenic assays techniques. Present protocols for observing TiO2 NPs localisation inside 
the cells and measuring their cytotoxicity. Protocol for detecting the reactive oxygen specious 
(ROS) are described.   
 
Chapter 4, Section A: This chapter present the obtained results and discussions of the 
experimental works conducted for synthesising and characterisation of anatase TiO2 NPs and 
this include; the size distribution, chemical compositions, crystal structure and surface 
modification characteristics of the synthesised nanoparticles. The results demonstrate that 
anatase crystal phase of TiO2 NPs were synthesised with average size of about 30 nm. The 
NPs were successfully modified with Aminopropyl trimethoxysilane (APTS) and Poly 
(ethylene glycol) trimethoxysilane (PEGTS) for in vitro and phantom based studies 
respectively.    
 
Chapter 5, Section B: Reports and discusses the results obtained from phantom based 
studies using PRESAGE® dosimeters and this includes; physical characteristics, radiological 
properties, and radiation dose enhancement effects induced by NPs. The physical 
characteristics results comprise the maximum absorption wavelength dependence and the 
radiation dose sensitivity of different radical initiators of PRESAGE® dosimeters. The 
maximum absorption was found to be at 630 nm and the PRESAGE® dosimeter with 
iodoform radical initiator was observed to have higher sensitivity that PRESAGE® dosimeter 
with chloroform radical initiator. The radiological properties include dose-response 
relationship, post response photo-stability and the water equivalency characteristic of the 
PRESAGE® dosimeters. The results demonstrate that the fabricated water equivalent 
PRESAGE® dosimeters have linear response relationship to radiation and are stable under 
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certain conditions.  This chapter also involves for the first time investigations of feasibility of 
employing different concentrations of the synthesised anatase PEG functionalised TiO2 NPs 
in the prepared PRESAGE® dosimeter for validation and quantification of the radiation dose 
enhancement employing low (kV) and high (MV) energy X-ray radiotherapy beams. The 
calculated dose enhancement factor (DEF) was observed to be maximum at kV and minimal 
at MV beams.  
 
Chapter 6, Section C: Contains the obtained results and discussions for in vitro studies and 
this includes; localisation of anatase amine functionalised TiO2 NPs inside the cells, the 
toxicological characteristic, and the radiosensitisation effects induced by various 
concentration of these NPs. The nanoparticles were observed as a black dots clustered in the 
cells cytoplasm with no toxicity. The cell survival curves for the different concentrations of 
anatase amine functionalised TiO2 NPs at kilovoltage (kV) and megavoltage (MV) energy X-
ray radiotherapy beams were obtained by MTS and clonogenic assays and the 
radiosensitisation induced by NPs were estimated. The radiosensitisation results from the 
physical and biochemical effects such as generation of free radicals and ROS respectively. 
The calculated DEFs were extrapolated from cell survival curves at 80% survival and the 
maximum DEF value for kilovoltage energy range is identified to be at 80 kV. The 
radiobiological parameter obtained from the cell survival curves such as alpha and beta 
values are analysed; the alpha value is found to increase as TiO2 NPs concentration increases. 
The generated ROS was proportionally dependent on TiO2 NPs concentrations. 
 
Chapter 7: Dedicated to the investigation of high-resolution 2D scanning feasibility study 
for PRESAGE® dosimeters, for the first time, using UV/VIS spectrophotometry 
(CLARIOstar microplate reader) and to simulate the tissue inhomogeneity behaviour. This 
chapter starts with an introduction to and review of PRESAGE® dosimeters scanning 
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techniques and its advantage over other dosimeters, followed by experimental methods, 
results and discussion. The water equivalent PRESAGE® dosimeter was fabricated with the 
inclusion of an inhomogeneity and the 2D dose distribution of megavoltage X-ray beams was 
obtained. The PDD curves and beam profile were validated against ionisation chamber 
measurements and the agreement is well within experimental uncertainties which 
demonstrate that performance of CLARIOstar microplate reader as a valid 2D dosimetry 
instrument. The dose distribution beyond the inhomogeneity were investigated which with 
this technique were relatively easily and quickly compared to optical CT or film dosimetry. 
There is also a potential to extend this method to obtain 3D dosimetry scanning by repeat 
measurements at various PRESAGE® angulations and then reconstruct the data in a volume.    
  
Chapter 8: Devoted to investigate the activation of anatase TiO2 NPs by proton beams that 
potentially can be employed for imaging application using PET scanner through the 
generation of gamma emitters (0.511 MeV). This chapter reports an introduction and review 
to commonly available radioisotopes employed as radioactive tracers and to nanoparticles 
recently tested as potential radioactive tracers in nuclear medicine applications, followed by 
experimental methods, results and discussion. The results demonstrate that this activation 
generate positrons and radionuclides with certain level of activity such as vanadium (48V) that 
potentially can be used for imaging and radiotracing agent in nuclear medicine applications. 
Therefore, TiO2 NPs can be considered as theranostic agents due to their compatibility for 
enhancing the radiation dose (chapter 5 & 6) and as potential imaging agent. 
 
Chapter 9: This chapter reports the general conclusions and future directions for this study. 
Chapter One: Introduction and Theory 
 
1 
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I. Introduction and theory 
 
This chapter contains an introduction and theory to radiotherapy and basic radiation 
physics. It explains the methods of X-rays production by conventional clinical modalities. In 
addition, a brief introduction to the cell biology and the effect of radiation interaction 
processes at an atomic level of biological system (in vitro) are described to facilitate a better 
understanding of the biological target damage caused by radiation. This chapter also provides 
an introduction into applications of nanotechnology in radiotherapy, and particularly the 
properties of titanium dioxide nanoparticles (TiO2 NPs) as radiosensitiser. Furthermore, it 
presents an overview of the fundamental theory and applications of PRESAGE® dosimeter 
that is employed to validate in vitro studies of this thesis.   
 
1.1 Introduction to radiation therapy (radiotherapy) 
 
Malignant tumours have being the major cause of mortality during this century [1]. 
Latest world cancer statistics, December 2013, by international agency for research on cancer 
(IARC) reported that 8.2 million death resulted from cancer, and around 14.1 million new 
cases were diagnosed in 2012, compared with 7.6 million and 12.7 million, respectively, in 
2008 [2]. In Australia, over 100,000 new cases of cancer are diagnosed each year [3]. 
Radiotherapy has currently become one of the primary and effective methods for cancer 
treatment, which involves delivery of high ionizing radiation dose [4]. During the course of 
their cancer patient’s treatment, slightly more than 50% of all cancer patients require 
radiotherapy [5]. Radiotherapy took advantages of ionising radiation and has been used for 
over 100 years to treat cancer tumour [6]. In the very beginning of introducing radiation 
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therapy, X-rays in kilovoltage energy range were designed for cancerous tissues treatment, 
but such radiation had a limited effect on deeply seated tumours. This is due to the low beam 
penetration abilities and sometimes delivering high doses (above threshold) to the healthy 
tissues, which it passed through to the tumour affecting these normal tissues. Later, serious 
efforts have been shown to overcome this shortcoming and as a result major advances have 
been made. One of these development was introducing electron linear accelerated (LINAC) 
within the last decade. The LINAC generates electron beams of megavoltage energy range 
and high energy X-rays (in the range of megavoltages) for radiation therapy uses. These are 
currently the most common sources of ionizing radiations used in clinical centres to deliver 
radiotherapy doses as required. In addition development in computers and information 
technology, over the last few decades, have made it possible to replace a conventional two 
dimensional (2D) radiotherapy using simple rectangular fields based on plan X-ray imaging 
to sophisticated three dimensional (3D) conformal radiotherapy techniques [2]. 
Consequently, improvements in the dose distribution and skin sparing effects have been 
achieved by such high energy X-rays and continues to improve the effectiveness of 
radiotherapy in cancer treatment as an appropriate and almost tailored  dose can be delivered 
to the tumours without producing serious reactions to the surrounding normal tissues or to the 
skin. As well as producing high energy X-rays, electron LINACs can also be used for 
generating extremely high energy electron beams (4 to 20 MeV) which are used for 
superficial cancer treatments and as a result most of the kilovoltage X-rays for such 
application have been replaced. In addition to the improvements of delivering various beam 
energy to the patient, technological sophistication in radiotherapy equipment provide better 
tumour targeting resulting in minimizing radiation dose to the surrounding normal tissues 
such as stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT) that 
produce conformal dose to the tumours with high accuracy [2, 4]. Image-guided radiotherapy 
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(IGRT), which is currently available in many radiotherapy centres and helps to achieve better 
tumours localisation by using imaging equipment which enhances the precision delivery of 
radiation doses to the tumours [7, 8]. Today in modern radiotherapy centres, LINACs are the 
most common modality employed for cancer treatments. However brachytherapy, which uses 
gamma-rays from radioactive sources such as iridium-192 or high radioactive source cobalt-
60, are serving as an alternative modality in radiotherapy for treating special types of cancer 
and in the meantime being less dependent on electrical energy [9]. Clinical applications uses 
other radiotherapy methods such as particle radiation therapy, this include heavy ion and 
proton beams which find their way to radiotherapy applications and are currently used in 
cancer treatment [10, 11]; whereas the high installation and maintenance costs,  they are less 
common. Particle radiotherapy provides localised dose concentrations at the specified 
tumours and has proved its ability of orbital tumours management such as base of skull 
sarcomas, this high focused energy beam deposited in tissue is commonly known as the 
Bragg peak. Although, particle therapy can have therapeutic complications where in the cases 
of accidental exposure to normal tissues can cause serious damages [12, 13]. 
 
1.2 Basic radiation physics 
 
In general, radiation is classified as ionizing and/or non-ionising radiation. Cancer 
treatment mainly utilizes ionising radiation, as it is more relevant in radiotherapy because it 
can kill cells efficiently by damaging their deoxyribonucleic acid (DNA) molecules. 
Radiation having sufficient energy to ionize atoms termed as ionizing radiation. Photons 
(gamma and X-rays) are most commonly used in radiotherapy, moreover other ‘particle type’ 
such as electrons, alpha, beta, protons, neutrons and heavy ions are used. The interaction of 
ionising radiation with the biological target causes damage in the structure of biological 
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system. The term ionization is further classified into two categories, indirectly ionising and 
directly ionising radiation. The directly ionizing radiation, type used in radiotherapy, is the 
direct interaction of charged particle (electron, proton and alpha particle) with matter which 
loses energy along the ionising track in the medium and then damage the target cells. The 
procedure of ejecting an electron from an atom as the incident particle have enough energy is 
called ionisation, while the absence of sufficient energy result in only movement of electron 
from lower energy levels to high energy levels which is called excitation. The secondary 
ionising radiation that is known as delta (δ)-rays can be produced if, in some condition, the 
ejected electrons have enough energy to eject further electrons [14]. However, in two multi-
steps process the indirectly ionising radiation, which include uncharged particles (photons & 
neutrons), deposit their energy in the target. Initially, absorbing radiation by the atoms will 
release charged particles, where photons release either electron or electron positron pairs and 
may release heavy ions or protons. Undoubtedly, interaction of photon with the target atoms 
will release secondary electrons that eventually produce a track of ionisation in the material. 
Incident radiations are responsible for most of the targets damage that result from energy 
deposited by this secondary electron [15]. That is why they are termed indirectly ionising 
radiation. In the following sections, a brief overview of electron interaction (directly ionising 
radiation) with target and X-ray or photon production is explained. 
 
1.2.1 Production of X-rays 
 
X-rays used in medical applications such as diagnostics or therapy are produced by 
two main different mechanisms, as a consequence two types of X-rays are generated; 
Bremsstrahlung X-ray and characteristic X-ray. In conventional X-ray tube or typical linear 
accelerator, electrons are generated and accelerated in vacuum and aimed at a high atomic 
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number (Z) target such as tungsten. Hence, irradiative “collision” interaction between the 
field of an atomic nucleus and the high-speed electron will generate a type of X-rays known 
as bremsstrahlung (braking radiation) [14]. In such an interaction, an electron passing near an 
atomic nucleus will lose energy by changing its direction due to the attractive force of the 
target nuclei. This lost energy will be irradiated as bremsstrahlung X-rays. Energy lost by the 
electron is equal to the energy of generated X-ray. Whereas, the other type of X-rays is 
generated when the high speed electron interact with the target atoms and eject K-shell orbital 
electron, due to unstable atom, electron from higher energy levels (L and M) will drop and 
fill the vacancy of the ejected electron in the lower energy level and therefore photon will be 
emitted, this emitted photon is called characteristic X-rays. The emission of bremsstrahlung 
X-rays may have any energy up to the initial electron energy but the characteristic radiations 
are emitted at discrete energies [14]. The mechanisms of both interactions are illustrated in 
Figures (1-1) and (1-2). 
 
 
Figure 1-1: Schematic diagram for bremsstrahlung X-rays production. 
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Figure 1-2: Schematic diagram for characteristic X-rays production 
 
 
1.2.2 Interaction of radiation with matter  
 
Early experiments showed the ability of X-rays in penetrating matter. A photograph 
shows a human hand bone was produced by two French physicists with in nearly one month 
of X-rays discovery [16]. This event has attracted researchers to deeply investigate the 
interaction between X-rays and objects. They demonstrated that the action of interaction 
initiate when an incident photon transfers along the path of the medium resulting in the 
release of secondary electrons from the atoms in the medium. The incident photon either 
causes target atoms to be excited or ionised depending on the photon energy. The probability 
of photon-atom interaction mechanism is mainly depend on Z number, X-rays energy, 
electron density and mass density of the target medium [14]. Four processes will occur when 
photon beam traverses through a medium, which are photoelectric, Compton scattering, pair 
production effects and photonuclear reaction. 
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1.2.2.1 Photoelectric effect 
 
The primary photoelectric effect “absorption” starts when the incident photon releases 
the most inner orbital (K-shell) electron from the atom. Photons having energy partially 
higher than atomic electron binding energy will eject electron from the k-shell level and the 
photon will be completely absorbed hence the term absorption. The kinetic energy of released 
electron is equal to the difference of photon energy and electron binding energy. As a result 
of electron escape, outer orbital electron will drop and fill the vacancy left in the inner orbit. 
Consequently characteristic X-rays or fluorescent photon will be emitted with energy exactly 
equal to the difference in levels energy (∆E). The local orbital electrons may absorb this 
generated characteristic X-ray and emit an orbital electron which is called Auger electron. 
These electrons are characterised as secondary photoelectric effect. The photoelectric effect is 
illustrated schematically in Figure (1-3). 
 
 
Figure 1-3: Schematic diagram for photoelectric interaction 
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Photon energy and atomic number of the absorbing materials are the two depending 
factors that the probability of photoelectric effect occurs. The relationship between the 
incident photon energy (E) is proportional to the cubic atomic number (Z3). Medium such as 
water or biological tissue require appropriate absorption photon energy > 0.1 MeV, whereas 
for high Z number materials such as lead, photoelectric absorption dominates at photon 
energies < 0.1 MeV [14, 17].   
 
1.2.2.2 Compton interaction 
 
Compton interaction occurs when a photon interacts with loosely bound electron (free 
electron) with energy much higher than electron binding energy. Only a portion of original 
photon energy is received by the outer orbital (M-shell) electron while the rest of the energy 
is carried out by the deflected photon which moves in a new direction as scattered photon. 
The very outer electron is then released from the atom. In the interaction when the incident 
photon energy is much higher than k-shell electron binding energy; therefore, Compton 
scattering will dominate photoelectric effect. Compton interaction obviously depend on free 
electron at a very outer-shell orbit and is independent on the material Z number [14]. Figure 
(1-4) is the schematic illustration of Compton scattering.  
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Figure 1-4: Schematic diagram for Compton interaction 
 
 
1.2.2.3 Pair production 
 
Pair production interaction occurs when the photon energy becomes more than 1.024 
MeV. Pair production process involves the interaction between incident photon and the 
magnetic field of a nucleus. In order to be absorbed, the incident photon energy must be more 
than twice the electron rest mass energy (0.511 MeV). Consequently, photon disappears and 
electron-positron pair will be created. The probability of pair production rises with the photon 
energy and Z number of the absorber. The positron combines with one of the free electrons in 
its vicinity to give rise to two annihilation photons, each of 0.511 MeV. Since momentum is 
converted in the process, the two photons are ejected in opposite directions [14], as illustrated 
in Figure (1-5).   
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Figure 1-5: Schematic diagram for Pair production interaction showing the production of annihilation 
radiations. 
 
 
1.2.2.4 Photo-nuclear reaction 
 
The photonuclear reaction is a physical process in which an extremely high-energy 
gamma ray (or x-ray) photons (nearly above 10 MeV) is absorbed by an atomic nucleus and 
causing the nuclei to inter an exited state which promptly decays by emitting protons (p), 
neutrons (n), or heavier particles from the nuclei and is then transformed into the nucleus of 
one or more other elements. The resulting daughter nuclei have a lower energy and mass 
(more stable) than the decayed parent nucleus. There are many possible reactions which some 
of them are (γ,n), (γ,2n), (γ,np), (γ,α), (γ,n2p), (γ,2np). The incident gamma ray photons 
energy must exceed the binding energy of the nucleons (proton, neutron) to be ejected from 
an atomic nucleus. The cross section (denoted by Greek letter σ) is the probability of 
interaction between a bombarding particle and the target nucleus. The cross section depends 
on the energy of the incident particle and on the properties of target nuclei. The total cross 
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section for all possible photonuclear reactions is called the gamma ray absorption cross 
section for a nucleus [14, 15]. 
In summary, photoelectrons, scattered X-rays, Compton electron, Auger electron and 
positrons are emitted from the atoms due to the interaction of X-rays with matter. Thus, the 
target atom will be ionised resulting in deposition of radiation energy “dose”. These low 
energy electrons are responsible for the damage caused to the biological systems. Hence, in 
the following section the attenuated fraction of photon energy by the material is described. 
 
1.2.3 Measurement of absorption and attenuation coefficients  
 
The photoelectric and Compton effect determines the absorption coefficient of the 
material for X-rays. The incident X-rays on any material will either be absorbed (P.E.) or 
scatter (C.S.) or involve in positron emission while the rest of the beam will traverse the 
target intact with no changes to its energy. In other words, the beam will be attenuated. The 
intensity (I) of radiation passing through a material of thickness (x) can be described as an 
exponential function “Lombar-Beer law” as equation (1-1) [14]. 
 
I(x) = I0 exp -μx   ……………….  (1-1) 
 
I(x) is the transmitted intensity through the absorber that do not interact with the 
material, I0 is the incident intensity on the absorber, x is the material thickness (distance 
travelled) and μ is the linear attenuation coefficient (cm-1) results from absorbing or removing 
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a fraction of photon while traversing through the material during attenuation process 
therefore x should be in cm. This coefficient is mainly depending on photon energy, target 
atomic composition and the density of the material. Mass attenuation coefficient (μ/ρ) is 
determined by removing density factor and only taking atomic composition of the material 
into account [14]. Furthermore, photon absorption and attenuation processes convert part or 
all of its energy to kinetic energy of electrons. Therefore, by using mass energy absorption 
coefficient (μen /ρ) and mass energy attenuation coefficient (μ/ρ), the absorbed or attenuated 
fraction of photon energy by the material can be obtained. 
From radiotherapy prospective, the absorption and attenuation coefficients from the 
interaction of radiation with biological target help to determine the sum of energy delivered 
to the target i.e. the radiation dose [15]. Hence, the biological effects of deposited radiation 
can be predicted. Therefore, a brief introduction to the cell biology and the influence of 
incident radiation on the biological system is explained in the following sections. 
 
1.3 Introduction to radiobiology 
 
Tumours are a category of biological tissue and are therefore living organisms. The 
study of targeting ionising radiation on the biological systems is called radiobiology [16]. 
Biological systems exposed to the ionizing radiations will absorb some or all of the radiation 
energy and undergo special interactions [14] as stated previously (sections 1.2.2). This 
interaction between biological materials and ionising radiations result in DNA damage and 
therefore cell death if the damage is unrepairable. In radiotherapy, it is very important to 
investigate how the tumour cell death occurs, which is the main objective, and in turn needs a 
good understanding of relevant aspects of the cell biology. 
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1.3.1 Cell biology 
 
Cell is the basic structural, functional and biological unit of all known living 
organisms. A cell is the smallest unit of live organs that can replicate independently. The 
study of cell is called “cell biology”. All organisms that are made from cells are arranged into 
more complex structures such as organs and tissues. Reproduction and responding to their 
environment are some of the essential functional aspects of the cells. In general, cells differ 
from each other but they have some common characteristics which therefore are classified as 
either prokaryotic or eukaryotic. Prokaryote cells were the first form of live on earth [17]. 
They are smaller, simpler, lack membrane-bound organelles such as the nucleus and 
independent; for example, the general type of these cells is bacteria. Eukaryote cells are about 
fifteen times wider than a typical Prokaryote cells and can be as much as thousand times 
greater in volume. The main distinguished feature of Eukaryote cells as compared to 
Prokaryotes cells is the presence of membrane-bound (plasma membrane) which isolate the 
inside components of cell from environment in which specific metabolic activities take place. 
Most important among these is a cell nucleus that houses the cell DNA molecules. Eukaryote 
cells usually exist in multicellular organisms such as plants and animals [17]. Ordinarily, 
creature cells are 5-20 μm in diameter. Organelle is the well-known name for the internal 
components of these cells, which include the nucleus, mitochondria, ribosome, cytoskeleton, 
Golgi apparatus, smooth endoplasmic reticulum, rough endoplasmic reticulum, vesicles, 
centrosome and lysosomes. Outside the cells wall include these structures capsule, fimbriae 
(pili) and flagella that cannot be found in animal cells and can exist in prokaryote cells, 
Figure (1-6) shows human keratinocyte (HaCaT) cells under high magnification microscope. 
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Figure 1-6: HaCaT cells under high magnification microscope.  
 
 
Cells experience diverse cellular processes for maintaining functions such as 
metabolism and growth. There are two main processes of metabolise organic molecules and 
cells harvest nutrients in to energy which are catabolism (breakdown pathway) and anabolism 
(biosynthetic pathway) [17]. In the first process (catabolic process) complex molecules are 
broken down by cells with the help of enzymes to generate energy. For example, cellular 
respiration, which consume oxygen as a reactant along with the organic fuel. In the second 
process (anabolic metabolism) complex molecules are constructed when cells consume 
energy. For example, synthesizing protein from amino acids, which other than anabolic 
pathway, it is also known as biosynthetic pathways. In order to produce energy, the 
breakdown of the complex sugar such as glucose takes place via a process called glycolysis 
within a biochemical cycle (Kreb’s citric acid cycle). Glucose will be broken down to make 
adenosine triphosphate (ATP) which is a form of energy, when the glucose is absorbed inside 
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the cells via diffusion process. This generated energy will be utilized by cells for all its 
functions such as cell proliferation, protein synthesis and cell movement. Nucleus, which is 
the largest organelle in a cell, controls all cellular functions. The nucleus contains genetic 
material in the form of deoxyribonucleic acid (DNA) molecules. DNA is organised into 
discrete units called chromosomes that carry the genetic information. Every chromosome is 
comprised of a material called chromatin, a complex of proteins, and DNA [17]. The DNA 
strand can be damaged by ionising radiation resulting in cell death and mutation. It has been 
founded that DNA and chromosome structure is the essential and primary target in the 
biological system damaging by ionising radiation [16]. 
 
1.3.2 DNA damage by ionising radiation 
 
In section (1.2.2) the interaction of ionising radiation with mater has been briefly 
detailed which describes the processes of free radicals and secondary electrons production via 
photoelectric effect and Compton scattering. Generation of free radicals (secondary electrons) 
can be considered as a consequence of the direct or indirect interaction processes. Direct 
process usually involves high linear energy transfer (LET), for example, neutrons and alpha 
particles emission. The direct interaction between ionising radiations and targets’ atoms will 
result in atoms to end up being ionised or excited. The generated free radicals will interact 
with other atoms and then causes a chain of biological impacts. Dissimilar to the direct 
process, indirect process can be defined as the interaction between ionising radiation and 
atoms or molecules rather than targets, such as water molecules, causing water derived free 
radicals. The free radicals react with nearby molecules or target in a very short time resulting 
in breakage of chemical bonds or oxidation (addition of oxygen atom) of proteins, DNAs or 
the effected molecules. The disruption of the chemical bonds will create new bonding and 
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cross linkage between these macromolecules that will affect cells’ vital function. The major 
effect in cells is DNA breaking since DNA consists of a pair of complementary double 
strands. The DNA double strand structure can be broken by either single strand breakage or 
double strand breakage. However, the latter is believed to be much more important (effective) 
biologically. Most single strand breakage can be repaired normally as the two strands 
complement each other, so using the template from the intact strand can serve as template for 
repair of its damaged strand and therefore may result in minor biological consequences only 
if the repair is incorrect. In cases of double-strand breaks, however, repair is more difficult 
and leads to erroneous re-joining of broken ends which causes significant effects leading to 
severe biological damage. These so-called disrepairs result in induction of mutations, 
carcinogenesis or leads to cell death [16]. The single and double strand breaks are illustrated 
in Figure (1-7).  
 
 
 
 
Figure 1-7: Illustrate free radical damaging DNA, A) Single strand break, B) Double strand break. 
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Ionising radiations may cause chromosomes aberration or chromatid aberration at 
higher doses. Chromosome is a thread-like structure of ribonucleic acids (RNA) and proteins 
exist in the nucleus of most living organs, carrying genetic information arranged in linear 
sequence. Chromatid is a two progeny strands of a duplicated chromosome joined at the 
centromere during meiosis or mitosis [16]. Chromosome breakage or aberration is shown in 
Figure (1-8). 
 
 
Figure 1-8: Illustration of chromosome breakage cause by free radical A) Two separate free radical 
breaks two chromosome B) Single free radical breaks two chromosome.  
 
 
Evaluation the damage caused to the biological target by ionising radiation is through 
utilising cell survival curves. Cell survival curves are the relationships between the absorbed 
radiation dose and the fraction of cells retaining their reproductive integrity as measured in 
vitro [16]. The cell-surviving fraction is displayed on a logarithmic scale. The shape of cell 
survival curve depends on the cell line and the type of irradiation. Cell survival behaviours at 
densely and sparsely ionising radiations are described in Figure (1-9). At densely ionising 
radiation (High LET), such as neutrons, cell survival curve is straight line; while, at the 
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sparsely ionising radiation, X-rays, cell survival curve begin with a linear slope at low doses, 
followed by a shoulder and afterward turn out to be straight again at high doses. The cell 
survival curve is described utilising radiobiological models and the most widely recognized 
models used is the linear quadratic (LQ) model which then is employed to fit the cell survival 
curve.   
 
 
Figure 1-9: Typical shape of cell survival curve for mammalian cells with the fraction of cells surviving as 
plotted on a logarithmic scale against dose on linear scale. The linear quadratic model is described by the 
linear component (αD), which is proportional to the dose and quadratic component (βD2), which is 
proportional to the square of dose. The α/β ratio is the value where the linear and quadratic components 
are equal [16]. 
 
 
The LQ model describes cell killing, both for tumour and healthy tissues by providing 
a satisfactory and practically useful explanation of fractionation and dose-rate effects 
observed at the macroscopic level [18]. Therefore, the LQ model can be used in particular for 
estimating the effect of delivered radiation doses on cells (i.e equipoise between healthy 
tissue complications and the probabilities of tumour cure) [18]. The LQ model suggests two 
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parameters for representing the sensitivity of cell death by radiations. One of the parameter 
(α) is proportional to the dose, while the other parameter (β) is proportional to the square of 
the dose [16]. Equation (1-2) described the model. 
 
 
S = e-𝛂D – 𝛃D2          ……… (1-2) 
 
 
S is the cell surviving fraction at dose D (for example the dose at 8 Gy as in Figure (1-9)) 
where α and β are constants. α represent the linear portion of the cell survival curve and β 
represent the quadratic component of the curve [16]. The linear part of the survival curve (α) 
demonstrates the probability of an interaction between the two chromosome breaks which is 
relative to the dose. At low doses, linear part of the survival curve, the two chromosome 
breakages results from the single electron been generated from the absorption of radiation 
interaction [16]. While at high doses, quadratic part of survival curve (β), the breakages of 
both of the two chromosomes results from two different electrons (Figure 1-10). The 
probability of this interaction is proportional to the square of the radiation dose [16]. Two 
chromosome breaks may cause the asymmetric exchange type aberration that results the 
cell’s loss of reproductive ability. The linear and quadratic contributions to cell killing that 
are proportional to the dose and square of the dose respectively are equal at a dose that is 
equal to the ratio of α to β as illustrated in equation (1-3) [16]: 
 
 
𝛼𝐷 =  𝛽𝐷2   →    𝐷 =
𝛼
𝛽
          ……… (1-3) 
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Figure 1-10: Relation between chromosome aberrations and cell survival curve. At low doses, the two 
chromosomes breaks are the consequence of a single electron set in motion by the absorption of X-ray or 
γ-ray. The probability of an interaction between the beaks is proportional to dose; this is the linear 
portion of the survival curve. At higher doses, its showing the two chromosomes breaks as a result of two 
separate electrons. The probability of this interaction is proportional to the square of the dose. The 
survival curve bends if the quadratic component dominates [16].      
 
 
The presence of nanoparticles in the biological target leads the researchers to innovate 
and use various models for quantifying the radiosensitisation induced by NPs; such specific 
theoretical and experimental models adopted for in vitro studies are shown in Figure (1-11). 
Only one of the most used models was employed in this thesis. 
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Figure 1-11: Graphical representation of quantifying the radiosensitisation effect induced by NPs from 
cell survival curves employing different models, A) Dose Enhancement Factor (DEF), B) Sensitizer 
Enhancement Ratio (SER), C) Radiosensitivity Enhancement Factor (REF), and D) Radiation 
Enhancement Ratio (RER) [19]. 
 
 
One of these models is termed the Dose Enhancement Factor (DEF) which is 
employed to quantify the difference between cell survival curves (Figure 1-11 A), and is 
defined as the ratio of the dose delivered in the control cell culture (i.e. without NPs), divided 
by the dose delivered in cells treated with NPs at % survival as illustrated in equation (1-4) 
[19].  
 
𝐷𝐸𝐹𝑥% =  
𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙
𝐷𝑁𝑃𝑠
     (For x% survival)          ……… (1-4) 
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This model is the most commonly used as it correlates well with clinical outcomes because 
the selected percentage region of the cell survival curve is nearly at dose of 2 Gy which is 
considered to be the best characterised region employed for data analysis with this model 
since 2 Gy represent the typical individual dose of conventional radiotherapy fractionation 
delivery [19]. Therefore, this model was adopted in this study for quantification the 
radiosensitivity induced by TiO2 NPs for in vitro studies, which is described in details in 
chapter six of this thesis.       
Alternative models are also employed to describe the cell survival curve. The model 
termed as Sensitizer Enhancement Ratio (SER) has quantified the radiobiological impact of 
NPs by calculating the ratio of the Mean Inactivation Dose (MID) of control cells to treated 
cells with NPs [19], as in equation (1-5) (Figure 1-11 B). 
 
 
𝑆𝐸𝑅𝑁𝑃 =  
𝑀𝐼𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙
𝑀𝐼𝐷𝑁𝑃𝑠
   ………... (1-5) 
 
 
Further model used for quantifying the radiobiological effect of NPs depends on the 
straight portion of the high dose region of the survival curve (. This model is termed as 
Radiosensitivity Enhancement Factor (REF) which is the ratio of the slope (D0,NPs) of the 
survival curve with NPs to the slope of control (D0,control) [19], as described in equation (1-6) 
(Figure 1-11 C).  
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𝑅𝐸𝐹 =
𝐷0,𝑐𝑜𝑛𝑡𝑟𝑜𝑙
𝐷0,𝑁𝑃𝑠
          ……… (1-6) 
 
 
This model applies at any point near exponential part of the survival curve when the dose 
reduces the cell survival to 37% of its value. The REF calculations are better suited at high 
dose levels and with the multiple target models providing a better description of the 
experimental data compared to the linear-quadratic model [19].  
The other model used to characterise the radiobiological effect of NPs is termed 
Radiation Enhancement Ratio (RER) (Figure 1-11 D), and is defined as the ratio of survival 
fraction without and with NPs at a given radiation dose as shown in equation (1-7) [19]. 
   
 
𝑅𝐸𝑅𝑥𝐺𝑦 =
𝑆𝐹𝑥𝐺𝑦,𝑐𝑜𝑛𝑡𝑟𝑜𝑙
𝑆𝐹𝑥𝐺𝑦,𝑁𝑃𝑠
          ……… (1-7) 
 
 
This model is limited to cell survival studies as it requires an accurate determination of the 
absorbed dose in the presence of NPs and assumes no change in the radiation quality; 
however, it has the advantage of directly describe the variation amount of the biological 
response caused by the NPs at a specific radiation dose. 
The damage caused by the ionising radiations to the biological materials is highly 
dependent on the number of radiation interactions and the dose deposited. Therefore, the 
presence of high concentration of nanostructure material in the tumour cells will enhance the 
probability of physical and biochemical effects due to further free radicals or reactive oxygen 
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species (ROS) production by the interactions previously reported (Section 1.2.2) and these 
effects are schematically described in Figure (1-12). These generated ROS and/or secondary 
electrons will then result in more chromosome breakages causing a significant damage to the 
DNA molecules in the cells and hence leading to cell death.  
 
 
 
 
Figure 1-12: Schematic diagram showing interaction of X-ray with TiO2 NPs result in the production of 
secondary electrons and ROS through physical and biochemical effects.  
 
 
Low atomic number nanoparticles are targeted in to the biological target for this 
study. A brief introduction of such nanoparticles “TiO2 NPs” is given in the next section. 
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1.4  Introduction to titanium dioxide nanoparticles (TiO2 NPs) 
 
Nanostructures and nanoparticles have now become common words in research and in 
daily life [20]. Invention of nanoscale materials had a huge impact in various applications 
including medicine. These nanoparticles have attracted considerable attention of scientists 
because of its wide potential applications especially biomedical applications which therefore 
resulted in an exponential growth of literature and publications in nanomedicine fields [21]. 
The possibility of effective diagnoses of diseases and their treatments has been shown to have 
bright future with the use of nanoparticles, typically with cancer. Researchers indicates that 
using nanoscale materials have particular features over conventional drugs in the 
management of malignant diseases such as targeted drug towards tumours based on 
nanotechnology drug delivery techniques [22]. Today these nanostructures can be synthesised 
and modified with various chemical reagents that allow them to be conjugated with 
antibodies or drugs of interest and this have opened a wide range of potential applications in 
biotechnology, targeted drug delivery and more importantly diagnostic imaging and 
treatments. The following sections will describe the nanoscale characteristic and provide an 
explanation of synthesis and properties of nanostructure samples used in this study that are 
titanium dioxide nanoparticles (TiO2 NPs). 
 
1.4.1 Nanometer size materials properties    
 
In terms of diameter, coarse particles are between 2500 and 10000nm, while fine 
particle are sized between 100 and 2500 nanometre (nm) and ultrafine particles covers a 
range between 1 and 100 nm. Nanomaterial’s can be defined as microscopic structures that 
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consist of number of molecules or atoms in the range of 1-1000 nm diameters [23, 24]. 
Accordingly, ASTM (American Society for Testing and Materials) developed the standard 
definition for nanoparticles as ultrafine particle with lengths in two or three dimensions 
smaller than 0.1 micrometer (100nm) and greater than 0.001 micrometer (1nm) in diameter 
range [25]. Materials brought from bulk to nanometer size materials will exhibit significant 
changes in their atomic basic properties such as electrical conductivity, melting point, 
structure, magnetic and optical characteristics [26, 27]. Moreover, cells can retain 
nanoparticle to longer duration more than bulk particle because of their small size [28], which 
is one of the advantages of using nano-sized particles for this study. Another advantage of 
materials being in nanoscale is the quantum confinement effects (size dependent phenomena) 
where the electrons become more confined in the particle as the particles size decreases 
(below the Bohr radius of the semiconductor materials) and result in the edge of the valance 
and conduction bands split into quantized, discrete, electronic levels [29]. In addition, 
unlike bulk materials, the quantized energy level characteristic in nanoparticles means the 
spacing of the band gap and electronic levels increases with particle size decrease which is 
due to the electron-hole pairs are now much closer and the Coulomb interaction between 
these pairs can no longer be neglected giving an overall higher kinetic energy [26]. 
Furthermore, the surface-to-volume ratio is much higher in nanoparticles than bulk materials. 
For radiotherapy aspiration, as hundreds of atoms can be packed in each nanoparticle, 
delivering one nanoparticle to the target results in transporting hundreds of atoms and 
therefor the probability hike of radiation interaction [30]. Also Surface Plasmon Resonance 
(SPR), which is the resonant oscillation of conduction electrons at the mediator between a 
positive and negative permittivity material stimulated by incident light, is one of the dubbed 
nanoparticle characteristic where free electrons are restricted in what is called quantum 
boxes. It has collective oscillation frequency that is the fundamental principle of color-
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based bio-sensing technology for applications in the area of biology, and medical sciences 
[26]. Finally, nanoparticles have much greater surface area per unit mass compared to the 
bulk particles, this means more atoms at the surface compared to those inside; therefore, the 
chemical reactions occurs at the surface for nanoparticles are much more and reactive than 
larger particles for a given mass [27]. The surface atoms been active chemically are due to 
having fewer adjacent coordinate atoms and more dangling bonds [27, 31]. Nanoparticle 
properties can be controlled through the surface characteristic factors. Indeed, further 
electronic states in the band gap will be induced at any modification to the nanoparticles’ 
surface and hence changes the chemical and physical characteristic of the nanoparticles [31]. 
In the next section, an introduction including physical and chemical characterisation 
of titanium dioxide nanoparticles (TiO2 NPs) which have been selected for this research is 
described. 
 
1.4.2 Titanium dioxide nanoparticles (TiO2 NPs) 
 
Titanium (Ti), is assumed to be the ninth most abundant element in the earth's crust. 
The average concentration of Ti in the earth's crust is 4400 mg/kg [32]. The absence of Ti as 
in metallic state in nature can be attributed to its great affinity for oxygen and other elements. 
The most well known oxidation state of Ti is +4, also +3 and +2 states exist. The most widely 
metallic compounds utilized in industry are titanium (Ti), titanium dioxide (TiO2) and 
titanium chloride (TiCl4). TiO2 is known as titanium (IV) oxide, titanic acid anhydride, 
titania, titanic anhydrid, which is the naturally occurring oxide of Ti [32]. It is common that 
TiO2 NPs occurs in nature in three obvious crystallographic phases: anatase, rutile and 
brookite [33]. In this thesis, anatase titanium dioxide nanoparticles (TiO2 NPs) have been 
applied due to reasons stated in chapter two. These TiO2 NPs have numerous and diverse uses 
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ranging from common products, like sunscreens, to sophisticated devices, environmental and 
biomedical applications. The significance and variety of these employments have prodded a 
large amount of researcher interest among fabrication, characterization and fundamental 
understanding of TiO2 NPs nanoparticles since past decades [34]. The structural 
characteristics of different types of crystalline TiO2 NPs are shown in Figure (1-13). 
 
 
Figure 1-13: Unit cell, crystal structure, solid representation and crystallographic facets of anatase, rutile 
and brookite titanium dioxide nanoparticles (TiO2 NPs) [34]. 
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1.4.2.1 TiO2 NPs synthesis 
 
The Studies of titanium dioxide synthesis that uses diverse techniques has been briefly 
stated and reviewed since beginning of twentieth century [33]. In this thesis, hydrolysis of 
titanium chloride (TiCl4) in sulfuric acid solution was used for synthesising anatase TiO2 
nanocrystal. 
 
1.4.2.2 Chemical and Physical Properties of TiO2 NPs 
 
TiO2 NPs is a white powder characterised as scentless and non-flammable. It has a 
molecular weight of 79.87 g/mol, melting point of 1843 °C, boiling point of 2972 °C. The 
refractive index is 2.488, 2.583 and 2.609 for anatase, brookite and rutile respectively. 
Anatase relative density is 3.78 g/cm3 and rutile density is 4.23 g/cm3 at 25 °C. TiO2 NPs is 
poorly soluble in water. Anatase is chemically more reactive than rutile [32, 35 and 36]. For 
example, NPs (80/20; anatase/rutile, 3–5 nm; 100 μg/ml) generated 6 fold more reactive 
oxygen species (ROS) than rutile after UV irradiation [32]. Indeed, exposing anatase to UV 
light will generate ROS, and therfore has been suggested that anatase TiO2 NPs has greater 
toxic potential than rutile TiO2 NPs [36, 37]. Size, shape, characteristic, surface and inner 
structure are the main parameters affecting the physiochemical properties of particles. Rutile 
TiO2 NPs are considered chemically inert. As previously stated for particle in general; 
therefore, TiO2 NPs surface area become gradually larger as the particles become 
progressively smaller [38]. Surface modification, as coating, influences the activity of 
TiO2 NPs. For example, surface modification of TiO2 NPs by a grafting-to-polymer technique 
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result in cytotoxicity diminishes [39]. Further study confirmed the effect of TiO2 NPs surface 
coating on biological response [40]. 
In the following sections, a brief introduction in to phantom based studies including 
PRESAGE® dosimeter and its potential application in radiotherapy is presented which is used 
to quantify the results of in vitro studies in this thesis.  
 
1.5 Introduction to 3D phantom (PRESAGE®) dosimetry in radiotherapy  
 
The technological advances in delivery techniques of radiotherapy, such as 3D 
conformal radiotherapy, SRS and IMRT techniques, have been playing a major rule in 
conforming the radiation dose deliver to the target volume is with a maximum fatal dose. 
This development enhance the therapeutic ratio and provide better tumour targeting while 
minimizing radiation dose to the surrounding normal organs, hence diminishing radiation-
related complications [41, 42]. However, optimisation protocols for these complex treatment 
delivery techniques involve very steep dose gradients and are subsequently, to a great degree 
delicate to errors in treatment delivery. To reduce such errors, 3D dosimeters were produced 
as a relative system for improving dose monitoring and delivery [42]. The 3D dosimeters can 
be generally classified into two types’ gel-based dosimeter [43, 44] or non-gel-based 
dosimeters [45, 46]. In this thesis, the non-gel based dosimeter were applied which is 
PRESAGE® dosimeter. Exposing the 3D PRESAGE® dosimeters to a radiation doses will 
change its optical density and therefore, this change can be quantitatively recorded and 
represents the dosimeter delivered dose [42]. Furthermore, the uses of PRESAGE® dosimeter 
has been expanded to the validation of dose spatial distributions and enhance dose in 
nanoparticle-enhanced radiotherapy via the sensitivity modulated advanced radiation therapy 
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(SMART) dosimeter [45]. The PRESAGE® dosimeter, which is briefly explained in the 
following section, is a phantom that helps in measuring the absorbed dose distribution in a 
full 3D geometry. It is nearly tissue equivalent and can be moulded to any required shape or 
compose. 
 
1.5.1 The PRESAGE® dosimeter  
 
PRESAGE® is a solid radiochromatic dosimeter made of polyurethane matrix. The 
solid characteristic of PRESAGE® makes it suitable to be designed as 3D dosimetry that has a 
potential application in advanced radiation treatment techniques. It is optically clear 
formulated using three ingredients which are a transparent polyurethane plastic prepolymers 
mixture, leuco dye (leucomalachite green (LMG)) as a reporter component, halocarbons 
(chloroform, bromoform or iodoform) as a radical initiator and optionally, for minimising 
dosimeter damage from UV radiation, ultraviolet (UV) stabilisers can be added [47, 48]. 
Upon irradiation, radical initiator will generate free radicals because the radical initiators 
possess unstable/weak covalent bonds with low bond dissociation energies, therefore, such 
compounds are easily cleaved under specific conditions (heat or radiation) leading to the 
production of free radical species. These free radicals will oxidise the leuco dye leading to a 
change in optical density (i.e., colour) (Figure 1-14) hence it is called radiochromic 
dosimeter [47]. 
Prior and post irradiation, PRESAGE® dosimeter must be stored in a cold (-18 °C) and 
dark environment to avoid any accidental absorbance change due to exposure to visible or 
ultraviolet light. 
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Figure 1-14: Transformation between leucomalachite green dye and its oxidised product [47]. 
 
 
The deformable characteristic of PRESAGE® dosimeter by replacing the polyurethane 
plastic by a transparent polyurethane rubber made it suitable for deformable designs 
dosimeter applications [49]. However, the usage of polyurethanes precursors as a matrix for 
the PRESAGE® dosimeter preparation is manly depending on the logic that these component 
can be mixed and polymerized at room temperature rather than polyesters or epoxides which 
require high curing temperature (Above 100 oC) which this temperature is high enough to 
oxidise the leuco dye prior to irradiation rendering the dosimeter unusable [50, 51]. 
Polyurethanes are a class of materials known as reaction polymers such as epoxies and 
polyesters [52, 53]. The polyurethane precursors consist of two components, referred to as 
Parts A and B; Part A is an aliphatic diisocyanate and Part B is a polymer with hydroxyl 
functional groups (polyol) [54]. The isocyanate group is highly reactive towards nucleophilic 
functional groups (e.g., hydroxyl groups). This reaction is generally utilized for 
polyurethanes preparations that have a wide range of applications [54].  
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The polymerisation reaction consist of reacting one isocyanate group of the 
diisocyanate with the hydroxyl group of the polyol to form a urethane linkage (– NH-(C=O)-
O) [54, 55]. This reaction produces heat (exothermic) and the rate of curing depends on the 
presence of a suitable catalyst, concentration of reactive groups and the temperature [56]. The 
polyurethane catalysts used in this reaction is to enhance the polymerization extent and rate, 
thus improving the structural integrity of the resin. The most commercial polyurethane 
catalysts (metal compounds) utilized in the polymerisation reaction is tin-based compounds, 
such as dibutiltin dilaurate (DBTDL), which is considered the standard catalyst for the 
promotion of the reaction of an isocyanate with the active hydroxyl groups of a polyol [53, 
57-59]. The typical polymerisation reaction is illustrated in Figure (1-15). 
 
 
 
Figure 1-15: Typical chemical reaction between diisocynates and polyols to form polyurethanes [54].  
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Radical initiators used in the composition of the PRESAGE® dosimeter are classified 
to: (i) organic peroxides, such as benzoyl peroxide; (ii) azo compounds; and (iii) halocarbons, 
such as chlorine (Cl), bromine (Br) or iodine (I) [60]. The organic peroxide and azo 
compounds are inherently sensitive to high temperatures and are unstable, while halocarbons 
have been shown to be suitable even with high-energy radiation [51]. Halogenated carbons 
(Halocarbons) are organic compounds containing covalently bonded carbon and halogens. 
Upon PRESAGE® dosimeter irradiation, the free radicals are generated from the homolysis 
of the bond between the carbon and the halogen. The number of free radicals produced is 
directly proportional to the C−X bond dissociation energy where X is either Cl, Br or I [61]. 
Leuco dyes are a class of chemicals that has featured forms, such as colourless [62]. 
There are different leuco dyes that are suitable for use as a reporter compound in the 
PRESAGE® dosimeter formulation, including LMG, orange aminofluoran, green 
diaminofluoran leuco and crystal violet lactone (LCV) [51]. Although LCV is the most 
sensitive to radiation dose and most stable post-exposure to radiation, LMG, which is used in 
this study, is the most desirable leuco dye as a reporter compound in the formulation of the 
PRESAGE® dosimeter. That is due to the typical visible maximum absorption wavelength 
(λmax) of its oxidised form (malachite green) is approximately 633 nm compared to 609 nm 
for LCV [50]. The 633 nm λmax corresponds to LED source or the helium-neon laser output 
(633 nm) of the commercially available optical scanning systems such as VistaTM (Modus 
Medical Devices Inc.) and OCTOPUSTM (MGS Research) [63]. Therefore, utilising LMG as 
a reporter compound allows the PRESAGE® dosimeter to be 3D scanned using these systems 
with optimum sensitivity.  
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1.5.2 Applications and limitations of the PRESAGE® dosimeter  
 
Dosimetry systems have been played a major role in the dose distribution verification. 
In typical clinical use of modern radiation therapy, the need for determination of three 
dimensional (3D) dose distributions with high resolution and accuracy has been arisen. The 
development of dosimeter systems over the past decade to achieve this challenge was the 
invention of a 3D radiochromatic dosimeter (PRESAGE® dosimeter) [64]. The unique 3D 
dosimeter (PRESAGE®) has a great potential value for use in clinical radiotherapy 
applications. The other specific applications of PRESAGE® dosimeter include the 
measurement of electron dose distributions around in-homogeneous tissue within the target 
volume [65]. In synchrontron microbeams, the peak-to-valley dose ratio was calculated [66]. 
In addition, the PRESAGE® dosimeter has been tested with beta-emitting radionuclides (e.g., 
Yttrium-90) and with proton bean for proton therapy application [67- 69].  
The potential advantages and features of PRESAGE® dosimeter over the other 
dosimeters are; it has a transparent properties which is very important from an optical 
imaging prospective since light has to pass through fewer interfaces on its transit through the 
dosimeter, therefore minimising optical artifacts and simplifying any optical modeling 
required [40]. In addition, PRESAGE® dosimeter has efficient dose respond properties that 
could be employed for measuring surface doses such as electron beam and deeper doses 
distribution such as photon beams [65]. In contrast to gel dosimeter, the solid characteristic of 
PRESAGE® dosimeter negating the need for an external mold and can be fashioned in to any 
required shape which is also easily handleable.  Other advantage of such dosimeter is the lake 
of sensitivity to the atmosphere exposure doses such as oxygen. Furthermore, it has the 
ability for high accuracy optical CT scanning due to radiochromatic optical contrast as 
opposed to light scattering contrast [70, 63, 64, 71-76].  
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In the other hand, there have been some limitations for PRESAGE® dosimeter. 
Majority of investigations have focused on potential clinical radiation therapy applications of 
the PRESAGE® dosimeter while a very few studies have demonstrates the influence of 
modifying PRESAGE® components including polyurethane, leuco dye and radical initiators 
on the inclusive properties of the PRESAGE® dosimeter such as stability, radiological 
properties and sensitivity to radiation doses. It has earlier shown that PRESAGE® dosimeter 
is of high effective atomic number (Zeff) about 8.65 which was due to the high concentration 
of halocarbons radical initiator in the PRESAGE® composition since these halocarbons are of 
high Z number [77], therefore PRESAGE® dosimeter was considered to be non-water 
equivalent dosimeter for kilovoltage energy range (10-100 kV) where photoelectric effect is 
predominant interaction [78]. Furthermore, the effect of incorporating of high Z metal 
compounds on the characteristics of the PRESAGE® dosimeter formulation (e.g., sensitivity 
to radiation dose) has not been well studied. However, most dosimetric applications are 
performed with relatively low radiation doses (< 5 Gy), therefore such sensitivity 
characteristic is an important factor to be considered which dosimeter need to have an 
efficient and linear response to low radiation doses, whilst maintaining tissue equivalent 
radiological characteristics.    
In contrast to gel-based dosimeters, the PRESAGE® dosimeter has been almost 
invented since a decade [64]. Therefore, there have been no obvious investigations about the 
mechanism by which the dosimeter changes its optical properties (i.e colour) post irradiation. 
The only mechanism and potential chemical pathways adopted is that the radical initiator 
oxides the LMG dye post irradiation and then change the dosimeter colour. Indeed, such 
information is valuable for further optimisation of the PRESAGE® dosimeter formulation for 
potential clinical applications. 
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2. Literature review and aims 
 
This chapter present a review of the works investigated about radiation dose 
enhancement produced by high and low atomic number (Z) materials in general and anatase 
TiO2 NPs in particular. Furthermore, it explains how theoretically to calculate the radiation 
dose enhancement factor (DEF). Finally, the specific objectives of this study are stated.  
    
2.1 Nanotechnology in radiotherapy 
 
There have been various major advancements in the field of radiotherapy during last 
few decades rendering this treatment safer and more reliable [79]. Most of these 
developments have been based on advanced technology used to further confine the beam on 
the targets and for reducing radiation doses to the surrounding healthy tissues [80]. These 
improvements were brought by invention modern techniques performed by LINACs such as 
intensity-modulated radiotherapy (IMRT), stereotactic radiosurgery (SRS) and image guided 
radiotherapy (IGRT) which provide high precision conformal dose and accurate delivery of 
enhanced radiation dose to the tumours; furthermore, it helps to better localize the tumours 
using ancillary imaging equipment’s. However, these technological improvements in 
radiotherapy needs to be combined with advanced understanding of tumour’s radiobiology 
properties to have best impact on the treatments [81, 82]. Hence, improving the treatment 
efficiency of radiotherapy requires serious efforts to complement the technological 
advancement which radiosensitising agents are one of the strategies that have been utilized 
for treatment efficiency improvement [82]. The most important improvements approached for 
radiation therapy comprise developing the radioresistance of health tissue, enhancing 
radiosensitisation of tumour tissue and reversing the radiation resistance of tumour tissue. 
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Tumours radiosensitivity has been modified by radiosensitising agents such as using 
nanoparticles that have played a key role in the enhancement of the radiation therapy by 
acting both as a therapeutic and as a carrier for other therapeutic. These agents are able to be 
selectively targeted to cancer cells and hence have a potential to enhance the effects of 
radiation on the tumours with the objective of delivering efficient radiation doses that can 
eradicate the cancer cells without exceeding normal tissue tolerance [83]. Currently such 
agents are used in the form of chemical agents in some special radiotherapy techniques 
termed “adjuvant” radiotherapy such as Fluorouracil (5-FU). Previously, enhancement of 
radiosensitivity of tumours by the effectiveness of oxygen as an agent was evaluated. Various 
examinations have shown that, tissue oxygen content show enhanced radiosensitisation 
compared to hypoxic cells and this is because of interaction of ionising radiation with oxygen 
atoms will result in reactive oxygen specious (ROS) generation which are of highly damaging 
abilities to the DNA molecules hence leading to cell death [84, 85]. Furthermore, 
chemotherapy drugs such as cisplatin and carboplatin have been investigated as a potential 
radiosensitiser, these observations have slight dose enhancement that therefore have been 
deemed as unsuitable strategy for future clinical application [86].  
 
2.2 Dose enhancement by high atomic number materials 
 
Early investigations of radiation dose enhancement were based on loading the target 
with high atomic number (Z) materials, which were reported in many publications since the 
middle of last century [87, 88]. Later, many other researchers have studied the interaction of 
X-ray with high Z materials and have observed an enhancing in dose due to the extra 
photoelectron production [89, 90]. Investigations were attributed the reason of dose 
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enhancement in the target to the increase in the number of photoelectrons produced due to the 
presence of high Z materials which deposit their energy in the target, whereas other studies 
reported that scattered electrons increases the dose in the vicinity of the high Z materials [90, 
91]. Researcher have shown that the increase in the number of photoelectron and/or scattered 
electron generated will affect the biological system, looking more closely at, when monolayer 
cells are irradiated with low energy X-ray adjacent to high Z materials, the number of killed 
cells were increased [92, 93]. 
The idea of utilizing high Z materials for radiosensitisation of tumours is due to the 
increase in the cross-section of radiation interaction and therefore produces more free radicals 
that enhance the dose due to extra photoelectron production [94, 95]. Since this hake in the 
interaction cross section is mainly due to the increase in the probability of interaction via 
photoelectric effect ‘P.E.’, therefore such effect are only significant at low energy X-rays 
where the probability of ‘P.E.’ is high. Over the last few decades, such strategies were 
explored and iodinated contrast agents were used as dose enhancing agents [96]. In phantoms 
and vitro studies, the potential applicability of iodine radiosensitiser as high Z materials for 
radiation dose enhancement has been observed [97, 98]. This exploration has continued with 
investigation of various high Z materials such as gold and bismuth compound nanoparticles. 
These nanoparticles have created adorable result for improving the outcome in cancer 
treatment in vitro [82, 99 and 100]. 
 
2.2.1 Dose enhancement by gold nanoparticles 
 
Gold nanoparticles unique physicochemical properties have placed it as one of the 
most efficient and well-studied agents for radiation dose enhancement [82]. Regulla et al 
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(1998) first described the radiation dose enhancement by gold by measuring dose 
enhancement effect on cells using gold sheet. Cells were grown on a gold sheet and were 
irradiated with low energy X-ray ranging from 40-120 KeV, the results showed an excellent 
dose enhancement in more than measurement [101]. Herold et al (2000) used gold 
microsphere (1.5 to 3.0 μm). The NPs were injected directly in the tumours to measure the 
radiosensitization [102]. Different types of cancer cells were used in this study and a 
reduction in plating efficiency was noticed which means increasing in the numbers of death 
cells [82]. Hainfeld et al (2006), for the first time, successes in identifying gold nanoparticles 
(AuNPs) as enhancing contrast agents in radiotherapy for in vivo computed tomography (CT) 
imaging [103]. The distinctive high absorption coefficient of Au (5.16 cm2.g-1) compared to 
Iodine (1.94 cm2 g-1) at KeV, and the significantly higher Z number (Au=79, I=53) lead to a 
three times greater contrast per unit weight for gold that Iodine [103]. AuNPs was first time 
applied on mice bearing subcutaneous EMT-6 mammary carcinoma for dose enhancement. 
AuNPs of 1.9 nm in diameter were delivered to the tumours and 250 KeV X-ray was used for 
irradiation. Result showed tumours eradication and mice survive for longer time [104]. 
Various researches, studied the feasibilities of AuNPs for radiotherapeutical application, have 
been published as a consequence of Hainfeld group first study success. The AuNPs were 
found to be non-toxic to the rat and were cleared rapidly from the body through Kidney 
[104]. The safety and toxicity of AuNPs still concern the researchers that need more 
investigation which they argue that delivering high doses of AuNPs may be linked to toxicity 
[105]. The solid property enables it to easily be functionalized with biocompatible coating. 
Many investigations have pointed out that the modulation of polymer coating and 
biocompatible surface decreases the toxicity of AuNPs [106, 107 and 108].  
The capability of AuNPs for dose enhancement has been noticed in vitro experiments 
[109-113]. Interm of size, AuNPs of 50 nm diameter could achieve the maximum dose 
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enhancement in comparission to larger and smaller diameter NPs as it has been reported by 
Chithrani (2010) [113]. 
Theoretical simulation and measurement of the interactions between AuNPs with 
various types of surface treatment techniques and beam energies have been investigated by 
Monte Carlo simulation software [114-119]. Low energy X-ray and gamma rays are found to 
be more efficient for radiation dose enhancement than high energy X-ray by using this 
computational simulation. Whereas, the obvious differences in the dose enhancement factors 
(DEFs) measured by many various investigation can be attributed to the type of code used 
and some imposed limitations such as the disability to measure the microscopic dose 
enhancement around the AuNPs that prevent absolute and accurate calculation of the DEFs 
[120]. Cho (2005), used BEAMnrc/DOSXYZnrc code to estimate DEF for several phantom 
test using gamma rays, kilovoltage and megavoltage photon beam with various concentration 
levels of AuNPs in the target [121]. Dose enhancement by gamma rays and low energy X-ray 
were found to be greater than high energy ones by up to 31%. Another study, Cho et al 
(2009), observed significant increase in the fluency photoelectron with AuNPs during gamma 
ray or low energy X-ray irradiation [122]. AuNPs dose enhancement by kilovoltage photon 
energy have attributed to the increase in photoelectron absorption due to the high Z materials. 
Clinically where megavoltage energies are predominant, such dose enhancement would not 
occur because Compton scatter is Z independent [15]. On the other hand, many researches 
have noticed an increase in cell death using AuNPs with clinically megavoltage energy beam 
[111, 120, 123 and 124]. In brief, clinical applications of AuNPs for radiation dose 
enhancement need a complete understanding of the effect of AuNPs size, concentration and 
polymer coating on this enhancement. This basic information is important for the logical 
development of AuNPs for clinical applications [82, 125]. Currently, several studies are 
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investigating new nanoparticle to alter the expensive AuNPs that would be efficient as well. 
Bismuth-based nanoparticles (BiNPs) are promising in that respect. 
 
2.2.2 Dose enhancement by bismuth compound nanoparticles 
 
Bismuth-based have been utilized for treating a number of medical conditions. The 
efficiency, costless and treating medical conditions efficacy has made it widely available in 
many countries worldwide. Clinically bismuth is used as antiulcer drugs [126]. Atmospheric 
oxygen can oxidise pure bismuth easily. It is found in the ores bismite (bismuth oxide) and 
bismuthinite (bismuth sulfide) [127]. In vivo computed tomography (CT), Bi2S3 have been 
shown an enhancement same as AuNPs [128-130]. PRESAGE® dosimeter doped with Bi2O3 
has caused a photoelectron and Auger electron emission of low energy that is considered to 
be responsible for the radiation dose enhancement [109, 131]. Bi2S3 NPs have shown to be a 
suitable contrast agent for radiologic imaging and recently proved to be radiosensitiser agent 
in vitro at kilovoltage range of X-ray energies. Therefore, BiS2 is considered as valuable 
theranostic agent at low energy in radiotherapy applications [132]. 
 
2.3 Dose enhancement by low atomic number materials 
 
In radiotherapy treatments, a very few number of investigations have been done for 
measurement of radiation dose enhancement resulting from low atomic number (Z) materials 
such as phosphorous (Z=15), calcium (Z=20), Titanium (Z=22) and others materials. For 
typical biological systems, the low Z number species present means that Compton scattering, 
which is inelastic scattering of the photon by a charged particle, is the predominant 
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interaction with ionising radiation across the entire energy range of the most interest to 
medical physics as illustrated in Figure (2-1) [133]. Since Compton scattering is dominant, 
the interaction of ionising radiations with these low Z-number materials will result in only a 
relatively small number of free radicals generation and hence low chance for significant 
damages to the DNA molecules in the cells and leads to cell death, which means negligible 
dos enhancement [133, 134].  
In recent years, investigation about improving the image quality and enhancing the 
radiation effect (radiosensitisation) at the target by using low Z number NPs has been of an 
increasingly interest by many researchers, especially about nano-sized materials which 
generate reactive oxygen specious (ROS). This attract can be attributed to the beneficial of 
ROS generation in biomedical science [135]. However, most of the searches are in simulation 
field using Monte Carlo simulations or using UV radiation and only a very few investigations 
have been done for measuring radiation dose enhancement at low range (kilovoltage) of X-
ray energies using low atomic number (Z) materials.  
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Figure 2-1: A plot showing the dominant process in determining the mass attenuation coefficient as a 
function of atomic number and X-ray energy. For low atomic number systems such as TiO2 NPs and at 
low-energy (kV) portion of this plot, the photoelectric effect is dominant, whereas Compton scattering 
dominates for the whole energy range of medical interest (i.e MV energy), whereas pair production 
dominates the high-energy portion [133]. 
 
 
2.3.1 Dose enhancement by anatase titanium dioxide nanoparticles (TiO2 NPs) 
 
Recently, researchers have shown interest in using TiO2 NPs for dose enhancement 
due to its ability in generating ROS [136, 137]. Most of the work done is in the range of using 
simulation, UV radiation and low energy (kV) X-ray beams. Jiang et al (2008) studied the 
ability of TiO2 NPs in generating ROS which was measured by using a fluorescent dye, 2’,7’-
dichlorofluorescein diacetate (DCFH-DA). Sodium hydroxide was used to cleave the acetate 
group from the reduced dye (DCFH). In the presence of hydrogen peroxide (H2O2) or 
oxidizing species generated by nanoparticles, DCFH was oxidatively modified into a highly 
fluorescent derivative, dichlorofluorescein (DCF), which was detected using a 
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spectrofluorometer (absorbance/emission maxima, 485 nm/535 nm). Also they established 
TiO2 NPS size dependent ROS activity using nine different sizes. Their observation 
demonstrates increase in the level of ROS with particle size and that highest ROS activity 
was observed for TiO2 NPs of 30nm and to be constant above 30 nm [134]. Chan et al (2011) 
investigated the interaction of two crystalline phases of TiO2 NPs with HaCaT cells. 
According to surface properties, they have shown that TiO2 NPs in anatase phase, in addition 
to having larger surface area and creation of free radicals; allow spontaneous ROS 
generation, which has a high impact in damaging DNA molecules, while rutile TiO2 NPs did 
not after dispersion [136, 137]. However, both anatase and rutile TiO2 NPs generate ROS 
when interact with cellular components but anatase phase showed to interact more effectively  
with cells as it’s found to be collected in the nuclei whereas rutile phase TiO2 NPs are found 
as small cluster or as single particle in the cytoplasm [136]. Jun-Jie et al (2012) determined 
the phototoxicity in human skin keratinocytes using TiO2NPs with different crystal phase and 
molecular sizes under UVA irradiation. They showed that the smaller particle size the higher 
cell damage and rutile phase showed less phototoxicity than anatase TiO2 NPs [136]. Helen et 
al (2012) succeeded in optimizing treatment in vivo of deeper tumour using X-rays instead of 
UV light that is limited by the penetration depth. Titania nanoparticles were doped with 
gadolinium to optimize the localized energy absorption from a conventional medical X-ray 
unit. They showed that TiO2 NPs irradiated by kilovoltage X-rays can result in ROS 
generation leading to DNA damage and then cell death. They also demonstrated that rare 
earth doped Titania nanoparticles injected in intratumoural can enhance the efficiency of 
radiotherapy in vivo where the tumour volume was reduced by around half in its original 
value by exposing it to 3 Gy of 200kV X-ray irradiator [139]. Mirjolet et al (2013) showed 
the ability of titanium nanotubes (TiONts) to penetrate human glioblastoma [one of the 
highly resistive tumours] cells in vitro and stay in the cytosol for over 10 days with no 
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cytotoxicity [140]. Babaie et al (2014) reviewed the characteristic of TiO2 NPs as radio 
sensitizers. TiO2 NPs and amino silanized oxidized silicon NPs provide oxidative stress by 
embedding in mitochondrial membranes, since TiO2 NPs has a lot of water, oxygen and 
hydroxides in its structure, it will generate ROS that act as a radio sensitizer. Also TiO2 NPs 
interact with radiation, free radicals such as OH•, H• and HO• (which are well known radio 
sensitizers) are generated [137]. Increasing the level of oxygen atoms in TiO2 NPs such as Ti-
peroxide have also been tested to be effective radiosensitiser as have been investigated by 
Nakayama, M., et al (2016)  [141]. However, this has only been tested with low energy X-
rays which have very limited uses in radiotherapy. Most of the investigation where in the 
range of applying UV-radiation, gamma radiation and/or low energy X-ray beams. 
Accordingly, anatase TiO2 NPs in the range of about 30 nm have been selected for this thesis 
which is extending the potential applicability of TiO2 NPs in radiotherapy to include wider 
ranges of energies by including the most commonly used beam in radiotherapy (i.e 
megavoltage beam) which has not been investigated to date and is one of the objectives of 
this study as indicated in section (2.6).  
 
2.4 Analysis of radiation attenuation and absorption in the presence of low Z materials 
 
The interaction of X-ray with atoms in any target result in the incident photons lose 
all or some of their energy where in photoelectric interaction, all of the X-rays energy is 
converted into kinetic energy for the ejected electron while in Compton scattering, part of the 
incident X-ray eject Compton electron and the rest will scatter as scattered photon. In soft 
tissue the most dominant X-ray interaction at kilovoltage energy range is Compton scatter, 
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while in the presence of TiO2 NPs in the target, the most dominant interaction is the 
photoelectric effects [72]. This clearly can be observed from the attenuation and absorption 
data obtained from Hubbell physical data [72], which the value for mass attenuation 
coefficient (μ/ρ) and mass energy absorption coefficient (μen/ρ) for Ti is noted to be 
higher than the value for water as shown in Figure (2-2). For example, at 40 keV photon 
energy, the μ/ρ for Ti and water are 2.21 cm2/g and 0.268 cm2/g respectively. At the same 
energy, the value of μen/ρ for Ti and water are 1.9 cm2/g and 0.0695 cm2/g respectively. 
These values indicate that more energy will be deposited and hence an increase in the 
generated photoelectrons will result from the presence of TiO2 NPs compared to the tissue 
alone. 
 
Figure 2-2: Mass attenuation coefficient (µ/ρ) and mass energy attenuation coefficient for Ti and water as 
function of energy.  
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2.5 Theoretical calculation of radiation dose enhancement by nanoparticles 
 
Radiation dose enhancement can be indicated by dose enhancement factor (DEF) 
which is defined as the ratio of absorbed dose in the target doped with nanoparticles over the 
absorbed dose in the target without nanoparticles as illustrated in equation (2-1). 
 
DEF =  
Dose deposited in target with TiO2 NPs
Dose deposited in target without TiO2 NPs
           ………. (2-1) 
 
 Roeske et al (2007) developed a method for calculating DEF for various high Z 
materials by analyzing the mass energy absorption coefficient (μen/ρ) [142]. They derived a 
mathematical formula for determining DEF values for poly energetic beams using the 
following equation (2-2): 
                                                                                                                                                                             
                                                                                                    ………… (2-2) 
 
 
μen/ ρ= the mass energy absorption coefficient 
E= energy ranging from background 0 to maximum 
Ψ= energy fluency 
Ψ´= differential photon energy fluency 
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NP= nanoparticles 
KNP= mass composition of the nanoparticles 
 
The above equation does not take into consideration the backscatter radiation created at the 
interface of high and low Z materials; it underestimates the dose enhancement by a factor of 
about 2 [142]. 
In addition, DEF values could also be evaluated by analysing the μen/ρ values for 
mono-energetic beam, which have been reported for gadolinium and iodine elements [143, 
144]. The ratio of the μen/ρ values of nanoparticles to water is the DEF value as shown in 
equation (2-3). 
 
 
                                                                                                                        ………….. (2-3) 
 
 
 
 
NP = nanoparticles  
μen/ρ = mass energy absorption coefficient  
wNP = fraction by weight of NP in the mixture  
E = energy of the monochromatic beam 
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Indeed, materials with high Z value enhance the radiation dose more effectively than 
materials with lower Z value as shown in Figure (2-3) [142].  
 
 
Figure 2-3: DEF values against various Z numbers for 140 kV energy [142] 
 
 
The DEF distribution curve shown in Figure (2-3) is only showing the effects of 
physical parameter, such as generated secondary electrons, for enhancing the radiation dose. 
Whereas recently it has been hypothesised that for in vitro and in vivo studies there are a very 
important factor, biochemical effects such as ROS, that have a high impact in enhancing the 
radiation dose and it is not considered in this DEF distribution curve. 
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2.6 Thesis objectives 
 
Recently, researchers interest have attracted to investigate the nanoparticles enhanced 
radiation dose at the target for radiotherapy that holds potentially very promising value in the 
treatment of cancer with minimal effects on normal tissues. This new technique aims to 
increase the differential radiation dose delivered to the target compared to the dose received 
by the surrounding healthy tissues. The main objective of this thesis is to investigate and 
pioneer the dual applications of anatase TiO2 NPs on cancer therapy as radiation sensitiser 
and imaging (potential theranostic agent). Therefore, it’s important to deeply study the 
characteristic of such nanoparticles and assessment in terms of in vitro and phantom based 
studies must be conducted to justify the anatase TiO2 NPs promising benefits for cancer 
treatments that outweigh any risks before consider them for clinical trials. This thesis mainly 
assesses the potential theranostic application of anatase TiO2 NPs in medical radiations. The 
studies are conducted using both PRESAGE dosimeter and cell in culture to quantify the 
produced dose enhancement factor (DEF) by anatase TiO2 NPs for low (kilovoltage) and high 
(megavoltage) radiotherapy X-rays energies. The most specific aims of this study are listed 
below: 
 
1. To Synthesis anatase crystal phase of TiO2 NPs and modify them using coupling 
agents such as PolyEthylene Glycol Trimethoxysilane (PEGTS) which makes the NPs 
hydrophobic and then dispersible in halocarbons (PRESAGE® chemical composition) for 
phantoms based studies and also with AmenoPropyl Trimethoxysilane (APTS) in order to 
make the NPs hydrophilic and then capable to be dispersed in cells-culture medium for in 
vitro studies. The physical and chemical characteristic of the synthesized TiO2 NPs were 
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studied by employing characterization techniques such as Transmition electron microscopy 
(TEM), X-ray photoelectrons spectroscopy (XPS), X-ray diffraction (XRD), 
Thermogravimetric analysis or thermal gravimetric analysis (TGA) and Fourier transform 
infrared spectroscopy (FTIR).  
 
2. Fabricate water equivalent PRESAGE® dosimeters to be employed for phantom based 
studies and study their characteristic such as physical and radiological properties. 
Furthermore, explore the radiation dose enhancement induced by anatase PEGS 
functionalised TiO2 NPs at kilovoltage and megavoltage radiotherapy X-ray beams using 
PRESAGE® dosimeters. 
 
3. For the first time, to measure the 2D dose distribution prior and after the 
inhomogeneous section in PRESAGE® dosimeter using CLARIOstar microplate reader 
(UV/VIS spectrophotometer) and then simulate the tissue inhomogeneity behavior.   
 
4. To study the inclusion of TiO2 NPs inside the cells and observe their distribution with 
in the cells. Two different techniques were employed to confirm the internalisation of TiO2 
NPs into the cells these includes flow cytometry to assess cell population with different 
concentration of TiO2 NPs relative to control and light microscopy through cell staining 
techniques. 
 
5. To assess the cytotoxicity of amine functionalised anatase TiO2 NPs to cells in regards 
to different concentration of TiO2 NPs and incubation time. Cell viability is the end point of 
the toxicity. 
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6. Feasibility of employing TiO2 NPs as radiosensitisation agents for in vitro studies 
using two different cells lines, and then the dependence of the radiosensitisation on the 
radiation energies including low (kilovoltage) and high (megavoltage) radiotherapy X-rays 
energies and on the TiO2 NPs concentrations to be established by two methods: Colorimetric 
(MTS) and Clonogenic assays. Also, to validate the biological studies by comparing it with 
phantom based studies.  
 
7. To predict the optimal kilovoltage energy range for maximum dose enhancement 
factor (DEF) which is determined in both in vitro and phantom based studies.  
 
8. To evaluate the radiobiological effect of amino functionalised anatase TiO2 NPs on 
different cell lines. Linear quadratic (LQ) model were used to analyse the experimental data 
which the plotted cell survival curves were fitted with linear quadratic model function and the 
linear (α) and the quadratic (β) parameters were extracted employing this model which these 
parameter then describe the DNA damage by radiation. 
 
9. To detect the reactive oxygen species (ROS) and specially hydroxyl radicals (•OH) 
generated from irradiated anatase TiO2 NPs for low and high X-ray energies. 
 
10. The study will be extended using proton beam, hence possibility of making TiO2 NPs 
as theranostic agents (enhancement treatment and imaging). 
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3. Methodology: Materials, Methods and Procedures  
 
 This chapter presents the materials, instrumentation and experimental methodologies 
used in this thesis. It is divided in to three parts and each of these parts is subdivided into 
several sections. The first part explains the process of synthesising the TiO2 NPs in anatase 
crystalline form and TiO2 NPs surface modification and characterisation. The second part 
provide details of the chemical components used in PRESAGE® dosimeters fabrication, 
handling, fabrication process, the methods of preparing and dispersing the TiO2 NPs in 
polymeric matrices, explaining the procedure of the PRESAGE® dosimeter irradiation with 
kilovoltage and megavoltage X-ray beams and last section of this part presents the techniques 
used for optical density measurements such as UV/VIS spectrophotometric, confocal 
microscope, optical CT scanner and CLARIOstar microplate reader. Finally, this chapter 
displays cell culture protocols, the TiO2 NPs association with cells, cytotoxicity 
measurements, irradiation procedure using different X-ray modalities, at the end of the third 
part, the method of obtaining cell survival curve and ROS detection is presented.  
 
3.1 SECTION A: Synthesis of nanoparticles for PRESAGE® dosimeter and in vitro 
studies  
3.1.1 Synthesis anatase crystalline phase of TiO2 NPs 
 
Anatase crystalline phase TiO2 NPs were synthesised according to a previously 
published procedure [145].The main material is titanium chloride (TiCl4) in the synthesising 
procedure. The process details are schematically shown in Figure (3-1). 
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Figure 3-1: Schematic diagram of preparation nanocrystal anatase TiO2 NPs. 
 
Briefly, sulfuric acid (15 mL, 10% H2SO4) was added to Milli Q explain (150 mL) 
and cooled to 0 °C in an ice-water bath. TiCl4 (10 mL) was slowly (2 mL at a time) added to 
the solution with vigorous stirring.  HCl, white fume, was emitted during the stirring process 
as a consequence of the TiCl4-water hydrolysis, and after 30 minutes, the mixture was heated 
to 85 oC for 1 h where the grey solution becomes clear colour solution. The pH was adjusted 
TiCl4 10% H2SO4 
TiOSO4 solution 
Ice-water bath 
NH3.H2O 
Precipitation 
Calcination at 400 0C & 600 0C Washing 
TiO2 anatase nanocrystal 
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to 7 via the drop wise addition of concentrated ammonia (30% NH3.H2O). The mixture colour 
was vitually seen changed to white as the concentrated NH3.H2O was added. The solution 
was cooled to room temperature and allowed to stand for 12 h. The resulting TiO2 NPs were 
washed with Milli Q (2 × 15 mL) and isolated via centrifugation (5000 rcf, 5 min), followed 
by drying in vacuum (80 °C,  15 Hg) in an oven. The dried TiO2 NPs were calcinated at 400 
oC and 600 °C for 2 h. The 400 0C produce off-white powders of mixture anatase and rutile 
TiO2 NPs after characterisation while the 600 
0C produce a bright white powder of pure 
anatase TiO2 NPs. The pure anatase was selected for this study. 
The chemical reaction processes passes through the following reactions.  
 
TiCl4 + H2O + H2SO4               TiO - SO4 + 4HCl    ………….. (1) 
  
The addition of concentrated NH3.H2O made the solution to become a white sediment, which 
can be described as reaction (2). 
 
 TiO - SO4 + 2NH3:H2O               H2TiO3   + (NH4)2SO4    ………... (2) 
 
Post filteration, washing and heating,  the composition of H2TiO3 are TiO2 and water as in 
reaction (3). 
 
H2TiO3                     TiO2 + H2O   ……………… (3)   
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3.1.2 Surface modification of TiO2 NPs 
 
All the experiments of TiO2 NPs surface modification were conducted at the 
chemistry department, Mawson institute, University of South Australia. Two types of TiO2 
NPs were prepared with different surface modifications. Aminopropyl trimethoxysilane 
(APTS) modified NPs (i.e., amine functionalised TiO2 NPs) were prepared in order to make 
the NPs hydrophilic [146-148], and then capable for aqueous dispersion and cell studies. Poly 
(ethylene glycol) trimethoxysilane (PEGTS) modified NPs (i.e., PEG functionalised TiO2 
NPs) were prepared which makes the NPs hydrophobic [149, 150], and then dispersible in 
halocarbons for incorporation into PRESAGE® formulations. 
 
3.1.2.1 AminoPropyl Trimethoxysilane (APTS) functionalised TiO2 NPs 
 
The reaction process is explained in the chemical reaction scheme, Figure (3-2). Bare 
TiO2 NPs (200 mg) were suspended in toluene (10 mL) with sonication in a flask complete 
with stirrer bar, then APTS (200 µL) and butylamine (50 µL) were added. The flask was 
directly sealed and the mixture was heated at 50 °C for 2 h with constant stirring. After 
cooling to room temperature, the NPs were isolated via centrifugation (2000 rcf, 30 s) and 
then resuspended in isopropanol (40 mL) containing concentrated hydrochloric acid (HCl) 
(0.2 mL). The NPs were isolated via centrifugation (2500 rcf, 180 s) and then resuspended in 
isopropanol (10 mL). This last washing step was repeated once more to remove the HCl 
effect, and the amine functionalised TiO2 NPs were isolated after drying in air for 12 h [146-
148]. 
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Figure 3-2: The chemical reaction scheme of TiO2 NPs surface modification with Aminopropyl 
trimethoxysilane (APTS). 
 
 
3.1.2.2 PolyEthylene Glycol Trimethoxysilane (PEGTS) functionalised TiO2 NPs 
 
Bare TiO2 NPs (200 mg) were suspended in toluene (10 mL) with sonication in a flask 
complete with stirrer bar, then PEGTS (200 µL) and butylamine (50 µL) were added. The 
flask was directly sealed and the mixture was heated at 50 °C for 6 h with constant stirring. 
After cooling to room temperature, the NPs were isolated via centrifugation (2000 rcf, 30 s) 
and then resuspended in isopropanol (40 mL). The PEG functionalised TiO2 NPs were then 
isolated via centrifugation (2500 rcf, 180 s) and air-dried for 12 h [149, 150]. The chemical 
reaction scheme for TiO2 NPs surface modification with PEGTS is explained in Figure (3-3). 
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Figure 3-3: The chemical reaction schemes of TiO2 NPs surface modification with PolyEthylene Glycol 
Trimethoxysilane (PEGTS). 
 
 
The characteristics of the synthesised NPs are then determined before making them ready for 
radiological applications; 
 
3.1.3 Characterization of TiO2 NPs  
 
Various systems were used to determine the physical and chemical characteristics of 
the synthesised TiO2 NPs which includes determination of the NPs size distributions, 
chemical composition and surface modification characteristic. The methods of 
characterisation are stated in the following sections. 
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3.1.3.1 Transmition electron microscopy (TEM) 
 
Transmission electron microscopy (TEM) was performed on a Jeol 1010 TEM (100 
KeV) (Joel Inc., Peabody, MA, USA) equipped with Gatan Orius SC600 CCD-2014 camera 
at RMIT Microscopy and Microanalysis Facility (RMMF), Melbourne, Australia, and was 
used to determine NP size distributions. TiO2 NP samples were prepared by dispersion in 
ethanol (0.1 mg/mL) with sonication for 180 s, and then a drop of the suspension was 
deposited onto GYCu200 mesh copper holey carbon (25ct) TEM grids and/or GSCu200C-50 
strong carbon TEM grids. More than 100 individual NPs were measured to determine the 
average diameter. The TEM operates on the same principle as the light microscope; the only 
difference is it uses electrons instead of light. These electrons are then focused by 
electromagnetic lenses in to a thin and coherent beam. This beam strikes the surface of the 
specimen and part of it transmit depending on the thickness and electron transparency 
characteristic of the sample. The transmitted beam is focused through objective lens and 
collected by CCD camera to generate a projection image that helps to obtain the specimen 
surface tomography and composition information [151]. Figure (3-4) is a schematic diagram 
and digital image of TEM. 
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Figure 3-4: A) Schematic diagram of a TEM. Generally, TEM is divided into two mail parts: illumination 
and imaging system, image not in scale. B) Digital image of TEM. 
 
 
3.1.3.2 X-ray photoelectron spectroscopy (XPS) 
 
X-ray photoelectron Spectrometry (XPS) at RMIT Microscopy and Microanalysis 
Facility (RMMF) Melbourne, Australia was performed on a Thermo K-alpha X-ray (Thermo 
Fisher Scientific Inc., Waltham, MA, USA), and was used to analyse the chemical 
composition of the TiO2 NPs.  Carbon tape was stacked on 5 mm diameter silicon disks to 
prevent the conductivity effect of silicon, and then the TiO2 NPs were spread on top of 
carbon tape side of the prepared disks. The prepared samples were cleaned with air duster and 
then loaded in the XPS machine conducted in a vacuum condition around 4×10-8 mbar. The 
principle working idea of XPS is when X-ray bombards TiO2 NPs samples with sufficient 
energy, some electrons in a specific bounds states become excited enough to escape the 
atoms of TiO2 NPs and are collected by an electron analyser that counts number of ejected 
electron and measure their kinetic energy. These electrons will produce characteristic set of 
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XPS peaks that are related to specific material; therefore, the peaks in the energy spectrum of 
intensity versus characteristic binding energy produced by electron analyser correspond to a 
specific element [152]. Figure (3-5) displays the principle workings of XPS.   
 
 
Figure 3-5: The principle working of X-ray photoelectron Spectrometry (XPS). Image not in scale. 
 
 
3.1.3.3 X-ray diffraction (XRD) spectroscopy 
 
X-ray diffraction (XRD) spectroscopy was performed on a BRUKER Axs D8 
ADVANCE (BRUKER AXS Inc., Madison, WI, USA) at the Separation Science and Mass 
Spectrometry Facility, RMIT University, Melbourne, Australia, and was used to determine 
the crystalline phase of the TiO2 NPs. The working principle of XRD is when a beam of X-
ray strike a lattice of atoms in the sample at a specific angle, the beam will reflect at the same 
angle of incident. A detector is used to collect the diffracted beams from different planes of 
the lattice. The distance between the planes (d-spacing) of the atoms is measured using 
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Bragg’s law. The X-ray scan will generate a characteristic sets of d-spacing that provide a 
unique pattern which then are compared to the standard reference patterns of materials to 
allow the identification of the crystal phase and structure of the samples [153]. Figure (3-6) 
is a schematic diagram of XRD. 
 
 
Figure 3-6: Schematic diagram of X-ray diffraction spectroscopy. Image not in scale. 
 
 
3.1.3.4 Thermogravimetric analysis (TGA) 
 
Thermogravimetric analysis (TGA) was performed on a Perkin Elmer Hyphenated 
Pyris 1 instrument (Perkin Elmer Inc., Boston, Massachusetts, USA) at the Separation 
Science and Mass Spectrometry Facility, RMIT University, Melbourne, Australia, and was 
used to study the TiO2 NP surface coating characteristics. The TiO2 NPs were loaded in the 
instrument and heated over a temperature ranges from room temperature up to 850 °C at a 
heating rate of 10 °C/min in a nitrogen flow, and then the weight (wt%) loss was recorder. 
The basic principle of TGA is that the heat of the sample in a furnace gradually raises and the 
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weight is measured using analytical microgram balance located outside the furnace. As the 
temperature is rising with time, the sample will lose weight due to reduction, decomposition 
or evaporation. The TGA tracks and records the change in weight as either a function of 
temperature or time. The recorded data are then analysed by analysing the characteristic of 
decomposition patterns to obtain the material surface coating characteristics [154]. Figure (3-
7) is the schematic diagram and digital image of TGA. 
 
 
Figure 3-7: A) Schematic diagram of TGA, image not in scale. B) Digital image of TGA. 
 
 
3.1.3.5 Fourier transform infrared spectroscopy (FTIR) 
 
Fourier transform infrared (FTIR) spectroscopy was performed on a BRUKER 
TENSOR 27 (BRUKER AXS Inc., Madison, WI, USA), at the School of Chemistry, The 
University of Melbourne, Melbourne, Australia. The TiO2 NPs were grinded and impregnated 
in potassium bromide (KBr) as discs and was used to study the chemical composition of the 
NP coatings. The KBr have no influence on NPs characteristics due to been 
chemically/physically stable and does not contain band in the mid IR-spectrum. The FTIR 
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depend on the fact that most molecules absorb infrared light of the electromagnetic spectrum 
due to the bonds presents in the molecules structure. The principle of FTIR operation is that 
the infrared light hits the beam splitter, which in turns sends the light in two different 
directions of right angles as shown schematically in Figure (3-8). One of the beams goes to 
the fixed mirror then back to beam splitter while the other goes to sliding mirror. Contrary to 
the beam reflected by fixed mirror, the beam that back from the moving mirror will have 
variable total path length due to the motion of mirror. The two beams recombine when they 
get into the beam splitter creating a destructive and constructive interference due to the 
difference in path length. The sample absorbs the different wavelengths of the recombined 
beam spectrum when it passes through the sample. The detector then record the output 
spectrum as the variation in energy versus time and send it to a computer which analyse the 
spectrum using mathematical function known as Fourier transform that convers intensity-time 
spectrum to intensity-frequency spectrum. This last spectrum is used to identify certain 
functional groups in the sample [155]. 
 
 
Figure 3-8: Schematic diagram of Fourier transform infrared spectroscopy. Image not in scale. 
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The dose enhancement induced by anatase PEGS functionalised TiO2 NPs was 
investigated through phantom based study employing PRESAGE® dosimeter. Therefore, in 
the following section a detailed description of PRESAGE® dosimeter preparation and 
characterisation study using different techniques are stated.  
     
3.2 SECTION B: PRESAGE® dosimeter study: 
 
The following section starts stating the required chemicals for phantom preparation 
then followed by presenting the methodology of PRESAGE® dosimeter fabrication, 
irradiation, characterisation, handling and disposal.  
 
3.2.1 Chemicals used for PRESAGE® dosimeter fabrication  
 
3.2.1.1 Polyurethane resins     
 
Polyurethane plastic prepolymers used were Crystal Clear 200 and Crystal Clear 206 
(Smooth-On, Easton, PA, USA), which are supplied in two parts (Part A and Part B). Both 
Crystal Clear 200 and 206 have similar physical properties according to the manufacturer. 
They only differ in the curing time and the pot life (i.e the period of time before these 
polymers become unworkable). 
The exact chemical compositions of the commercially available prepolymer mixtures 
are often protected as trade secrets. However, many researchers reported that the typical 
elemental compositions of polyurethanes are C: 63.3%; H: 9.4%; N: 5.0%; O: 21.3% [63, 
64]. The specific gravity of polyurethane used in this study is 1.036 g/cm3 as determined by 
the manufacturer. 
Chapter Three: Methodology: Materials, Methods and Procedures 
 
 
70 
 
3.2.1.2 Radical initiators  
 
Halocarbons are the radical initiators used in this study. These chemicals have one or 
more carbon atoms covalently linked with one or more halogen atoms (e.g., bromine, 
chlorine or iodine). Two types of halocarbon radical initiators were used in this study which 
are chloroform and iodoform (Sigma Aldrich- St Louis, MO, USA). These radical initiators 
are used in the PRESAGE® dosimeter formulation since it has the ability to oxidise the 
Leucomalachite green (LMG) and then change the optical density (colour) of the PRESAGE® 
dosimeter.  
 
3.2.1.3 Leuco dyes  
 
The most desirable leuco dye as a reporter compound used in the formulation of the 
PRESAGE® dosimeter is Leucomalachite green (LMG) which is colourless (Sigma Aldrich-
St Louis, MO, USA). This is attributed to the fact that the maximum absorption wavelength 
(λmax) is at approximately 633 nm for its oxidized form (malachite green), which get along 
with the helium-neon laser output or LED source (633 nm) of commercially available optical 
CT scanning systems such as OCTOPUSTM (MGS Research) and VistaTM (Modus Medical 
Devices Inc.) [63]. At optimum sensitivity, these scanning systems can reconstruct a 3D 
dosimetry images for PRESAGE® dosimeter with the beneficial of colourless characteristic 
of the LMG as a reporter compound. Upon PRESAGE® dosimeter exposed to radiation, the 
optical density of the dosimeter will change as a result of LMG oxidisation, and hence it’s 
employed in the dosimeter formulations. 
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3.2.1.4 Catalysts  
 
In this thesis, Dibutyltin dilaurate (DBTDL) (Sigma Aldrich-St Louis, MO) was 
predominately used as catalyst compound. The main reasons for utilising DBTDL in the 
PRESAGE® dosimeter formulation is for improving the structural integrity of the polymers 
and accelerating the polymerisation process.  
 
3.2.2 Potential health risks  
 
Direct contact with polyurethane precursors can cause irritation to the skin, eyes and 
respiratory tract. They may cause allergic reactions to the lungs and skin. Furthermore, the 
direct contact with leuco dye (LMG) (Type used in this thesis) can cause damage to the eye, 
tissue and skin. Inhalation of LMG dust may also produce gastrointestinal tracts and severe 
irritation of respiratory. Moreover, both halocarbons used in this study are toxic and 
carcinogenic. Most halocarbons are considered volatile organic compounds (VOCs); 
therefore, inhalation of high concentrations of their vapour may cause incoordination, 
disorientation, dizziness, vomiting or nausea and ultimately leading to unconsciousness. In 
general, chronic exposure to some halocarbons is believed to cause liver and kidney damage. 
Most importantly, halocarbons are air and water pollutants and their release into the 
environment has substantial risks [156, 157]. Finally, TiO2 NPs synthesized for this work can 
carry considerable health risks depending on their characteristics such as composition, 
morphology and size [158, 159]. The potential human toxicity from combining NPs with the 
PRESAGE® dosimeters has yet to be investigated.  
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3.2.3 Chemicals Handling and disposal  
 
The chemicals used in this thesis are considered to be harmful and have serious 
hazardous to both humans and the environment due to their toxicity and potentially 
carcinogenic [156]. Therefore, storage and handling of such chemicals was strictly carried out 
according to the recommendations outlined in the Material Safety Data Sheet (MSDS) 
supplied by the manufactures. Lab coats, gloves, masks and safety glasses were worn 
throughout the fabrication procedure. In addition, to limit exposure to hazardous vapours, 
dusts or fumes, all fabrication methods were conducted in laboratory fumehood with dynamic 
means of ventilation. All the waste resulted from manufacturing PRESAGE® dosimeters such 
as the waste solution resulting from cleaning the chemicals containers and dosimeters that 
have been used or rejected due to damage during the fabrication process were disposed 
according to the guidelines of the relevant laboratory/University. Such samples were labelled 
indicating the potential toxic ingredients (e.g. halogenated waste) and then sent to a 
specialised waste disposal company (Envirochem) that treat waste according to its physical 
and chemical characteristics. 
 
3.2.4 Storage of the PRESAGE® dosimeters 
  
All the prepared PRESAGE® dosimeter samples were stored in a cold (ca. -18 °C) 
and dark environment prior and post irradiation to avoid any absorbance change (colour 
fading) and or accidental exposure to visible or external ultraviolet light.  
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3.2.5 PRESAGE® dosimeter fabrication procedure  
 
PRESAGE® dosimeters were fabricated according to previously described procedures 
[61, 63]. The PRESAGE® dosimeters were formulated using the following ingredients: 
polyurethane prepolymer (Crystal Clear 200 and/or 206, 48.9 wt% part A and 44 wt% part B; 
Smooth-On, Easton, PA, USA), 2 wt% leuco dye (leucomalachite green-LMG) as a reporter 
component, 0.1 wt% dibutyltin dilaurate (DBTDL) and 5 wt% chloroform (Sigma Aldrich-St 
Louis, MO) was used as a halocarbon radical initiator. Two parts (A and B) of polyurethane 
plastic polymers are mixed together to produce an optically clear polyurethane matrix of the 
PRESAGE® dosimeter which is capable to be scanned optically. The fabrication procedure 
consists of five steps, as follows: (i) One equivalent polyol (Part B) was thoroughly mixed 
with two equivalents of the diisocyanate (Part A) to form a prepolymer. (ii) The reporter 
compound (LMG) and chosen free radical initiator were thoroughly mixed with a specific 
equivalent of Part B with continued stirring. (iii) The solutions prepared in steps (i) and (ii) 
were combined together and thoroughly mixed [63]. The catalyst (DBTDL) was added to the 
prepared solution in step (iii) with continuous starring until all the mixed chemicals been 
uniformly distributed. The final prepared solution was then poured in to poly (methyl 
methacrylate) moulds depending on the required shape which were then placed in a chamber 
(pressure pot) under pressure (ca. 60 psi) for 48 hours for curing. This was done in order to 
eliminate the formation of air bubbles inside the dosimeters as a result of outgassing [61, 63 
and 160]. 
The PRESAGE® dosimeters have different colour depending on the radical initiators 
used like chloroform, iodoform or bromoform. Such optical appearance is attributed to the 
colour of the chemicals used in the composition of PRESAGE® dosimeter that has no effect 
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on the dosimeter optical properties changing colour with radiation [61, 160]. For example, 
chloroform and bromoform are colourless; however, if the trace impurities present in such 
compound such as bromine then they will provide colour. The dosimeters prepared with 
iodoform will have yellow colours due to the naturally yellow colour of iodoform. The same 
with LMG, sometimes, because of MG impurities it is slightly green. For the first time, PEG 
functionalised TiO2 NPs were homogenously dispersed in radical initiator compounds 
(chloroform or iodoform) with sonication to afford desired TiO2 NP concentrations required 
for the dose enhancement factor measurement with PRESAGE® dosimeters. 
 
3.2.6 TiO2 NPs Dispersion in polymeric matrix 
 
Dispersing nano-sized materials in liquids is intrinsically challenging due to the 
presence of unfavourable strong attractive inter-particle forces [161]. This high attractive 
force between nanoparticle atoms can form aggregates (formation of clusters). This basically 
minimise the particle surface area and surface activity which is a key aspect of nanoparticles. 
Furthermore, incompetent dispersion of nanoparticles in liquids may causes poly-disperse 
agglomerates with different morphologies and sizes on the micron scale, resulting in various 
interactions and electrical properties that impede potential exploitation of nano-scale 
phenomenon [162]. As a result, significant care was taken to ensure that the nanoparticles 
used were well dispersed within the PRESAGE® fluids. 
In this study, and for the first time, TiO2 NPs were embedded in to 3D radiochromatic 
dosimeters (PRESAGE® dosimeters). In general, the dynamic viscosity of polyurethane resin 
precursors is approximately 600 cps at 23 °C, which is much higher than that of water (0.928 
cps at 23 °C). Therefore, ensuring complete dispersion of TiO2 NPs in the PRESAGE 
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dosimeters was challenging and required to develop a reliable and efficient procedure. The 
most commonly used methods for homogenously disperse nanoparticles in liquids are by 
using vortex mixture and ultrasonication. In vortex mixture, a rotary motor is used to create a 
vortex inside liquids while ultrasonication utilised sound waves to break up agglomerated 
nanoparticles [163]. Ultrasonication system is shown to be more efficient than vortex mixing 
due to the power of ultrasounds and its ability to disperse nanoparticles in relatively large 
volumes compared to vortex mixing which is limited to standard test tube volume [162]. 
Sonication of TiO2 NPs was performed by using a Branson 2510 ultrasonicator (Branson 
Ultrasonics Corporation, Danbury, CT, USA), operating at a power of 100 W and frequency 
of 40 kHz. Desired amount of TiO2 NPs was added to a predetermined amount of 
polyurethane resin precursor (part B) in a beaker (made from polypropylene). The preference 
of chosen part B over part A for dispersing TiO2 NPs is because Part B has a lower dynamic 
viscosity than Part A (2.5 and 8 cps at 23 °C, respectively) and does not react with moisture 
from the atmosphere. Sonication for 30 min at room temperature was sufficient for the TiO2 
NPs concentrations (0.5, 1 and 4 mM) used in this study to homogenously disperse in part B 
as shown in Figure (3-9). 
 
Figure 3-9: Photograph of TiO2 NPs (A) before and (B) after dispersion in part B polyurethane precursor 
via ultrasonication for 30 min.  
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3.2.7 PRESAGE® dosimeter irradiation  
 
All the prepared PRESAGE® dosimeter were irradiated using external sources with 
energies ranging from kilovoltage to megavoltage beam. The kilovoltage X-rays energy was 
obtained from a superficial therapy machine, the megavoltage X-rays from a LINAC. All 
these treatment machines were located at the Alfred Health Radiation Oncology, Alfred 
Health and/or Australian Radiation Protection and Nuclear Safety Agency ARPANSA, 
Melbourne, Australia. 
 
3.2.7.1 PRESAGE® dosimeter irradiation with kilovoltage X-rays 
 
PRESAGE® dosimeters were irradiated using superficial X-ray therapy (SXRT) 
machine (Therapax 3 Series, Pantak Inc., Branford, CT, USA). A range of low energy X-ray 
beams were used for dosimeters irradiation which were (80, 100 and 150) kV at various 
radiation doses ranging from 0-25 Gy. At 80 kV energy, irradiations was delivered at a single 
fraction with a dose rate of 1.090 Gy/min using a 15 cm diameter collimator with filter 5 and 
2.2 mm Al HVL (applicator factor: 1.035). At 100 kV, irradiations was delivered at a single 
fraction irradiation with a dose rate of 1.149 Gy/min using a 15 cm diameter collimator with 
filter 5 and 4.9 mm Al HVL (applicator factor: 1.039). At 150 kV, irradiations was delivered 
at a single fraction irradiation with a dose rate of 1.112 Gy/min using a 15 cm diameter 
collimator with filter 5 and 1 mm copper HVL (applicator factor: 1.051). The source-surface 
distance (SSD) (i.e. distance from the X-ray source to the PRESAGE® dosimeter) was fixed 
to 25cm. The setup of irradiation with kilovoltage X-ray beam is shown in Figures (3-10). 
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Figure 3-10: The schematic setup picture of PRESAGE® dosimeter irradiation with kilovoltage X-ray 
beam. Illustrations not to scale. Digital image showing SXRT instrument. 
 
 
3.2.7.2 PRESAGE® dosimeter irradiation with megavoltage X-rays 
 
Megavoltage irradiation experiments were performed at 6 MV X-ray beam using 
medical linear accelerator (LINAC) (Clinic 21EX, Varian Associates Inc., Palo Alto, CA, 
U.S.A.). The PRESAGE® dosimeters were positioned centrally on the cross-plane axis of the 
X-ray beam to ensure all samples received a uniform radiation dose and placed on top of a 
solid water phantom (water equivalent plastic) to provide a full scatter environment with field 
size of 10 cm2. The collimator and gantry angle were set at 0 ° and at 100 cm SSD. Solid 
water phantom layer of 5 cm was placed on top of the samples so that the maximal and 
uniform dose was delivered to the dosimeters. A single fraction irradiation was delivered to 
the PRESAGE® dosimeters with constant dose rate of 600 MU/min and radiation doses 
ranging from 0-25 Gy. The process set up is shown in Figures (3-11).     
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Figure 3-11: The schematic setup picture of PRESAGE® dosimeter irradiation with Megavoltage X-ray 
beam. Illustrations not to scale. Digital image showing LINAC instrument. 
 
 
3.2.8 PRESAGE® dosimeters scanning procedure 
 
Three different techniques were employed for scanning the PRESAGE® dosimeters 
including UV/VIS spectrophotometer, optical CT scanner and CLARIOstar microplate reader 
as described in the following sections: 
 
3.2.8.1 UV/VIS spectrophotometer  
 
UV-VIS spectrophotometry was performed on a dual-beam Perkin Elmer Lambda 25 
UV-VIS spectrophotometer (Perkin Elmer, Waltham, MA, USA), and was used to measure 
changes in optical density (ΔOD) of the dosimeter cuvettes at an absorption maxima of λ = 
633 nm [63, 164]. 
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3.2.8.1.1 The principle of spectrophotometry  
 
The beam of light consists of a stream of photons. Chemical compounds absorb, 
reflect or transmit light over a certain range of wavelengths depending on their chemical 
structure. Spectrophotometry is widely used for quantitative analysis which is a measurement 
of an amount of absorbed or transmitted lights by chemical substance at a particular 
wavelength. Spectrophotometer is used for this purpose, which is an instrument that measures 
the fraction of the incident light transmitted through an object. UV-visible spectrophotometer 
can be classified into two types depending on the range of its wavelengths; Ultraviolet (UV) 
light, which uses lights over the range (185 - 400 nm), and visible light, which uses light over 
the range (400 - 700 nm) of electromagnetic radiation spectrum. Hence it’s called UV/Vis 
spectrophotometer. 
 
3.2.8.1.2 Components of spectrophotometer  
 
The basic structure of a UV-VIS spectrophotometer components are illustrated in 
Figure (3-12). It consists of a light source, a collimator (entrance slit), a monochromator 
(prism), a wavelength selector (slit), a cuvette for desired PRESAGE® dosimeters, a 
photoelectric detector, and a digital display or a meter. 
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Figure 3-12: Basic components of a spectrophotometer. Image not in scale. 
 
 
 
 
Detailed mechanism of spectrophotometer is described as; in general, the instrument 
consists of two devices; a spectrometer and a photometer. A spectrometer is a device that 
produces a desired range of light wavelengths. First an entrance slit that allows a straight 
beam of light to pass through to a prism that splits it into a spectrum. Then the slit transmits 
only the desired wavelengths, which for case of PRESAGE® dosimeters, the wavelength 
absorption maxima (λmax) is 633 nm. A photometer indicates the photoelectric detector that 
measures the intensity of transmitted light. After the desired range of wavelength of 
light passes through the dosimeter’s cuvette, the photo-detector measures and converts the 
radiant energy absorbed and then sends a measurable signal to a digital display. 
 
3.2.8.1.3 Optical absorption measurements  
 
The PRESAGE® dosimeters changes colour upon exposure to ionising radiation; 
therefore, the change in optical density (ΔOD) (absorbance change) at a particular 
wavelength is recorded. The optical absorption was acquired using a dual-beam Perkin Elmer 
Lambda 25 UV-VIS spectrophotometer (Perkin Elmer, Waltham, MA, USA). Initially, the 
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radiochromic response maxima (λmax) of the PRESAGE® dosimeters was determined by 
measuring the absorption spectrum over the visible wavelength region (400–750 nm) with 1 
nm intervals [160, 164], which is then set as optimal wavelength for OD acquisitions in any 
given radiochromic dosimeter. The OD peak was found at the red region of the spectrum with 
a λmax at 633 nm; therefore, the spectrophotometer absorption wavelength was assigned to 
633 nm for all measurements in this work. The OD values of each PRESAGE® dosimeter 
cuvettes were recorded pre- and post-irradiation. The change in the OD “ΔOD” was 
determined by subtracting the measured OD of the irradiated cuvette from the un-irradiated 
one [63, 160]. Both absorbance and OD terms were used interchangeably in the literature, 
however, the term OD is most commonly used in 3D dosimetric investigations. Therefore, in 
this thesis the latter term was used instead of the former. 
 
3.2.8.1.4 Post-response photostability  
 
The colour (recorded ΔOD) fading characteristic of the irradiated PRESAGE® 
dosimeters is assessed by measuring the absorption at different time intervals ranging from 1-240 
hours post-irradiation. The dosimeter cuvettes were stored in a cold (-18 °C) and dark 
environment in between measurements to avoid any accidental absorbance change due to 
exposure to visible light or ultraviolet. 
 
3.2.8.2 Optical CT scanning 
 
The design of an optical CT scanner is based on a combination of wide field LED 
light illumination (cone beam) source and a CCD camera [165] as illustrated in Figure (3-
13). The optical CT scanner reconstructs a 3D map of the optical densities of an object 
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suspended in the scanner’s field of view using a series of captured 2D optical projections. 
The system is designed to work with radiochromic 3D dosimeters such as PRESAGE® 
dosimeter that have an absorption peak at 633 nm. The dosimeter is submerged in an ethyl 
benzoate solution (Sigma-Aldrich Pty. Ltd., St Louis, Mo, USA) filled aquarium to provide 
index refraction matching between the colour of un-irradiated dosimeters and the solution. 
This helps the blank dosimeter images to show zero contrast and therefore any variations in 
image optical density are result from irradiation [166]. This scanner is capable to scan 
dosimeters up to 15 cm diameter and 12 cm long at a volumetric data acquisition with a total 
scan time of less than 10 mins, which is particularly advantageous from a clinical perspective 
[167, 168]. However, light scatter artefacts resulting from the wide area of detection is one of 
the drawbacks of this scanner [169]. Nevertheless, recent methods have been suggested to 
minimise such imaging artefacts [168, 170].  
 
 
 
Figure 3-13: Schematic of a typical cone beam optical CT scanner. Image not to scale 
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3.2.8.2.1 Operation of optical CT scanning  
 
VistaTM cone beam optical CT scanner (Modus Medical Devices Inc., London, ON, 
Canada) with a 633 nm LED light panel filtered by an optical band pass filter placed in front 
of the camera. This camera was used for acquiring 3D images for radiochromic (PRESAGE®) 
dosimeters (Figure 3-14). The scanner was left to warm up for at least 2 h prior to 
performing any scanning to ensure light source stability. A two-dimensional (2D) projection 
of ΔOD in the horizontal direction is acquired at each scan; therefore, as the dosimeter rotate 
over 360º, a set of 512 light intensity transmission projections (1024 × 768 pixels each) were 
acquired. This resulted in the production of 256 × 256 × 256 elements with a reconstructed 
voxel resolution of 0.86 × 0.86 × 0.86 mm. A frame rate and a shutter speed were set on 7.5 
fps and 133.2 ms respectively. A series of 2D optical image projections are captured through 
the region of interest while the dosimeter is being rotated and then these multiple slices are 
used to reconstruct the 3D image using Feldkamp-filter back projection [167].  
 
 
Figure 3-14: (A) Image of the VistaTM commercial optical CT scanner used in this thesis, (B) Interior 
section showing the LED lamp and rotating stage (C) The matching fluid tank. 
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3.2.8.2.2 Characterisation of the physical and radiobiological properties of PRESAGE® 
dosimeter by optical CT scanner 
 
Vista cone beam optical CT scanner was employed, first to analyse the radiation 
transport characteristics of the PRESAGE® dosimeters in order to determine their water 
equivalency characteristic. Then the absorption maxima and the dose response relationship 
were studied by this technique. 
 
3.2.8.3 CLARIOstar microplate reader  
 
For the first time the PRESAGE® dosimeters are scanned with a 2D scanner using 
CLARIOstar microplate reader. This technique was used to measure the depth dose curve and 
the beam profile of PRESAGE® dosimeters with high resolution in 2D; moreover, it was 
employed to investigate the dose distribution beyond the inhomogeneity with in the dosimeter 
[171]. Detailed description of scanning the PRESAGE® dosimeters with CLARIOstar 
microplate reader is stated in chapter 7 (section 7.3.3.1) of this thesis. 
    
3.2.9 Experimental uncertainties and statistical analysis 
 
It’s well-known that in any experimental work, there are limitations and statistical 
errors either during conducting the experiment or during measurements. In this work we tried 
to minimise the errors by repeating the experiments and performing the measurements each 
time under similar conditions as much as possible and with high precision, however, still 
there were some uncontrolled errors during PRESAGE® dosimeter preparation, irradiation 
and scanning procedures. In preparation, although the same chemicals and methods are used, 
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there was a variation in the weight percentage (wt %) of each chemical of approximately ± 
0.5% which results in different batches of dosimeters used for various experiments. In 
irradiation, since different modalities are used, therefore dose delivered varies for both X-ray 
linear accelerators and superficial X-ray therapy with uncertainty of about ± 5% [171] as 
measured by ionisation chamber. In scanning, for minimising errors factor and ensure that the 
ΔOD of the PRESAGE® dosimeter is only resulting from the irradiation, ΔOD values were 
acquired by subtracting the OD value of each irradiated sample from the un-irradiated sample 
(control/blank). The influence of significance of the statistical errors were reduced by 
increasing the number of measurements. All results presented for PRESAGE® dosimeter 
studies are the means of three independent experiments. Statistical analysis was performed 
using OriginPro 2016 SR1 v9.3.1.273 software. Two-way analysis of variance (ANOVA) 
was applied to determine significance, followed by a Tukey test for post-hoc comparisons 
when significance was indicated. Results were considered to be statistically significant at p 
values of ˂ 0.05 [172]. 
 
In the other hand, the radiosensitasation induced by anatase amino functionalised 
TiO2 NPs was investigated through in vitro study. Therefore, in the following sections a 
detailed description of the methods and techniques utilised for determining the 
radiosensitasation are stated as following. 
 
3.3 SECTION C: In vitro studies: 
 
This section presents in vitro study using two types of cell lines which includes the 
experimental methodology of cell culture protocols, the TiO2 NPs association with cells, cell 
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irradiation, toxicity and viability measurements and finally reactive oxygen specious (ROS) 
measurements.  
 
3.3.1 Cell culture protocol 
 
In this study, human keratinocyte (HaCaT) and prostate (DU145) cell lines were used. 
These cells were cultured in RPMI medium 1640 (1X) and MEM (Gibco by Life 
Technologies Pty. Ltd., Mulgrave, VIC, Australia) supplemented with 5 % and 10 % heat 
inactivated foetal bovine serum (FBS, In Vitro Technology Pty. Ltd., Noble Park, VIC, 
Australia), respectively, and 1 % penicillin streptomycin (Gibco by Life Technologies Pty. 
Ltd., Mulgrave, VIC, Australia). Cells were grown in 75 cm2 flasks (Sigma-Aldrich Pty. Ltd., 
St Louis, Mo, USA), and subcultured at approximately 80 % confluency using trypsin 
ethylenediaminetetraacetic (EDTA) (Sigma-Aldrich Pty. Ltd., St Louis, Mo, USA). The cells 
were incubated in a humidified atmosphere at 37 oC, 5% CO2. Cells in passages 4-12 were 
used in this research. Figure (3-15) shows a sample of cell culture flask.  
 
 
Figure 3-15: A sample of cell culture in 75 cm2 flask. 
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3.3.2 TiO2 NPs preparation for in vitro studies   
 
The synthesised anatase crystalline TiO2 NPs and functionalised with APTS were 
used for in vitro studies in this thesis. The spherical TiO2 NPs were obtained in a powder 
format. The mass of the TiO2 NPs powder was calculated, the dried NP power was dispersed 
in either RPMI medium 1640 (1X) or MEM (gibco by Life Technologies Pty. Ltd., Mulgrave, 
VIC, Australia) for human keratinocyte (HaCaT) and prostate (DU145) cells lines, 
respectively, to provide the desired concentrations in Mol/L. The resulting solutions were 
sterilised twice, firstly by filtering through a 0.22 μm polysulfonic membranes (Sartorius, 
Goettingen, Germany), and secondly by sonication for 30 min to make sure the TiO2 NPs 
were dispersed uniformly and all bacteria were removed or killed and then it will be ready for 
use in cell studies. The HaCaT and DU145 cells were seeded at densities depending on the 
type of plate and/or assay used. In general, cells were seeded in 6, 24 and 96 well culture 
plates with total of 3×105, 1.5×104 and 3×103 cells per well respectively and then incubated at 
37 °C and 5 % CO2. After 24 h incubation, the cells were exposed to amine functionalised 
TiO2 NP concentrations of 0.5, 1 and 4 mM for 24 hours. (The capital letter “M” is referred 
to molar or molarity, which is defined as the number of dissolved moles of solute per litre of 
solution (M=mol/L) and is the common method of expressing the concentration of a solute in 
a solution), Figure (3-16) shows a typical 24 well plates with and without TiO2 NPs.  
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Figure 3-16: The cell culture samples in 96-well plate with and without TiO2 NPs. 
 
 
3.3.3 TiO2 NPs inclusion in cells  
 
The observation of any uptake of TiO2 NPs by cells was assessed using the following 
two techniques. In first technique, cell population was assessed by taking advantage of the 
increased visible-light scattering caused by TiO2 NPs relative to untreated control; however, 
this technique is unable to determine the localisation of NPs if they are within the cells or 
bounded to the cell surface, this method is followed using flow cytometry. In second method, 
light microscopy was used to image the stained cells and observe for any foreign objects 
within the cells.  
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3.3.3.1 Flow cytometry observation 
 
The culture medium was removed and the cells were rinsed with PBS and harvested 
using 0.05 % trypsin-EDTA (1X) (Gibco by Life Technologies Pty. Ltd., Mulgrave, VIC, 
Australia). The solution was centrifuged at 300 gs for 5 min and the cells were resuspended 
in PBS (2 mL). The uptake of TiO2 NPs by HaCaT cells was determined by flow cytometry 
(FACS Canto II, BD Biosciences). 10,000 gated events were counted and forward and side-
scatter were recorded. Changes in side-scatter were assessed relative to an untreated control 
cell population. 
 
3.3.3.2 Light microscopy observation 
 
Cells were seeded in slide flasks (Nunc, Roskilde, Denmark) and incubated at 37 °C 
and 5 % CO2 overnight.  Subsequently, the plated cells were exposed to anatase amine 
functionalised TiO2 NPs at concentrations of 1 and 4 mM. After 24 h incubation, cells were 
washed three times with Milli-Q water, and then fixed in (1:7) oleic acid/ethanol solution for 
5 min and stained with a 0.5 % crystal violet in ethanol solution for 15 min. Light microscopy 
(Leitz DM-IC inverted microscope, Leica Microsystems, Wetzlar, Germany) at 40X 
magnification with spot pursuit camera was used to capture images of the stained cells and 
the Spot Advanced software version 4.6 (Diagnostic Instruments Inc., Sterling Heights, MI, 
USA) were utilised for microscopic analysis. 
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3.3.4 Cytotoxicity of TiO2 NPs  
 
The effect of anatase form of TiO2 NPs on the proliferation and cell viability was 
experimentally studied. The HaCaT and DU145 cells were seeded into 24-well plates at a 
density of 3×104 cells per well. Cells were then incubated for 24 h at 37 °C and 5 % CO2, and 
then treated with amine functionalised TiO2 NP solutions in culture media at concentrations 
ranging from 0-30 mM. A tetrazolium dye-based cell viability assay (CellTiter 96® AQueous 
One Solution Cell Proliferation, Promega Corp., Madison, WI, U.S.A.) was utilized to assess 
the cytotoxicity of TiO2 NPs [173]. Cytotoxicity was measured at 24, 48 and 72 h after TiO2 
NP addition. In this preliminary assay, cells were not exposed to any radiation. Measurements 
of cell viability were used to determine TiO2 NP cytocompatibility.  
 
3.3.5 Cell irradiation 
 
The cells irradiation methodology followed the design/set-up, energies and procedures 
previously detailed in the PRESAGE® dosimeter irradiation section of this chapter (Section 
3.2.7). The only differences were the target (i.e the target was replaced to cells in culture 
instead of PRESAGE dosimeter) and the exposed radiation doses which it were ranged from 
0-8 Gy. The irradiation processes set-up for kilovoltage and megavoltage are shown in 
Figures (3-17) and (3-18). 
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Figure 3-17: The schematic setup of cell irradiation with kilovoltage X-ray beam. Illustrations not to 
scale. Digital picture showing SXRT machine. 
 
 
 
Figure 3-18: The schematic setup of cell irradiation with megavoltage X-ray beam. Illustrations not to 
scale. Digital picture showing LINAC machine. Build up were placed on top on the plate to ensure 
maximum dose to the cells. Also, the cell medium was filled to reduce the air gap effects. 
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3.3.6 Cell survival assays 
 
Two methods were implemented for cell survival measurements: 
 
3.3.6.1 MTS survival assay  
       
                                                                                                                                                     
MTS assay were employed to obtain cell survival curves using a CellTiter 96® 
AQueous One Solution Cell Proliferation Assay, (Promega Corp., Madison, WI, USA). It 
contains (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium) and an electron coupling reagent (phenazine ethosulphate; PES). This compound 
will bio-reduce in to a coloured formazan product if interact with metabolically active cells.  
This coloured formazan product is soluble for use in tissue culture medium [174]. 
Metabolically active cells contain dehydrogenase enzymes that produce a cellular reducing 
agent, either NADPH or NADH (nicotinamide adenine dinucleotide phosphate) [174]. Figure 
(3-19) shows how cellular reducing agents convert the MTS tetrazolium compound to the 
formazan products.  
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Figure 3-19: The bioreduction process showing changes in MTS tetrazolium chemical structure into 
formazan products, A) Without MTS reagent, B) With MTS reagent after 45 min incubation in 37 0C and 
5% CO2.  
 
 
MTS is a pale yellow compound that will turn into a dark brown formazan product 
indicating the metabolic activity of the cells. The MTS assay is similar in principle to the 
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay which has 
previously been used [175]. The advantage of MTS assay over MTT assay is that MTS 
produces a soluble formazan product, whereas the MTT assay produces a crystalline 
precipitate that requires an additional step in the procedure of dissolving the crystal before 
absorbance is measured [174]. Figure (3-20) is the schematic diagram of MTS assay. 
Cells were seeded in 24 and/or 96-well plates at a density of 1.5×104 and 3×103 cells 
per well respectively and incubated at 37 °C, 5 % CO2 for 18 h. The culture media was 
removed, and the cells were treated with 0, 0.5, 1 and 4 mM of amine functionalised TiO2-
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NPs (200 µL in fresh media) for 24 h. The culture medium was changed and the cells were 
then irradiated with kV and MV energies according to the specifications previously stated 
(section 3.3.5). After irradiation, cells were incubated for 24 h, and the media was changed 
and then incubated for a further 48 h. Subsequently, the medium was removed and 300 μL of 
culture medium and 60 μL of CellTiter 96® AQueous One Solution Cell Proliferation Assay 
reagent were added. The assay is light sensitive and therefore, cell culture plates were 
wrapped with aluminium foil upon incubation. A CLARIOstar microplate reader (BMG 
LABTECH Inc, Ortenberg, Germany) was used for measuring the absorbance (optical 
density) of the solutions at a wavelength of 490 nm. The absorbance was recorded directly 
after adding the MTS (for background subtraction), and again after 40 min incubation period. 
Measurements are expressed as a percentage relative to the negative control cells as shown in 
equation (3-1). 
 
 
𝑆𝑢𝑟𝑣𝑖𝑣𝑖𝑛𝑔 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 =
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑖𝑟𝑟𝑎𝑑𝑖𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠−𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑
𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑜𝑓 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑐𝑒𝑙𝑙𝑠−𝑏𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑
× 100 %        … (3-1)                                                     
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Figure 3-20: MTS assay using CellTiter 96® AQueous One Solution Cell Proliferation Assayn for cell 
survival measurement. 
 
 
3.3.6.2 Clonogenic survival assay 
 
Clonogenic cell survival assay was established on 1950s to study the cells-radiation 
effects [176, 177]. This assay has played an essential role in radiobiology by generating 
much of the information on the effects of radiation on mammalian cells. The cell is said to 
be clonogenic if it has the ability to proliferate indefinitely, thereby retaining its 
reproductive ability to form a large colony that can be visualized, whereas, the cell that go 
through one or two mitoses in retaining its ability to synthesize DNA and proteins, and is 
unable to divide and produce continuous progeny is considered dead. The loss of this 
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ability as a function of radiation doses is described by the dose-survival curve [178]. The 
steps involved in the clonogenic assay are briefly outlined in Figure (3-21). 
 
 
Figure 3-21: Schematic representation of steps involved in setting up a clonogenic cell survival assay. 
 
 
In this thesis, cells are prepared in a culture medium suspension. The number of 
cells per milliliter in this suspension is counted using a Coulter counter or a 
hemocytometer. After counting, cells were seeded in 6-well plates for clonogenic survival 
assay at densities shown in Table (3-1). Cells were treated with amine functionalised TiO2 
NPs and irradiated in an identical procedure to that described in the MTS assay (section 
3.3.6.1), and then incubated at 37 °C, 5 % CO2 for 14 d. All the cells that make up the 
colony are the progeny of a single cell. For example, if 150 cells are seeded into 6 well 
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plates, the number of colonies formed may be anywhere from 0 to 150. It is rarely the case 
to ideally expect the number to be 150 due to several possible reasons, including errors in 
counting the number of cells initially plated, suboptimal growth medium, and the loss of 
cells by trypsinization and general handling. 
 
Table 3-1: HaCaT and DU145 cell seeding densities in 6-well plates for clonogenic 
survival assays at specified doses.  
Dose (Gy) Density of seeded cells in 6-well plates (cells/well) 
HaCaT DU145 
0 150 250 
1 250 500 
2 250 750 
3 500 1000 
4 500 1500 
5 750 2000 
6 750 2500 
8 1000 3000 
 
 
 The cells were then fixed with oleic acid, this is done by removing the culture 
medium from six well plates and add 0.5 ml of (1:7) oleic acid/ethanol solution onto each 
well of six plates for 5 min. The cells, after removing the fixing solution, were stained with 
0.5 % crystal violet in ethanol solution for 15 min. The plates were then gently washed with 
water; care must be taken in this step to prevent the colonies from loosening and washing 
off. The plates were then allowed to air-dry overnight. Next day, the colonies were digitally 
scanned using a Leica DMD 108 digital micro-imaging instrument (Leica Microsystems 
CMS GmbH manufacture, Mannheim, Germany), and counted manually in each well of six 
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plates to obtain the plating efficiency. The term plating efficiency indicates the percentage 
of cells seeded that finally grow and form a colony. A cluster of blue-staining cells is 
counted as a colony if it shapes at least 25–50 cells [179] (Figure 3-22). To make sure there 
are no variations introduced between experiments, it is very important to keep the smaller cut 
off constant. Average the number of colonies counted for the three experiments of each 
condition and then divide the counted mean by the number of cells plated, and this will give 
the plating efficiency (PE) [179, 180] as in equation (3-2).   
 
𝑃𝐸 =  
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 𝑐𝑜𝑢𝑛𝑡𝑒𝑑
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑠𝑒𝑒𝑑𝑒𝑑
 × 100                                … (3-2) 
 
The cells surviving fraction (SF) of a given treatment were then calculated after 
determination of PE. First, normalize all the plating efficiencies of the treated samples to that 
of the un-irradiated plates (control), considering that to be 100%. Then determine the SF by 
dividing the PE of the treated cells by the PE of the controls, and then multiplying by 100 as 
shown in equation (3-3). 
 
 
𝑆𝐹 =  
𝑃𝐸 𝑜𝑓 𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠
𝑃𝐸 𝑜𝑓 𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙𝑠 (𝐶𝑜𝑛𝑡𝑟𝑜𝑙)
 × 100                             … (3-3) 
 
 
Cell survival curve are then obtained by plotting SF against the delivered radiation doses. 
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Figure 3-22: Representative picture of colonies. 
 
 
3.3.7 Dose Enhancement Factor (DEF) measurements  
 
The radiosensitisation induced by anatase amine functionalised TiO2 NPs for in vitro 
studies were quantified through employing dose enhancement factor (DEF) on the obtained 
cell survival curves form both MTS and clonogenic assays explained in the previous section. 
Different X-ray energy beams ranging from kV to MV with various radiation doses were 
used to study the effect of amine functionalised TiO2 NPs on the dose enhancement. 
Furthermore, concentrations of TiO2 NPs ranging from 0.5 mM to 4 mM were used to 
investigate the NPs influence on the levels of radiosensitisation. It should be noted that the 
terms radiosensitisation and dose enhancement are used interchangeably however, it is more 
appropriate to use radiosensitisation with the cells studies as the particles affects the cells 
biology too. The DEF represents the ratio of the dose delivered in the control cell culture (i.e. 
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without TiO2 NPs) at 80 % survival, divided by the dose delivered in cells treated with TiO2 
NPs that produce 80 % survival as shown in Figure (3-23). Equation (3-4) is employed for 
determination of the DEF extrapolated at 80% survival from the cell survival curves obtained 
from MTS and clonogenic assays.  
 
 
𝐷𝐸𝐹80% =
𝐷𝑐𝑜𝑛𝑡𝑟𝑜𝑙
𝐷𝑇𝑖𝑂2 𝑁𝑃𝑠
           ……… (3-4) 
 
 
 
 
 
Figure 3-23: DEF extrapolated from cell survival curve at 80% survival. 
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3.3.8 In vitro detection of ROS 
 
This method comprises dissolving 2’,7’-Dichlorofluorescin diacetate (DCFDA) 
(Sigma-Aldrich Pty. Ltd., St Louis, Mo, USA) in dimethyl sulfoxide (DMSO) at a 
concentration of 100 µM, and stored at -20 °C in the dark. Immediately before use, the 
DCFDA solution was diluted 1:1000 in PBS (phosphate buffered saline). Black 96 well plates 
were used in this experiment, with total solution volumes of 200 µL per well (100 µL 
DCFDA solution). Various concentrations of amine functionalised TiO2-NPs (0.5, 1 and 4 
mM) were prepared in 100 µL PBS. The samples were irradiated with 6 MV X-ray beams 
from an ELECTA LINAC at doses of 15 or 40 Gy. The nonfluorescent DCFDA is converted 
to highly fluorescent product post-oxidisation in the presence of ROS. The total fluorescence 
of the samples was measured using a CLARIOstar microplate reader with excitation and 
emission wavelengths of 483 and 530 nm, respectively. All fluorescence measurements were 
performed in the dark and at room temperature. 
 
3.3.9 Statistical analysis 
 
All data represents the mean of three independent experiments. Results are reported as 
mean ± SEM. Statistical analysis was performed using OriginPro 2016 SR1 v9.3.1.273 
software. Two-way analysis of variance (ANOVA) was applied to determine significance, 
followed by a Tukey test for post-hoc comparisons when significance was indicated. Results 
were considered to be statistically significant at p values of less than 0.05 (* p < 0.05, ** p < 
0.01, *** p < 0.001). 
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4. SECTION A: Results and discussions of TiO2 NPs characterisation 
 
This chapter contains presentations and discussions of the experimental results 
obtained in synthesising and characterisation of TiO2 NPs using different characterisation 
techniques as stated in the following sections.  
 
4.1 Results 
 
Anatase crystal form of TiO2 NPs were synthesised by chemical reactions (Figure 4-
1). The anatase TiO2 NPs were modified to be soluble in water for in vitro study and/or in 
PRESAGE dosimeter for phantom’s study. The size, elemental compositions, chemical 
structure, purity and surface modification characteristic of the synthesised TiO2 NPs were 
studied by utilising techniques such as TEM, XPS, XRD, TGA and FTIR. The TiO2 NPs 
characterisation results are expressed in details in the following sections.  
 
 
 
 
 
 
 
 
Figure 4-1: Synthesised TiO2 NPs and calcinated at 400 oC and 600 oC. 
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4.1.1 TiO2 NPs characterisation 
The nanoparticles were characterized by the following techniques. 
 
4.1.1.1 Transmission Electron Microscopy (TEM) 
 
The synthesised TiO2 NPs were suspended into ethanol and the TEM image captured 
revealed NPs to be spherical/parallelepiped with a mean diameter of 30 ± 5 nm for more than 
100 particles measured by image j software (Figure 4-2). 
 
Figure 4-2: A) TEM image of the synthesised TiO2 NPs (scale bar = 50 nm) B) size distribution of TiO2 
NPs from TEM image. 
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4.1.1.2 Thermo K-alpha X-ray photoelectron spectroscopy (XPS) 
 
The elemental composition of the TiO2 NPs was determined via Thermo K-alpha X-
ray photoelectron spectroscopy (XPS), which revealed peaks with characteristic binding 
energies for titanium and oxygen (Figures (4-3) and (4-4)). The additional peak for carbon 
was used to calibrate the relative energies and all peaks are in agreement with previous 
studies [181] (Figure 4-3). 
 
 
 
Figure 4-3: X-ray Photoelectron spectroscopic (XPS) spectra of the synthesised TiO2 NPs. 
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Figure 4-4: A) Titanium, B) Oxygen peaks of XPS spectra of the synthesised TiO2 NPs. 
 
B 
A 
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4.1.1.3 X-ray diffraction (XRD) 
 
X-ray diffraction (XRD) patterns of the synthesised TiO2 NPs revealed a primary 
peak at 25.3 angle and numerous smaller peaks that confirmed the TiO2 anatase structure 
[182] with an 84.6 % crystal phase (Figure 4-5). 
 
 
Figure 4-5: X-ray diffraction (XRD) of synthesised TiO2 NPs.  
 
 
4.1.1.4 Thermogravimetric analysis (TGA) 
 
Perkin Elmer Hyphenated TGA was used to characterize the surface modification of 
synthesised TiO2 NPs. The samples experience only one main step-down loss of weight over 
temperature ranges of 270-550 °C through TGA test (Figure 4-6). In comparison to bare 
TiO2 NPs, TGA analysis of the amine- and PEG-functionalised TiO2 NPs revealed in total ~ 
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6-7 wt% loss over temperature ranges up to 850 °C, which is attributed to the decomposition 
of the organic coating. 
 
 
Figure 4-6: TGA curves recorded at a heating rate of 10 °C/min in a nitrogen flow for functionalised TiO2 
NPs.  
 
 
4.1.1.5 Fourier transforms infrared spectroscopy (FTIR) 
 
Fourier transform infrared spectroscopy (FTIR) studies were carried out in the 400–
4000 cm−1 frequency range (Figure 4-7). For the infrared absorption spectra, the samples 
were formed into pellets with KBr and the spectra were recorded on a BRUKER FTIR 
Spectrometer. IR spectroscopy in the transmission mode gives qualitative information about 
the way in which the adsorbed molecules are bonded to the surfaces as well as the structural 
information of solids. 
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Fourier transform infrared spectroscopy (FTIR) of the bare and functionalised TiO2-
NPs showed a typical TiO2 pattern ranging between 500 ~ 700 cm
-1
, which is attributed to Ti–
O–Ti vibrations in the TiO2 lattice [150, 183]. The absorption peak at 1639 cm-1 and the 
broad band at 3344 cm-1 in all samples are attributed to the surface hydroxyl groups (OH) 
present in the TiO2-NPs (Figure 4-7 (a, b, c)) [148, 183]. The band at 993 cm
-1 (Ti–O–Si) 
confirms the condensation reactions between the methoxy groups of APTS and the TiO2-NPs 
surface hydroxyl groups has occurred (Figure 4-7, (c)) [148, 150]. The peak at 1047 cm-1 is 
due to the (Si–O–Si) asymmetric vibrations indicating occurrence of condensation reaction 
with the silanol groups (Figure 4-7, (c)) [147]. The peaks at ~1130 cm-1 for the amine and 
PEG functionalised TiO2-NPs are consistent with C–N and C-O vibrations, respectively, 
which demonstrate successful grafting to the surface of the modified nanoparticles [150]. 
Peaks at 1384 cm-1 and 2931 cm-1 in all samples were attributed to the asymmetrical C–H 
vibrations [147, 148 and 183]. 
 
 
Figure 4-7: FTIR spectra for bare and surface functionalised TiO2 NPs.  
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4.2 Discussion  
 The synthesised TiO2 NPs for this study were characterised to be uniform nano-
crystalline structures with highly pure phase of titania anatase [145]. The XPS peaks at 458.9, 
464.6, and 530.1-533.4 eV are characteristic binding energies of Ti2p3/2, Ti2p1/2 and O1s, 
respectively, which are indicators of the titanium and oxygen signals in the TiO2 lattice 
(Figure 4-4). The TiO2 composition by weight is 59.93% for Ti and 40.06% for O2. The 
anatase crystal form of TiO2 is preferable as the anatase structure creates more free radicals, 
has a larger surface area to volume ratio and therefore generates ROS more effectively than 
other types of TiO2 NPs [184-188]. All these features in combination have a high impact on 
DNA damage to target cells during irradiation. However, the peak at 284.97 eV is attributed 
to the C1s binding energy resulting from the carbon holding TiO2 NPs. While the peak at 
401.12 eV is attributed to N1s binding energy of nitrogen gas used to flow through the 
system in order to eliminate and/or minimise the effects of oxygen or other environment 
gases in the measurements. Data from the TiO2 NPs calcined at 600 
o C indicated that the 
anatase phase was predominant and no impurity phases were observed as indicated in the 
XRD analysis (Figure 4-5).  
The surface modification reactions are referred to as a silanisation. The TiO2 NPs 
have hydroxyl groups on their surface at neutral pH. These hydroxy groups act as 
nucelophiles and attack the silane of the siloxy bonds (Si-OMe) resulting in the formation of 
a Ti-O-Si bond and elimination of ethanol (MeOH). The siloxy groups (SiOMe) can also be 
hydrolysed by water to form silanols (Si-OH) that can react with other SiOMe groups 
resulting in Si-O-SI bonds and a cross-linked siloxane coating. Subsequently, the bare TiO2-
NPs were functionalised through silanization with either 3-aminopropyl trimethoxysilane 
(APTS) or poly (ethylene glycol) propyl trimethoxysilane (PEGTS) to afford amino- and 
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PEG-functionalised NPs that could be easily dispersed in aqueous and organic solutions, 
respectively (Figure 4-8).  
 
 
Figure 4-8: Surface modification of TiO2-NPs via silanisation with APTS and PEGTS. 
 
 
TGA analysis of the functionalised TiO2 NPs showed that coatings were ~ 6-7 % of 
the total NP mass (Figure 4-6). This indicates that most of the observed dose enhancement or 
radiosensitisation results from X-ray interaction with the TiO2 NPs as stated in chapters five 
and six, as the bulk of the particle is mainly composed of Ti and oxygen atoms. The peaks at 
1047 and 1128 cm-1 observed in the FTIR spectra demonstrates that the APTS and PEGTS 
surface coatings were successfully grafted on the TiO2 NPs. 
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In conclusion, all these characteristics investigation of the NPs indicate that pure 
anatase TiO2 NPs were synthesised with the preferred size, average of 30 nm, for ROS 
generation. Furthermore, the TiO2 NPs were successfully modified to disperse in PRESAGE 
chemical composition and in water for phantom and in vitro studies respectively which these 
studies are described in details in the following two chapters. 
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5. SECTION B: Results and discussions of the phantom based studies using PRESAGE® 
dosimeters 
 
The aim of this chapter is to present and discuss the results obtained from phantom 
based study using PRESAGE® dosimeters. This part of the study involves mainly 
investigating and for the first time the feasibility of employing the synthesised anatase PEG 
functionalised TiO2 NPs in the prepared PRESAGE® dosimeter for determination of the 
radiation dose enhancement utilising low and high energy radiotherapy X-ray beams. These 
radiation dose enhancement results caused by the generated free electrons as a result of TiO2 
NPs exposed to X-ray radiotherapy type radiations.   
 
5.1 Results  
 
The physical properties of the prepared PRESAGE® dosimeters such as maximum 
absorption wavelength dependence and the radiation dose sensitivity were studied first. In 
addition, the analyses of the radiological characteristics of the PRESAGE® dosimeter were 
presented as the dose-response relationship, post response photo-stability and the water 
equivalency characteristic of the PRESAGE® dosimeters. Also, the uniformity distribution of 
the synthesised anatase PEG functionalised TiO2 NPs in the chemical compositions of 
PRESAGE® dosimeter were assessed. Furthermore, the experimental validation and 
quantification of the radiation dose enhancement induced by different concentrations of 
anatase PEG functionalised TiO2 NPs employing both kilovoltage (kV) and megavoltage 
(MV) X-ray beam were determined. Finally, the dose enhancement factor (DEF) was 
calculated as a ratio between the slope of the curve of the TiO2 NPs doped dosimeters optical 
density (OD) and the slope of the curve of the non-doped dosimeters OD (control).   
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5.1.1 PRESAGE® dosimeters  
 
Two different types of PRESAGE® dosimeters in regards to the used halogenated 
carbon radical initiators (chloroform, iodoform) were fabricated as in method stated 
previously in chapter 3 (section 3.2.5). The images of the prepared PRESAGE® dosimeters 
are shown in Figure (5-1). In the following sections a detailed description of the physical and 
radiological characteristic results of the prepared PRESAGE® dosimeters are presented.  
 
 
 
 
Figure 5-1: Images of the PRESAGE® dosimeters with different halogenated carbon radical initiators (A) 
Chloroform and (B) Iodoform. 
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5.1.2 Physical properties of PRESAGE® dosimeters  
 
In literature, the general characteristics of PRESAGE® dosimeter are well investigated 
and established [189].  In this thesis, some of the important physical properties for the both 
formulation types of PRESAGE® dosimeters are studied such as the mean physical density 
(ρ), electron density (ρe), effective atomic number (Zeff), and maximum absorption 
wavelength (λmax). The calculated physical properties for both types of PRESAGE® 
dosimeter are tabulated in Table 5-1. The Zeff was obtained employing Mayneord equation 
(equation 5-1) [104, 190]. It is observed that the obtained physical density and Zeff number 
differ for each type of the radical initiator used, where for PRESAGE® with iodoform were 
higher than PRESAGE® with chloroform. 
 
𝑍𝑒𝑓𝑓 = √∑ 𝑎𝑖𝑍𝑖
2.94𝑛
𝑖=1
2.94
                  ………. (5-1) 
 
Table 5-1: Mean physical density (ρ), electron density (ρe) and relevant effective atomic 
number (Zeff) of PRESAGE® dosimeters fabricated with different radical initiators in 
this study compared to water. 
 
Materials                                    ρ (Kg.m-3)               ρe (x1029 em-3)                      Zeff    
Water                                             1000                          3.3428                              7.42 
PRESAGE® (Chloroform)         1045-1047                    3.4348                              6.62 
PRESAGE® (Iodoform)             1089-1097                    3.5873                             14.37 
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The identification of the absorption maxima (λmax) was the other important parameter 
to be considered for scanning PRESAGE® dosimeter. The absorbance spectrum is the change 
in OD as a function of wavelength (λ) and is used to select the optimal λ for OD acquisitions 
in PRESAGE® dosimeter. The obtained absorption spectra of PRESAGE® dosimeter with 
both chloroform and iodoform radical initiators after exposed to 6 MV radiotherapy X-ray 
beam are shown in Figure (5-2). The absorption λmax is found at a peak of 633nm that is the 
visible red region of the energy spectrum.  
 
 
Figure 5-2: Absorption spectra of PRESAGE® dosimeters with both chloroform and iodoform radical 
initiator after exposure to 25 Gy of 6 MV radiotherapy X-ray beam, showing the absorption maxima to 
be at 633 nm. The reference cuvette (control) is used as a baseline to establish the zero value. 
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5.1.3 Radiological characteristic of PRESAGE® dosimeterss 
 
The results of radiological properties of PRESAGE® dosimeters such as dose-
response relationship with optical density, radiation sensitivity, post-response photostability 
and water equivalency characteristic will be presented in the following sections.   
 
5.1.3.1 Leucomalachite green (LMG) oxidation in PRESAGE® dosimeters 
 
The LMG in PRESAGE® dosimeter oxidise by forming a carbon centred radicals as a 
results of X-ray radiation induced homolysis of alkyl halocarbons, its hypothesised that the 
carbon centred radicals extract the methane proton from LMG resulting in a resonance 
stabilised radical cationic form of the dye as shown in Figure (5-3). These radicals’ possibly 
dimerisation with halide radicals that displace the halide anion or some other processes such 
as electron transfer leading to convert the cationic radicals to the cationic malachite green 
(MG) [190].  
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Figure 5-3: Proposed chemical scheme of leucomalachite green (LMG) oxidation via radicals to malachite 
green (MG). 
 
 
5.1.3.2 Dose-response relationship of PRESAGE® dosimeters 
 
The linearity characteristic of PRESAGE® dosimeter towards X-ray radiation doses 
was investigated in this study. The absorption spectra of PRESAGE® dosimeter with 
chloroform and/or iodoform halocarbons formulation are displayed in Figures (5-4) and (5-5) 
respectively. The absorption spectra acquired for both types of PRESAGE® dosimeters are 
the measured absorbance changes at λ = 633 nm versus radiotherapy X-ray radiation 
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absorbed doses. However, the intercepts of the dose–response relationship plots are nearly 
zero and good correlation coefficient linearity (R2 > 0.99) for the dose response is observed in 
both halocarbons dosimeter formulations over the applied radiation doses range.  
 
 
Figure 5-4: Recorded absorbance changes as a function of absorbed radiation dose for chloroform 
PRESAGE® dosimeter formulations at 6MV energy. Error: ± standard deviation in the measurement 
(n=3). Correlation coefficient parameters of fitted line are shown in the bottom right inset.  
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Figure 5-5: Recorded absorbance changes as a function of absorbed radiation dose for iodoform 
PRESAGE® dosimeter formulations at 6MV energy. Error: ± standard deviation in the measurement 
(n=3). Correlation coefficient parameters of fitted line are shown in the bottom right inset.  
 
 
5.1.3.3 Sensitivity of PRESAGE® dosimeters  
 
The sensitivity, which is other radiobiological property, of chloroform and/or 
iodoform–based PRESAGE® formulation towards radiation doses was studied. The 
sensitivity is expressed as the change in optical density (optical linear attenuation coefficient) 
per radiation doses (Gy-1.cm-1). The sensitivity enhancement factor (SEF) was defined as the 
ratio between the slope of iodoform–based PRESAGE® formulation and the slop of 
chloroform–based PRESAGE® formulation [191]. The change in optical density versus the 
absorbed radiation dose varied significantly between the two types of halocarbons used, and 
this is clearly visible to naked eye as shown in Figure (5-6). It is observed that the slope of 
the dose response curve for iodoform-based PRESAGE® formulation (slope = 0.06328 Gy-
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1.cm-1) showed significantly higher sensitivity than chloroform-based PRESAGE® 
formulation (slope = 0.00565 Gy-1.cm-1) resulting in the SEF to be 11.2 at the same applied 
radiation dose and halocarbons molar concentration.  
 
 
Figure 5-6: Recorded absorbance changes as a function of absorbed radiation dose for chloroform and 
iodoform PRESAGE® dosimeter formulations at 6MV energy. Error: ± standard deviation in the 
measurement (n=3). Correlation coefficient parameters of fitted line are shown in the top left. Insets: 
digital images showing chloroform and iodoform PRESAGE® dosimeter exposed to different doses with 6 
MV X-ray beams. 
 
 
5.1.3.4 Post-response photostability 
  
The post-response photostability of PRESAGE® dosimeters with different radical 
initiators was investigated. The results shown in Figure (5-7) clearly demonstrate that both 
types of halocarbons used in PRESAGE® dosimeter’s formulation had reasonable effect on 
the post-response photostability over a period of 10 days from the day samples been exposed 
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to X-ray radiation. On the other hand, the influence of PEG functionalised TiO2 NPs on the 
photofading of the PRESAGE® dosimeters was studied (Figure 5-7). The recorded ΔOD was 
also stable over the same period of time. It was observed that chloroform and iodoform 
PRESAGE® compositions without (control) and with inclusion of 1 mM TiO2 NPs showed 
photofading of the rates of~ 5.9 - 6.8 and 4.3 - 5.1% respectively, post 240 hour exposure to 4 
Gy dose of X-rays and when stored in a cold (-18 °C) and dark environment. Finally, it was 
found that the amount of delivered dose have no influence on the photofading of both 
PRESAGE® formulation investigated. 
 
 
Figure 5-7: Variation in optical density against time for different halocarbons based PRESAGE® 
formulations after exposed to 4 Gy dose at 80 kV X-ray energy beam. Each PRESAGE® composition is 
referred to the type of radical initiator used with and without inclusion of TiO2 NPs. Error bars: ± 
standard deviation in the measurement (n=3). The best fitting approach was achieved at Polynomial 
fitting of second order.    
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5.1.3.5 Percentage Depth Dose (PDD) measurement 
 
One of the essential characteristics of PRESAGE® dosimeter to meet application 
specific dosimetry requirements is the water equivalency in order to be applied in future 
clinical radiotherapy techniques; hence, this property was examined in this study. Figure (5-
8) represent the experimental percentage depth dose curve (PDD) acquired for PRESAGE® 
dosimeters using optical CT scanner and for water using ionisation chamber at 6 MV X-ray 
beam energies and under full scatter conditions as described in chapter 3 (section 3.2.7). 
Dose variation with depth was measured up to approximately 6 cm in the PRESAGE® 
dosimeter. The findings demonstrate that the shape of the PDD curves in the PRESAGE® 
dosimeters is matching to those obtained by ionisation chamber measurements with a 
variation of about 2%. 
 
 
Figure 5-8: Measured relative percentage depth dose (PDD) curves for PRESAGE® dosimeter and 
ionisation chamber at 6 MV energy beam. 
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5.1.4 Dose enhancement induced by TiO2 NPs 
 
In this study, X-ray radiotherapy energy beams ranging from kilovoltage (kV) to 
external megavoltage (MV) were employed to determine the dose enhancement induces by 
PEG functionalised TiO2 NPs in PRESAGE
® dosimeter.  
 
5.1.4.1 Low energy “kV” X-ray irradiation 
 
The first experimental validation and quantification of the radiation enhancement 
caused by PEG functionalised TiO2 NPs at kV energy X-rays of the type used in superficial 
X-ray therapy (SXRT) beams was determined by phantoms. PRESAGE® dosimeter, for the 
first time, was doped with PEG functionalised TiO2 NPs during the preparation procedures as 
previously stated in chapter 3 (section 3.2.6). The PRESAGE® dosimeter can be easily 
loaded with NPs and our group have previously used this approach [45, 192-193]. PEG 
functionalised TiO2 NPs concentrations of 0, 0.5 and 1 mM were used to investigate NP dose 
enhancement. It was not possible to go beyond 1 mM of NPs concentration, for example 4 
mM (the case employed for in vitro study (Chapter 6)), as this high concentrasion was 
shelding the incident light of spectrophotometer passing through the PRESAGE® dosimeter 
samples and resulting in artefacts. The samples were irradiated using SXRT machine with 
beam energies of 80, 100 and 150 kV and for radiation doses of 0-25 Gy. Figure (5-9) is a 
photograph of PRESAGE® dosimeter samples without and with 1 mM TiO2 NPs before and 
after exposed to various doses of 80 kV X-ray beams.     
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Figure 5-9: Photographs of the reference PRESAGE® dosimeter cuvettes without (control) and the same 
formulation with 1 mM PEG functionalised TiO2 NPs (a) before and (b) after exposure to 80 kV X-ray 
energy beam. 
 
Dose enhancement in PRESAGE® dosimeters doped with PEG functionalised TiO2 
NPs is obtained by measuring the change in optical density (ΔOD) using a UV-VIS 
spectrophotometer as previously stated in chapter 3 (section 3.2.8.1) compared to the case of 
without NPs. The dose enhancement factor (DEF) was determined as a ratio between the 
slope of the curve of the TiO2 NPs doped dosimeters OD and the slope of the curve of the 
undoped dosimeters OD (control) as in equation (5-2) [191, 194].  
 
𝐷𝐸𝐹 =  
𝑆𝑙𝑜𝑝𝑒  𝑐𝑢𝑟𝑣𝑒 𝑜𝑓 𝑑𝑜𝑠𝑖𝑚𝑒𝑡𝑒𝑟 𝑤𝑖𝑡ℎ 𝑃𝐸𝐺𝑠 𝑇𝑖𝑂2 𝑁𝑃𝑠 
   𝑆𝑙𝑜𝑝𝑒 𝑐𝑢𝑟𝑣𝑒 𝑜𝑓 𝑑𝑜𝑠𝑖𝑚𝑒𝑡𝑒𝑟 𝑤𝑖𝑡ℎ𝑜𝑢𝑡 𝑃𝐸𝐺𝑠 𝑇𝑖𝑂2 𝑁𝑃𝑠
       ……. (5-2) 
 
 
The ΔOD of the dosimeters versus the applied radiation dose at 80, 100 and 150 kV 
energy beams are shown in Figures (5-10) (5-11) and (5-12) respectively. An excellent 
linear correlation coefficient (R2 > 0.99) for the dose response was observed for both the 
control and NP doped dosimeters over the applied radiation doses range. However, a 
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noticeable enhance in the sensitivity of PRESAGE® dosimeters doped with PEG 
functionalised TiO2 NPs compared to control (without TiO2 NPs) was observed for samples 
irradiated with 80 kV compared to 100 and 150 kV X-ray energy beam. The sensitivity 
enhancement (dose enhancement) was inversely dependent on energy and the calculated DEF 
for different concentration of TiO2 NPs and at each kV energy are documented in Table (5-1) 
shown in the following section.  
 
 
 
Figure 5-10: Recorded optical density changes (ΔOD) as a function of absorbed radiation dose for the 
chloroform PRESAGE® formulation without and with different concentrations of PEG functionalised 
TiO2 NPs at 80 kV X-ray energy. Correlation coefficient parameters of each fitted line are shown in the 
inset of the graph. Error bars: ± standard deviation (n = 3). The optical density (OD) was measured using 
UV/Vis spectrophotometer. 
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Figure 5-11: Recorded ΔOD as a function of absorbed radiation dose for the chloroform PRESAGE® 
formulation without and with different concentrations of PEG functionalised TiO2 NPs showing the 
response to 100 kV X-ray energy. Correlation coefficient parameters of each fitted line are shown in the 
inset of the graph. Error bars: ± standard deviation (n = 3). The OD was measured using UV/Vis 
spectrophotometer. 
 
Figure 5-12: Recorded ΔOD as a function of absorbed radiation dose for the chloroform PRESAGE® 
formulation without and with different concentrations of PEG functionalised TiO2 NPs showing the 
response to 150 kV X-ray energy. Correlation coefficient parameters of each fitted line are shown in the 
inset of the graph. Error bars: ± standard deviation (n = 3). The OD was measured using UV/Vis 
spectrophotometer. 
Chapter Five: Results and Discussions of Phantom Based Studies Using PRESAGE® Dosimeter 
 
129 
 
 
5.1.4.2 High energy “MV” x-ray irradiation 
 
The methods described in the previous section (5.1.4.1), were repeated to measure the 
dose enhancement of PEG functionalised TiO2 NPs in PRESAGE
® dosimeter irradiated with 
6 MV beams (high energy beams). A slight dose enhancement (Table 5-1) was detected for 
0.5 and 1 mM NPs concentrations with the PRESAGE® dosimeter as shown in Figure (5-13).  
 
 
Figure 5-13: Recorded ΔOD as a function of absorbed radiation dose for the chloroform PRESAGE® 
formulation without and with different concentrations of PEG functionalised TiO2 NPs showing the 
response to 6 MV X-ray energy. Correlation coefficient parameters of each fitted line are shown in the 
inset of the graph. Error bars: ± standard deviation (n = 3). The OD was measured using UV/Vis 
spectrophotometer. 
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Dose enhancement factors at low (kV) and high (MV) X-ray energy beams and for 
each concentration of PEG functionalised TiO2 NPs are tabulated as shown in Table (5-2). 
The numbers represent a percentage increase, for example “1.40” means enhance of 40 %.  
 
Table 5-2: Calculated DEFs for different concentrations of PEG functionalised TiO2 
NPs in PRESAGE® dosimeter irradiated with low (kV) and high (MV) X-ray energy 
beams.  
PEG functionalised  
TiO2 NPs concentrations 
  
  
    80 kV 
                                 
             
     100 kV               
DEF
           
       150 kV 
 
          
   6 MV 
0.5 mM 1.12 1.061 1.065     1.04 
1 mM 1.40 1.20 1.13     1.03 
 
 
In brief, a large dose enhancement is obtained when PRESAGE® dosimeters are 
exposed to low energy X-rays while very small dose enhancements are observed when 
exposed to high energy X-rays (in megavoltage ranges). 
 
5.2 Discussion 
 
In this chapter, the discussion is divided in to two main sections. The first section will 
explain the reasons behind the main findings of physical and radiological properties of 
PRESAGE® dosimeters and the second section will contain explanation for the reasons 
behind dose enhancement induced by PEG functionalised TiO2 NPs.   
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5.2.1 Physical and radiological properties of PRESAGE® dosimeter 
 
The results of phantom studies confirms that the incorporation of the halogenated 
carbons (iodoform and chloroform), only one is used at a time, as a radical initiators in the 
composition of PRESAGE® dosimeter resulted in variations in the physical and radiological 
properties of the dosimeters. It is observed that the obtained physical properties such as 
physical density and Zeff of PRESAGE
® dosimeters with iodoform radical initiator were 
higher than those obtained when chloroform radical initiator is used (Table 5-1). This 
increase in physical density and Zeff is due to the high atomic number (Z) and density of 
iodine (Z=53, ρ=4.008 g.cm-3) compared to the chlorine (Z=17, ρ=1.489 g.cm-3). A 
comparison between these two radicals PRESAGE® formulation and water in regards to the 
Zeff and physical density (Table 5-1) demonstrate that characteristic of chloroform 
PRESAGE® formula is more water equivalence than iodoform PRESAGE® formula, 
therefore, PRESAGE® fabricated with chloroform is selected to be applied for dose 
enhancement measurements in this thesis. These results are in good agreement with 
previously published results [189, 190]. However, the absorption λmax of PRESAGE® 
dosimeters with both radical initiators after exposure to 6 MV beam are found at a peak of 
633nm (Figure 5-2) which is the visible red region of the energy spectrum. This absorption 
λmax is comparable to the oxidised form of leucomalachite green (LMG) and is in good 
agreement with previous study [63]. Furthermore, the absorption λmax of PRESAGE® 
dosimeter (633 nm) corresponds to the LED source of commercially available VistaTM OCT 
scanner (Modus Medical Devices Inc.) [63]. Therefore, such PRESAGE® dosimeter can be 
used as a 3D dosimetry using VistaTM OCT scanner system.  
The radiological properties of the fabricated PRESAGE® dosimeters have been 
investigated. As previously stated in chapter 3 (section 3.2.8.1.3), the absorption 
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measurements were calculated by subtracting the relevant measurement of a reference cuvette 
from the same batch with zero radiation dose (control) from that of the irradiated cuvettes; 
therefore, the absorbance changes against radiation dose absorbed are in fact only due to the 
absorbed radiation dose [61, 194]. Consequently, the plots intercept in both chloroform and 
iodoform PRESAGE® dosimeters were at -0.0018 and -0.0178 respectively, with linear 
correlation coefficient (R2) of > 0.99 (Figure 5-4 & 5-5). The interception of chloroform 
PRESAGE® dosimeter is lower and closer to zero than iodoform PRESAGE® dosimeter 
suggesting that PRESAGE® dosimeter with chloroform could be used without the need for a 
correction factor/s in the attenuation function better than iodoform PRESAGE® dosimeter for 
both kilovoltage energy were P.E. is predominant interaction which is Z dependant (The Zeff 
values of chloroform PRESAGE® dosimeter is closest to that of water than iodoform 
PRESAGE® dosimeter (Table 5-1)) and megavoltage energy were Compton scatter is 
predominant interaction which mainly depend on density (The density of chloroform 
PRESAGE® dosimeter is more water equivalent than iodoform PRESAGE® dosimeter 
(Table 5-1)). Whereas the linearity (R2 > 0.99) of control PRESAGE® dosimeter plot indicate 
that the response of PRESAGE® dosimeter is reliable and is faithfully following the well-
known ionisation chamber linearity characteristic obtained by the same way, also the linearity 
of PRESAGE® dosimeter plot doped with TiO2 NPs indicated that the TiO2 NPs were 
homogeneously dispersed throughout the dosimeter. In addition, it was noted that the slope of 
the PRESAGE® dosimeter’s response containing iodoform as a radical initiator was 
significantly higher than chloroform (SEF = 11.2) as shown in Figure (5-6). This indicates 
that iodoform enhance the sensitivity of the dosimeter to radiation dose more than 
chloroform. The apparent difference in sensitivity to radiation dose for chloroform and 
iodoform is attributed to the bond dissociation energy C-X (X = I or Cl). The iodoform C–I 
and chloroform C–Cl bond dissociation energies are (57.6 kcal.mol-1 and 83.7 kcal.mol-1) and 
Chapter Five: Results and Discussions of Phantom Based Studies Using PRESAGE® Dosimeter 
 
133 
 
the densities are 4.008 g.cm-3 and 1.489 g.cm-3 respectively. The generated free radicals from 
the radiolysis of the halocarbon bonds upon PRESAGE® dosimeter exposed to X-ray 
radiation is directly proportional to the C–X bond dissociation energy [195, 196]. 
Accordingly, less energy is required to cause homolysis of iodoform and produce free 
radicals than chloroform which these generated free radicals in turn oxidises more LMG 
leading to a greater increase in optical density change, hence iodoform have higher sensitivity 
than chloroform which this could be an advantage for employing iodoform PRESAGE® 
formulation for applications with very low radiation doses. These findings are in good 
agreements with previous observations [61, 194]. Moreover, there was no noticeable effect 
on the post-response photostability of the PRESAGE® dosimeter for both halogenated 
carbons used in this study and the recorded ΔOD were almost stable over the period of 240 
min. These findings are in good agreement with previous studies [160]. In general, the 
reasonable photofading rates observed with both PRESAGE® compositions without (control) 
and with inclusion of TiO2 NPs (Figure 5-7) is attributed to the small concentration of 
halocarbons employed (chloroform < 5 wt% and iodoform <2 wt%) [194]. However, 
inclusion of metal compounds (TiO2 NPs) have shown to slightly improve the post-response 
photostability, where similar results were obtained by others when they include carboxylate 
compounds in the PRESAGE® compositions [197, 198]. Finally, the PDD results 
demonstrate that PRESAGE® formulations have identical radiological properties to water 
(water-equivalent characteristics) as shown in Figure (5-8), due to the PDD data for 
PRESAGE® dosimeter obtained using optical CT scanner matches those obtained for water 
from conventional and clinically well used air ionisation chamber. This finding is in 
agreement with literature investigation [199]. As a result, the fabricated PRESAGE® 
dosimeters are suited for clinical applications in both kilovoltage and megavoltage clinical X-
ray beams. 
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5.2.2 Dose enhancement induced by TiO2 NPs  
 
The results of phantom study (Figures (5-10) to (5-13)) confirms that dose 
enhancement induced by PEG functionalised TiO2 NPs at kilovoltage X-ray energy beams 
(80, 100 and 150) kV, especially at 80 kV as it produce higher dose enhancement which this 
study focus on, is significant compared to the negligible dose enhancement detected at 6 MV 
X-ray energy beams (Table 5-2). This is due to the fact that at 80 kV the photoelectric effect 
(PE) is the dominant process of interaction. While at 6 MV, the interaction of X-ray photons 
is mainly through Compton scattering. At 80 kV, the probability of interaction via PE is 
strongly dependent on cubic power of atomic number (Z3); therefore, the interaction of X-ray 
photons with Ti atoms in the TiO2 NPs doped dosimeters will be much higher than the 
interaction with the control PRESAGE® dosimeter (without TiO2 NPs) since the effective 
atomic number of TiO2 is 18.49 and that of PRESAGE
® dosimeter is about 6.62; therefore, 
taking the probability of interaction via PE to be dependent on Z3 which results in the ratio of 
the probability of PE interaction with TiO2 NPs doped dosimeters compared to the control 
dosimeters will be about 21.8 and then causes an increase in the interaction probability 
leading to the generation of copious secondary electrons [181, 192]. These generated 
secondary electrons could directly or indirectly interact with LMG dye in the PRESAGE® 
formulation. The direct interaction would be between the generated electrons from TiO2 NPs 
and the LMG dye converting it to its oxidised form (MG), whereas the indirect interaction is 
between the generated electrons from TiO2 NPs and the radical initiators resulting in the 
production of further secondary radicals and increasing the extent of LMG dye oxidation. 
Hence, these generated electrons are responsible for the radiation dose enhancement at the 
target with 80 kV. Also increasing the TiO2 NPs concentration in the PRESAGE
® 
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formulation leads to an increase of the dosimeter sensitivity to radiation, which this clearly 
demonstrates an increase in the number of produced secondary electrons as the concentration 
of TiO2 NPs increased. However, at 6 MV, the addition of PEG functionalised TiO2 NPs in 
the PRESAGE® formulation slightly increased the physical density of the dosimeter and 
reduces the density of the free electrons as a result of low free electron density of TiO2 NPs 
(2.86×1029 e m-3) compared to PRESAGE® dosimeter (3.434×1029 e m-3); therefore, the NPs 
effect on the PRESAGE® dosimeter cancels out. Thus, there is no significant physical dose 
enhancement detected by PRESAGE® dosimeter at 6 MV energy beams. The slight 4 % dose 
enhancement determined is likely to originate from the PE contribution, as the energy 
spectrum of the MV beam shows some residual low energy which will be involved in PEs, 
which have been previously observed with Au NPs [183, 192]. These reasons combined are 
reflected in the results of this study, which indicates clearly that the dose enhancements in 
PRESAGE® dosimeter caused by the inclusion of the TiO2 NPs were much higher at low 
energies (especially at 80 kV) compared to those measured at high energies (6 MV). 
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6. SECTION C: Results and discussion for in vitro studies 
 
            The results obtained for in vitro study are reported in the first part of this section then 
the discussion of those results is presented. The focus of this chapter is on radiosensitisation 
caused by anatase amine functionalised titanium dioxide nanoparticles (TiO2 NPs) on two 
types of cells, prostate cancer (DU145) and human keratinocyte (HaCaT) cell lines which 
results from the generation of free radicals and increased reactive oxygen specious (ROS). It 
should be noted that the term dose enhancement is replaced in these section with radio-
sensitisation as the effects of the particles are manifested biologically as well.  
 
6.1 Results 
 
The localisation of anatase amine functionalised TiO2 NPs inside two different types 
of cells (HaCaT and DU145) were assessed using various techniques. Then the toxicological 
characteristic of these NPs were investigated. With both types of cells, various concentrations 
of amine functionalised TiO2 NPs using kilovoltage (kV) and megavoltage (MV) X-ray 
radiotherapy beams were employed to estimate the cells’ radiation dose sensitisers by such 
NPs. Cell survival curves are used as an end point to analyse the radiosensitisation effects by 
amine functionalised TiO2 NPs. The dose enhancement factor (DEF) was calculated from the 
cell survival curves. The analysis of radiobiological parameters was conducted on the 
obtained survival curves. Finally, the reactive oxygen species (ROS) generated from TiO2 
NPs was detected.     
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6.1.1 TiO2 NPs association with cells 
 
The observation of TiO2 NPs uptake and localisation inside the cells for both types of 
cells (HaCaT & DU145) was assessed using two different techniques. Firstly, the cell 
population was assessed using FCM which compares the scattered light resulted from TiO2 
NPs-treated cells with the untreated control, however, this method cannot distinguish if the 
NPs are within the cells or bounded to the surface. Therefore, in second method, high 
magnificent light microscopy was employed to observe the foreign objects within the cells. 
  
6.1.1.1 Flow cytometry (FCM) observation 
 
FCM was used to observe the cellular association and/or uptake of NPs by taking 
advantage of the increased visible-light scattering caused by TiO2 NPs, relative to the mostly 
translucent cellular environment. The scattered light are classified to forward scattered light 
(FSC) and side scatter light (SSC). The FSC represents the size of the cells that is 
proportional to the size and surface area of the cell and is a measurement of mostly diffracted 
light, which is detected just off the axis of the incident laser beam in the forward direction by 
a detector. Whereas, the SSC represents the granularity of the cells which is proportional to 
cell granularity or internal complexity (i.e. cells with internal complexity will produce more 
side scattered light) and is a measurement of mostly refracted and reflected light that occurs 
at any interface within the cell where there is a change in refractive index. In FCM dot plot, 
each event is represented as a single point on a scatter plot. Intensities of two different 
channels are represented along the x-axes. Event with similar intensities are clustered 
together in the same region on the scatter plot. The black region is referred to the population 
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of light scattered from all events while the red region represent the light scattered from cells 
population. HaCaT cells were exposed to amine functionalised TiO2 NP concentrations of 
0.5, 1 and 4 mM for 24 h. Untreated cells were used as controls (Figure 6-1). The FSC and 
SSC were analysed as shown in (Table 6-1). The percentage values represent a ratio of mean 
FSC or SSC light of cells treated with TiO2 NPs to the control cells. In treated samples, the 
percentage intensity of forward scatter (x-axis) shows negligible change (suggesting no 
change in object size), whereas the percentage of side-scatter intensity (y-axis) increased by 
945 % (0.5 mM), 1307 % (1 mM) and 2045 % (4mM) as compared to the granularity of 
control cells (100%) as shown in Figures (6-2), (6-3) and (6-4) respectively. This suggests a 
strong association between the cells and the NPs in the treated samples, though it does not 
distinguish between NPs within the cells and those bound to the cell surface. 
 
 
Figure 6-1: Flow cytometry scatter plots of HaCaT cells without any treatment (control). 
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Figure 6-2: Flow cytometry scatter plots of HaCaT cells treated with 0.5 mM TiO2 NP solutions. 
 
 
Figure 6-3: Flow cytometry scatter plots of HaCaT cells treated with 1 mM TiO2 NP solutions. 
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Figure 6-4: Flow cytometry scatter plots of HaCaT cells treated with 4 mM TiO2 NP solutions 
 
 
Table 6-1: Recorded forward and side-scatter by flow cytometry for observing various 
concentrations of TiO2 NPs association with HaCaT cells. 
TiO2 NPs Concentration (mM)  % Forward scatter (FSC-A) % Side scatter (SSC-A) 
Control 100.00 100.00 
 
0.5 88.08 945.27 
1 79.06 1306.64 
4 67.62 2044.93 
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6.1.1.2 Light microscopy observation 
 
In this thesis, the distribution of TiO2 NPs inside the cells was investigated by light 
microscopy. The plated cell and after treated with 4 mM of ~30 nm anatase amine 
functionalised TiO2 NPs for 24 h were three times washed with Milli-Q water to remove the 
NPs attached to the cell’s surface. The cells were then fixed in (1:7) oleic acid/ethanol 
solution for 5 min and stained with a 0.5 % crystal violet in ethanol solution for 15 min that 
made the nucleus to be stained with blue dye. Light microscopy with 40X magnification 
observed the TiO2 NPs as a black dots cluster in the cytoplasm of the cells and these black 
dots (aggregation of TiO2 NPs) is clearly shown in Figure (6-5). It was also observed that 
there were no NPs inside the nucleus. 
 
 
 
Figure 6-5: HaCaT cells stained with a 0.5 % crystal violet in ethanol, A) without nanoparticles, B) With 
TiO2 NPs which aggregate as black dots in the cytoplasm. The TiO2 NPs are surrounding the nuclei. 
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6.1.2 Cytotoxicity of TiO2 NPs  
 
In this study, the toxicity induced by amine functionalised TiO2 NPs in the cells was 
examined by measuring the cell viability. Initial studies were performed to explore the time 
and concentration-dependent cytotoxic effects of TiO2 NPs. Concentrations up to 30 mM was 
used to investigate the highest concentration of TiO2 NPs that can reliably suspended in the 
culture medium with the cells incubated for up to 72 h without causing visible damage to a 
monolayer of cells. The TiO2 NPs with an average size of ~30 nm were specifically prepared 
for usage with the cells for this type of study. HaCaT and DU145 cell lines were exposed to 
amine functionalised TiO2 NPs at concentrations ranging from 0.5 to 30 mM for 24, 48 and 
72 h to investigate the kinetic tolerance of these cell lines to TiO2 NPs. Cell viability was 
measured via MTS assays [200]. Cell viability was expressed as a percentage of treated 
cultures (with TiO2 NPs treatment) to untreated controls (without TiO2 NPs treatment). The 
results indicated that TiO2 NPs were nontoxic for both types of cells up to 4 mM post 72 h of 
treatment as the cell viability for these concentrations (up to 4 mM) of TiO2 NPs did not 
show any statistically significant difference (p > 0.05). The effects of amine functionalised 
TiO2 NPs on DU145 cell’s viability are clearly displayed in Figures (6-6). HaCaT cells show 
similar result. When cells were exposed to higher concentrations (up to 8 mM), viability 
remained constant (100 %) after 48 h and again these results did not show any statistically 
significant difference (Figure 6-7), whereas with further concentrations (up to 30 mM), it 
was observed that the viability was reduced by up to 22 % post 48 h which statistically show 
significant difference (Figure 6-8). 
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Figure 6-6: Cell viability for DU145 cells exposed to different concentrations of TiO2 NPs as a function of 
time. The errors are standard deviation from three independent experiments (mean ± SD, n=3). The data 
mean comparisons for different concentration at the same time are not significantly different (P > 0.05, 
ANOVA test). HaCaT cells show similar results.  
 
 
Figure 6-7: Cell viability for HaCaT cells exposed to TiO2 NPs of concentrations up to 8 mM at 48 h. The 
errors are standard deviation from three independent experiments (mean ± SD, n=3). The data mean that 
cell viability remain constant (100%) and is not significantly different with TiO2 NPs concentrations (P > 
0.05, ANOVA test). 
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Figure 6-8: Cell viability for HaCaT cells exposed to TiO2 NPs of concentrations up to 30 mM at 48 h. The 
errors are standard deviation from three independent experiments (mean ± SD, n=3). The data mean that 
cell viability drops beyond 8 mM TiO2 NPs concentrations and is significantly different (P < 0.05, 
ANOVA test). 
 
 
To conclude, the cytotoxic responses in the HaCaT and DU145 used in this study 
were found to be independent on the TiO2 NPs concentrations up to 4 mM post 72 hours 
incubation in 37 oC and 5 % CO2 which were selected to be used for in vitro studies of this 
thesis. 
 
6.1.3 Radiosensitivity induced by amine functionalised TiO2 NPs using X-ray 
radiotherapy 
 
In this study, X-ray radiotherapy energy beams ranging from kilovoltage (kV) to 
external megavoltage (MV) were employed to determine the radiosensitisation caused by 
amine functionalised TiO2 NPs in two types of cells.    
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6.1.3.1 kV superficial X-ray radiotherapy 
 
Ranges of kV X-ray radiotherapy beams in combination with different concentrations 
of anatase amine functionalised TiO2 NPs were employed to investigate the DEF dependence 
on beam energies at this ranges and its dependence on the particle’s concentrations. The 
effective kV energy that create highest dose enhancement was then selected to be applied for 
in vitro studies of this thesis. Figures (6-9), (6-10) and (6-11) shows HaCaT cells survival 
curves for the three kV X-ray energies (80, 100 and 150 kV) at radiation doses of 0-8 Gy and 
with 0.5, 1 and 4 mM concentrations of TiO2 NPs employing MTS assay. Data were plotted 
as log % percent survival fraction vs nominal dose (nominal dose is a term used for standard 
dose that has been measured by calibrated ionisation chamber) and fitted with a linear 
quadratic model. The DEFs are extrapolated at 80 % survival. The DEFs are estimated as a 
ratio of the control survival fraction to the survival fraction of the treated cells with TiO2 
NPs. At 80 kV X-ray energy, DEFs are 1.21, 1.57 and 1.70 (i.e. radiosensitivity enhancement 
of 21, 57 and 70% respectively). At 100 kV energy, DEFs for the same concentration are 
1.10, 1.21 And 1.37 respectively. At 150 kV energy, DEFs for the same concentration are 
1.018, 1.044 And 1.12 respectively. 
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Figure 6-9: Cells survival fractions curves for HaCaT cell line employing MTS assay with various 
concentrations of TiO2 NPs irradiated with 80 kV X-rays from SXRT machine. The errors are standard 
error mean from three independent experiments (mean ± SEM, n=3). The curves are fitted with linear 
quadratic model and DEF was obtained at 80% survival. 
 
Figure 6-10: Cells survival fractions curves for HaCaT cell line employing MTS assay with various 
concentrations of TiO2 NPs irradiated with 100 kV X-rays from SXRT machine. The errors are standard 
error mean from three independent experiments (mean ± SEM, n=3). The curves are fitted with linear 
quadratic model and DEF was obtained at 80% survival. 
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Figure 6-11: Cells survival fractions curves for HaCaT cell line employing MTS assay with various 
concentrations of TiO2 NPs irradiated with 150 kV X-rays from SXRT machine. The errors are standard 
error mean from three independent experiments (mean ± SEM, n=3). The curves are fitted with linear 
quadratic model and DEF was obtained at 80% survival. 
 
 
The results indicate that the DEF increases with reducing X-ray energy at kV ranges. 
The other observation is, with increasing the concentrations of TiO2 NPs, the DEF is 
increased and the maximum is at 4 mM. The measured DEFs for 80, 100 and 150 are 1.68, 
1.37 and 1.12 respectively at 4 mM (i.e. 68, 37 and 12% dose enhancement). These 
measurements demonstrate that radiosensitisation was observed to be highest at 80 kV with 
all the concentrations of TiO2 NPs. Figure (6-12) shows the DEF versus the applied X-ray 
beam energies at different concentrations of anatase amine functionalised TiO2 NPs. 
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Figure 6-12: DEF comparison of various concentrations of TiO2 NPs at different kV X-ray beams. 
 
 
Therefore, for low energy X-ray radiotherapy beams, the main focus was on using 80 
kV beam at radiation doses of 0-8 Gy to obtain the DEFs for in vitro studies. HaCaT and 
DU145 cells lines were used to investigate the radiosensitivity effects of anatase amine 
functionalised TiO2 NPs at concentrations of 0.5, 1 and 4 mM. Clonogenic and MTS assays 
were employed for determination of the DEF. Results indicates that there are significant 
radiosensitisation with TiO2 NPs concentration. The DEFs for HaCaT cell line with MTS 
assay are 1.21, 1.57 and 1.70, whereas with clonogenic assay are 1.17, 1.34 and 1.56 for 0.5, 
1 and 4 mM concentrations of TiO2 NPs, respectively. For DU145 cell line, the DEFs for the 
same concentrations with MTS assay are 1.27, 1.45 and 1.77 while for clonogenic assay are 
1.21, 1.40 and 1.68, respectively. The survival curves with and without TiO2 NPs are 
displayed in Figures (6-13) to (6-16), which shows the effects of TiO2 NPs concentrations. 
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Figure 6-13: Cells survival fractions curves for HaCaT cell line employing MTS assay with various 
concentrations of TiO2 NPs irradiated with 80 kV X-rays from SXRT machine. The errors are standard 
error mean from three independent experiments (mean ± SEM, n=3). The curves are fitted with linear 
quadratic model and DEF was obtained at 80% survival. 
 
 
Figure 6-14: Cells survival fractions curves for HaCaT cell line employing clonogenic assay with various 
concentrations of TiO2 NPs irradiated with 80 kV X-rays from SXRT machine. The errors are standard 
error mean from three independent experiments (mean ± SEM, n=3). The curves are fitted with linear 
quadratic model and DEF was obtained at 80% survival. 
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Figure 6-15: Cells survival fractions curves for DU145 cell line employing MTS assay with various 
concentrations of TiO2 NPs irradiated with 80 kV X-rays from SXRT machine. The errors are standard 
error mean from three independent experiments (mean ± SEM, n=3). The curves are fitted with linear 
quadratic model and DEF was obtained at 80% survival. 
 
 
Figure 6-16: Cells survival fractions curves for DU145 cell line employing clonogenic assay with various 
concentrations of TiO2 NPs irradiated with 80 kV X-rays from SXRT machine. The errors are standard 
error mean from three independent experiments (mean ± SEM, n=3). The curves are fitted with linear 
quadratic model and DEF was obtained at 80% survival. 
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6.1.3.2 External MV X-ray radiotherapy 
 
Similar method described with kilovoltage as in previous section was repeated to 
measure the radiosensitivity of amine functionalised TiO2 NPs for in vitro with 6 MV X-ray 
beams. DEFs for HaCaT cell line with MTS assay are 1.09, 1.19 and 1.50, whereas with 
clonogenic assay are 1.13, 1.18 and 1.37 for 0.5, 1 and 4 mM concentrations of TiO2 NPs, 
respectively. For DU145 cell line, the DEFs for the same concentrations with MTS assay are 
1.14, 1.26 and 1.67 while for clonogenic assay are 1.10, 1.19 and 1.43, respectively. Results 
revealed significant radiosensitisation of ~ 50-67 % following the MTS assays and 37-43 % 
from the clonogenic assays at TiO2 NPs concentration of 4 mM. The biological effects on 
both types of cells by TiO2 NPs utilising external megavoltage X-ray beams are displayed in 
Figures (6-17) to (6-20). 
 
 
Figure 6-17: Cells survival fractions curves for HaCaT cell line employing MTS assay with various 
concentrations of TiO2 NPs irradiated with 6 MV X-rays from LINAC machine. The errors are standard 
error mean from three independent experiments (mean ± SEM, n=3). The curves are fitted with linear 
quadratic model and DEF was obtained at 80% survival. 
Chapter Six: Results and Discussions for In vitro Studies 
153 
 
 
 
Figure 6-18: Cells survival fractions curves for HaCaT cell line employing clonogenic assay with various 
concentrations of TiO2 NPs irradiated with 6 MV X-rays from LINAC machine. The errors are standard 
error mean from three independent experiments (mean ± SEM, n=3). The curves are fitted with linear 
quadratic model and DEF was obtained at 80% survival. 
 
 
Figure 6-19: Cells survival fractions curves for DU145 cell line employing MTS assay with various 
concentrations of TiO2 NPs irradiated with 6 MV X-rays from LINAC machine. The errors are standard 
error mean from three independent experiments (mean ± SEM, n=3). The curves are fitted with linear 
quadratic model and DEF was obtained at 80% survival. 
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Figure 6-20: Cells survival fractions curves for DU145 cell line employing clonogenic assay with various 
concentrations of TiO2 NPs irradiated with 6 MV X-rays from LINAC machine. The errors are standard 
error mean from three independent experiments (mean ± SEM, n=3). The curves are fitted with linear 
quadratic model and DEF was obtained at 80% survival. 
 
 
 
The results of DEFs value obtained from the cell survival curves at 80% survival 
using equation (3-4) at both kV and MV X-ray beams with HaCaT and DU145 cell lines 
indicates that the calculated dose enhancement by MTS assay are higher than that measured 
by clonogenic assay as tabulated in Table (6-2). 
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Table 6-2: DEFs for TiO2 NPs for in vitro studies at 80 % cell survival. 
 
 
 
6.1.4 Radiobiological parameters of radiosensitivity  
 
Comparison the shape of the cell survival curves in Figures (6-13) to (6-20) 
qualitatively demonstrate that there are more cell killing by irradiation with the presence of 
anatase amine functionalised TiO2 NPs compared to the control (without TiO2 NPs) and the 
number of killed cells will increase as the concentration of NPs increase. In addition, the type 
of cells, X-ray energy beams and the type of assay used affects cell surviving by irradiation 
which is clearly visualized from the different shapes of the cell survival curves. 
Radiobiological models are typically utilized for quantitatively describing the shape of the 
cell survival curves and the most widely recognized model is the linear quadratic model. In 
this study, the experimental data plotted as cell survival curves are fitted by a linear quadratic 
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model. In this model, two components; the linear part and the quadratic part are employed to 
describe the DNA damage by the ionising radiations. The linear part is represented by a 
parameter called alpha (α) while the quadratic part, beta (β). These two terms have been 
explained in details in chapter one (Section 1.3.2). Tabulated α and β values as parameters 
fitting the cell survival curves for all beam energies, TiO2 NPs concentration and assays are 
displayed in Table (6-3).  It is noted that α value tends to increase with the inclusion of TiO2 
NPs much more significantly than β. For example, the cell survival curve for DU145 cell line 
at 6 MV analysed with clonogenic assay shows that α value for 0, 0.5, 1 and 4 mM are 
0.0899, 0.0943, 0.1012 and 0.1578 respectively. The β values and at the same conditions are 
0.0134, 0.0162, 0.0194 and 0.022 respectively, which does not show significant changes with 
the increase of TiO2 NPs concentrations. 
 
Table 6-3: The radiobiological linear (α) and quadratic (β) values extrapolated from cell 
survival curves of HaCaT and DU145 cell lines at various concentrations of TiO2 NPs 
employing both MTS and clonogenic assays. 
 
Energy
Assay 
Type
Cell Type
α β α β α β α β
MTS
 80 kV
Colony
   
MTS           
 6 MV
Colony
0.13643 0.00381 0.1507 0.00265
HaCaT
DU145
HaCaT
DU145
HaCaT
DU145
HaCaT
DU145 0.16133
0.07538 0.0001592
0.02926 0.01465 0.03887 0.014960.01421 0.04537 0.0143 0.07586
0.00184 0.17157 0.00347
0.00248
0.04402 0.0002346 0.04669 0.0001418 0.0517
0.00344 0.02056 0.00268 0.029820.01329 0.00314 0.01393
5.925E-05
0.01948 0.15786 0.02202
0.0162
0.08997 0.01346 0.09434 0.01621 0.10122
0.1539 0.1037 0.01739 0.18105
0.0007392 0.04305 0.00256
0.10176 0.01228 0.10175
0.00529
0.02848 0.00141 0.03562 0.0007784 0.05205
0.00308 0.04317 0.00396 0.058040.0159 0.00592 0.04526
TiO2 NPs   Concentration (mM)
Control - 0 mM 0.5 mM 1 mM 4 mM
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6.1.5 Generation of ROS by TiO2 NPs 
 
The 2’,7’-Dichlorofluorescin diacetate (DCFDA) (Sigma-Aldrich Pty. Ltd., St Louis, 
Mo, USA) reagent, a fluorogenic dye that measures primarily hydroperoxide ROS activity 
[201], was used to detect the reactive oxygen species (ROS) generated from anatase amino 
functionalised TiO2 NPs following the method described in chapter three (Section 3.3.8). 
Figure (6-21) shows the ROS detected after 6 MV beam exposure of aqueous solutions 
without (control) and with TiO2 NPs as measured using DCFDA. The PBS+DMSO solution 
was used as a negative control to show that there was no contribution from this solution to the 
ROS generated. The results clearly indicate that ROS generation was dependent on TiO2 NPs 
concentrations. This illustrates that biochemical effects were a key factor for enhancing the 
cellular radiosensitivity, which would be an important consideration in radiosensitivity 
measurements. This is just a proof for the dose enhancement measured with high-energy 
beams where MC simulations have shown that there is no DE [202]. 
 
Figure 6-21: ROS generated from TiO2 NPs, detected by DCFDA after exposed to 6 MV X-ray beam at 
radiation doses of (15 and 40) Gy. Results are considered to be statistically significant at p values of less 
than 0.05 (* p < 0.05, ** p < 0.01, *** p < 0.001). 
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6.2 Discussion   
  
In this section, the reasons behind the main findings will be discussed starting with 
the association of amine functionalised TiO2 NPs with cells where TiO2 NPs were found to 
be localised inside the cytoplasm of the cells. Furthermore, the amine functionalised TiO2 
NPs were found to be non-toxic to cell up to 8 mM concentration. Finally, the amine 
functionalised TiO2 NPs have shown to work as a radiosensitiser agent for in vitro studies. In 
other words, the results just displayed and presented in the previous sections will be 
discussed in this part;  
 
6.2.1 TiO2 NPs association with cells  
 
The increased side scatter observed in the flow cytometry for amine functionalised 
TiO2 NPs exposed cells as shown in Figures (6-1) to (6-4) implies close association (which 
means particles are either in the cells or attached to them) between the NPs and cells after 
incubation for about 24 hours. These data does not necessarly indicate uptake. Nevertheless, 
the NPs will still be in close proximity to the nucleus and intracellular uptake may not be an 
absolute necessity for radiation dose enhancement [203]. Other in vitro studies do indicate 
that TiO2 NPs can be internalised by various cell lines [192, 204-205], and it has been 
demonstrated that in the absence of cytotoxicity, cells can effectively absorb TiO2 NPs to 
quite high concentrations [192, 206].  
The light microscopy utilised to study the amine functionalised TiO2 NPs distribution 
inside the cells post 24 hours incubation revealed that these NPs are clustered in subcellular 
components in the cell’s cytoplasm and appears as a black dots as shown in Figure (6-5). 
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Other investigations about cellular uptake of TiO2 NPs have found that, TiO2 NPs were 
internalized by both U373 and C6 cells post 24 h of treatment, and were located in large and 
small vesicles in the cytoplasm. However, they did not observe intracellular location of solid 
core NPs in cell organelles [207].  
In Summary, this study and other researches findings stated above have demonstrated 
that TiO2 NPs are mostly aggregated in the perinuclear regions surrounding the nucleus; 
however, these investigations clearly have shown that there were no NPs inside the nucleus. 
 
6.2.2 Cytotoxicity of TiO2 NPs 
 
The cytotoxicity results presented in this chapter illustrate that the amine 
functionalised TiO2 NPs were cytocompatible up to concentrations of 4 and 8 mM post 72 
and 24 h respectively as shown in Figure (6-6) and (6-7). When the concentration was 
increased up to 30 mM, the cells viability slightly reduced to a maximum of 22% as shown in 
Figure (6-8). Therefore, the concentration ranges of NPs used in vitro in this study 
(preferable maximum of 4 mM) were suitable for studying radiosensitisation effects without 
confounders. Conversely, it is not possible to exceed a 1 mM concentration with heavy atoms 
based NPs such as Au, Ag, Pt, Bi etc…[109, 206]. This finding is in agreement with other 
studies documented in the literature which have shown that titanium dioxide and titanium 
nanotubes can penetrate human glioblastoma cells in vitro and stay in the cytosol for over 10 
days without inducing cytotoxicity or decreasing DNA repair efficiency after irradiation with 
a linear accelerator [140, 192, 206]. 
However, it should be noted that the cytotoxicity of TiO2 NPs depends on many 
factors such as crystal structure, the NPs size, surface charge, and on cell type. Regarding the 
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crystal structure, a study demonstrates that both anatase and rutile TiO2 NPs has no indication 
to alter the biological system of pulmonary cells [208] . While others have compared the 
DNA damaging effects caused by anatase and rutile TiO2 NPs of 200nm size (we used 30 
nm) on human bronchial epithelial cells and they demonstrate a significant enhance in the 
generation of hydrogen peroxide in cells treated with rutile TiO2 NPs but not by anatase TiO2 
NPs if incubated in the dark [209]. A sample containing anatase and rutile with equal surface 
area shows higher toxicity to the cells than the pure anatase samples [209]. In general, studies 
have shown that cells take up spherical NPs in the range of 20 to 50 nm in highest rates 
compared to the  other NPs sizes; however, this is not the case for all cell types [210]. 
Furthermore, most NPs with positive surface charge have advantage of higher cellular uptake 
and disadvantage of greater cytotoxicity in cells which causes plasma-membrane disruption 
and apoptosis [210, 211]. TiO2 NPs synthesised as described in this research showed very 
low toxicity for the cells investigated.  
 
6.2.3 Radiobiological analysis of radiosensitisation  
 
Figures (6-13) to (6-20) show clearly that cells incubated with TiO2 NPs are more 
sensitive to radiations by having the slope of the curves shortened. There are many ways of 
indicating the levels of dose enhancements using these curves. The one used in this thesis is 
by fitting the survival curves with linear quadratic model and extrapolate the DEFs at 80% 
survival using equation (6-1). Radiobiological analysis of linear (α) and quadratic (β) 
parameters derived from the cell survival curves using radiobiological linear quadratic model 
shows that α significantly increase with the increase of the TiO2 NPs concentration; however, 
β values change insignificantly with the concentration of TiO2 NPs (Table 6-3). Since α is 
the probability of an interaction between single electron ejected as a result of absorbing X-ray 
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and two chromosomes breaks [16], hence this is an indication of an enhancement in double 
strand DNA breaks as a consequence of inclusion TiO2 NPs. Accordingly, the DEF results 
(Table 6-2) obtained for phantom study and from extrapolation of the cell survival curve for 
in vitro study are in an excellent agreement with the above hypothesis (α increase with the 
TiO2 NPs concentration increase).  
 
6.2.4 Radiosensitazation induced by TiO2 NPs 
 
The results of this study confirm that radiosensitisation induced by amine 
functionalised TiO2 NPs on HaCaT and DU145 cell lines at 80 kV is greater than at 6 MV for 
X-ray energy beams as clearly can be seen in Table (6-3), and this supports the work of a 
large number of investigators for other types of NPs [104, 106 and 109]. The primary 
difference in the effect of these two energies is the type of radio-biological interaction. At 
low energies (80 kV), the dominant process of interaction is the photoelectric effect (PE), i.e., 
absorption of an incident X-ray photon. While at high energies (6 MV), the interaction of X-
ray photons is mainly through Compton scattering. Moreover, it is well known that the 
probability for the photoelectric effect depends strongly on the atomic number (Z). Thus it is 
anticipated that at 80 kV (where PE is dominant), the interaction of X-ray photons with Ti 
atoms in the TiO2 NPs will be much higher than the interaction with the tissues. The effective 
atomic number of TiO2 is 18.49 and that of tissue is about 7.4 that were calculated using 
Mayneord equation (equation 5-1). Therefore, taking the probability of interaction via PE to 
be dependent on Z3, the ratio of the probability of PE interaction with TiO2 NPs compared to 
that with tissue will be about 15.6. Even though the concentration of Ti is relatively low, this 
extremely high affinity for the PE interaction could cause a greatly increased interaction 
probability and lead to the generation of copious secondary electrons [14]. This generation 
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electrons are reflected in the results of this study, which indicates clearly in both the phantom 
(Chapter Five) and in vitro studies that the dose enhancements caused by the inclusion of the 
TiO2 NPs were much higher at low energies (80 kV) compared to those measured at high 
energies (6 MV) [192].  
The other point of interest in the results is the observed differences in dose 
enhancement between the PRESAGE® dosimeter (Chapter Five) and cell culture studies, 
especially at high energies (6 MV). The addition of TiO2 NPs slightly increased the physical 
density of the systems, while reducing the density of the free electrons – this is due to the 
TiO2 NPs free electron density being about 2.86×10
23, whereas in tissue it is 3.34×1023. This 
will result in a slight reduction in the density of free electrons when TiO2 NPs are present in 
the target. Thus in general, there should be no significant physical dose enhancement with the 
6 MV beam and this is what the PRESAGE® dosimeter study confirmed.  
There is clearly some disagreement between the phantom “PRESAGE® dosimeters” 
and in vitro studies with regards to the level of radiosensitisation. The cell studies showed 
higher enhancements in radiosensitivity than the phantom dosimeters (Compare figures 
related to section (5.1.4.2) with section (6.1.3.2)). This can be attributed to the PRESAGE® 
dosimeters being only able to detect electron free radicals directly generated (the physical 
effect) and being not suited to the generation of ROS due to a lack of free water molecules. 
Conversely, cells can be affected by a host of the biochemical events, such as ROS 
generation, which are additional stresses above those, generated by secondary electrons, and 
thus results in greater radiosensitivity. This specific point was illustrated in this study through 
three sets of experiments measuring ROS levels generated by irradiations in the presence and 
absence of TiO2 NPs as shown in Figure (6-21). The common ROS generated by TiO2 NPs 
when exposed to ionizing radiation are superoxide (O2
–), hydroxyl radical (·OH), hydrogen 
peroxide (H2O2), and singlet oxygen (
1O2) [138]. As the fluorescence probe (DCFDA) does 
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not discriminate against different ROS, it is not possible to identify a specific ROS that is 
responsible for the produced oxidative stress observed in these studies. These results are in 
agreement with previously documented studies which have shown that upon irradiation, 
anatase TiO2 NPs generate free radicals that facilitate the spontaneous generation of reactive 
oxygen species (ROS), which can damage nucleic acids (e.g., DNA) [138, 139, 188, 192 and 
212]. It has also been reported that increasing the mole fraction of oxygen atoms by inclusion 
of Ti-peroxide can also improve radiosensitisation efficiency [213]. The explanation of X-ray 
interaction with TiO2 NPs inside a cell and then resulting in the production of free radicals 
and ROS via physical and biochemical effects was schematically shown in chapter one 
(Figure (1-12) in section 1.3.2).  
The variations with maximum of 17% in DEFs observed between clonogenic and 
MTS assays at 80 kV and 6 MV energies for the similar conditions (i.e. same type of cells, 
concentration of NPs and energy) can be attributed to few reasons. Firstly, it could be due to 
number of cells plated for example, with MTS assay, the control plate of each HaCaT and/or 
DU145 cells were seeded at density of 3000 cells/well, whereas for clonogenic assay, the 
control plates were seeded at densities of 150, 250 cells/well for HaCaT and DU145 
respectively (Table 3-1). Secondly, these variations could be due to the proliferation duration 
after irradiation, which for MTS assay was only 3 days while for clonogenic assay was 14 
days. However, the slight variations in DEFs results observed between the two types of cells 
with similar assay could be due to the difference in their response to the radiations and to 
their uptake of the TiO2 NPs.  
The findings of radiosensitisation show that TiO2 NPs improve the efficiency of dose 
delivery, and demonstrate the potential of TiO2 NPs for the enhancement of clinically 
relevant kilovoltage (kV) and megavoltage (MV) radiotherapy beams which has implications 
for future radiotherapy treatments [192]. Recently, techniques such as kilovoltage X-ray 
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intraoperative radiotherapy are increasingly used in breast cancer treatment by radiations; 
therefore, improvement to therapeutic effects generated by TiO2 NPs also could be highly 
useful for such treatments [214] also electronic brachytherapy [215]. In the cases of 
employing extremely high dose rates such as Myofascial Release Techniques (MRT) can also 
benefit from the addition of TiO2 NPs in order to reduce the employed high dose [216].  
 In conclusion, these results clearly demonstrate that with the inclusion of TiO2 NPs in 
the target, same fraction of cells were destroyed with lower radiation doses compared to the 
case of absence of TiO2 NPs. This means if TiO2 NPs are added to the target, when 
kilovoltage and megavoltage X-rays are used for treatment, an external dose reduction can be 
achieved to deliver the same local control as without the inclusion of TiO2 NPs. This 
reduction of radiation dose delivered to the target results in obviously reducing the dose to 
the surrounding healthy tissue during treatment which is of primary concern in all 
radiotherapy treatment procedures. 
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7.1 Summery 
The purpose of this investigation was to provide a high-resolution 2-D scanning 
feasibility study for PRESAGE® dosimeters using UV/VIS spectrophotometry. Previously 
the light absorbance of PRESAGE® has only been made at a single point using UV/VIS 
spectrophotometry. The CLARIOstar microplate reader can operate as a 2-D scanning 
UV/VIS spectrophotometer measuring the light absorbance at multiple points of a 
PRESAGE® dosimeter. Water equivalent PRESAGE® dosimeters were fabricated in a 
rectangular shape and were irradiated with 6 and 18 MV X-ray beams using a medical linear 
accelerator. The optical density values of the PRESAGE® dosimeters were measured pre and 
post-irradiation using a CLARIOstar microplate reader. Depth dose curves and beam profiles 
were validated against ionisation chamber measurements. The agreement between the two 
dose measuring devices is well within experimental uncertainties. This investigation 
demonstrated that depth dose curves and beam profiles can be measured with high resolution 
in 2-D for megavoltage X-ray beams with PRESAGE® dosimeters using UV/VIS 
spectrophotometry. Additionally, one PRESAGE® dosimeter was also fabricated with the 
inclusion of an inhomogeneity to investigate the effect on the dose distribution beyond the 
inhomogeneity. There is also the potential to extend this method to obtain 3-D dosimetry 
scanning. 
 
7.2 Introduction 
 
 Due to the current complexity in radiotherapy instrumentation, verification of 
radiation dose delivery as planned by the treatment planning system is challenging for 
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techniques such as stereotactic radiosurgery (SRS), intensity modulated radiotherapy (IMRT) 
and volumaetric modulated radiotherapy (VMAT) [217]. Consequently new three-
dimensional (3-D) dosimetry systems such as gel and PRESAGE® dosimeter systems have 
been developed to potentially measure the dose distribution and/or the absolute dose 
delivered [218]. 
 PRESAGE® is a 3-D solid radiochromic dosimeter fabricated from clear polyurethane 
resin combined with a leuco-dye and halogenated carbons [190]. These dosimeters undergo a 
peak radiochromatic response around 633 nm and can be read using optical CT for 3D dose 
distribution measurements [64] or UV/VIS spectrophotometry for single point dose 
measurement [164], and confocal fluorescence microscopy for high resolution  [219]. 
 The advantages of PRESAGE® dosimeters over other dosimeters are that they are 
solid, not sensitive to oxygen, easy to handle, sub-mergeable in water, can be fabricated to 
any size or shape and optically clear which allows light to pass through with minimum 
artifacts. In addition PRESAGE® can be formulated to be radiologically tissue or water 
equivalent [62].  
The conventional technique of reading PRESAGE® is with a UV/VIS 
Spectrophotometer [65]. The main limitation of this technique is the fact that the optical 
density (OD) is a measure per single point through the whole of the cuvette. Other methods to 
read PRESAGE® are Optical Computed Tomography (OCT) and laser fluorescence confocal 
microscopy (LFCM). OCT allows for 3-D dose measurements however the optical CT 
scanner, reconstruction software and chemicals needed for optical compatibility can be quite 
expensive and time consuming. Spectral artifacts produced from a mismatch in the refractive 
index matching fluid and edge artifacts from the edges of the dosimeters are also drawbacks 
of OCT [75]. LFCM can take high resolution 2-D images at different planes through a sample 
to produce a 3-D dose distribution however an expensive microscope and expert user are 
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needed to perform the scanning. The field-of-view is also limited (< 3 mm) and is better 
suited for small fields.  
Radiochromic films, such as gafchromic films, are normally used as dosimeters for 
two dimensional (2-D) radiation dosimetry measurements in clinical radiation oncology. 
However, these films have some limitations and drawbacks that affect the accuracy of OD 
measurements. Variation may arise in the OD from non-uniformity of the scanner light 
source and light scattering with respect to the scan line direction as well as orientation with 
the flatbed scanner. In addition, consecutive scans may increase the scanner temperature and 
change the OD response of the film [220]. Radiochromic films are energy independent in the 
photon energy range 100 keV to 18 MeV but below 100 keV the absorbed-dose energy 
dependence is no longer constant which can be attributed to changes in the mass energy 
absorption coefficient ratios of water to film materials, as well as an increase in the number 
of electrons being created and scattered in the central surface layer of the film [221]. In 
contrast to PRESAGE® dosimeters the radiochromic film can be immersed in water for only a 
very short period, therefore most experiments using radiochromic films have to be conducted 
using solid water phantoms with air pockets and gaps between the film sheets and the blocks 
of solid water contributing to the dose uncertainty. High-density heterogeneity experimental 
dose assessments have been studied using thermoluminescent detectors (TLDs) and were 
found to be an appropriate choice for measuring the absorbed dose in bone [222]. However 
the TLD configuration is unrealistic from clinical perspective since solid water was used 
which leads to the existence of air gaps between its layers and can contribute to dose 
distribution uncertainty. Similarly dose distributions through inhomogeneities can be 
investigated with radiochromic film but solid water needs to be used. The PRESAGE® 
dosimeter however can be manufactured as a dosimeter with inhomogeneities, Figure (7-1). 
Chapter Seven: Two-Dimensional Scanning of PRESAGE® Dosimetry Using UV/VIS spectrophotometry and its 
Potential Application in Radiotherapy 
169 
 
This configuration allows the investigation of depth and profile dose distribution for low-
density in-homogeneities in a sample that can be submerged in water.   
 
   
 
 
 
 
Figure 7-1: Inhomogeneous PRESAGE® dosimeter. 
 
 
PRESAGE® dosimeters also have better radiological properties than TLDs, and are 
similar to water, solid water and soft tissue [222-225]. Table (7-1) compares radiological 
properties and the effective atomic number (Zeff) using the Mayneord equation (5-1) [14]. 
However calculations based on all photon energy absorption processes using the Auto Zeff 
software [226] is plotted in Figure (7-2). The Zeff of the PRESAGE
® dosimeters fabricated 
matches that of water and soft tissue compared with solid water (RW3) or LiF TLD-100 for 
effective energies ranging from 10 keV to 10 MeV.  
 
Table 7-1: Mean physical density (ρ), electron density (ρe) and relevant effective atomic 
number (Zeff) of PRESAGE® dosimeters fabricated in this study and gafchromic films 
compared to water. 
Materials                                    ρ (Kg.m-3)              ρe (x1029em-3)                     Zeff    
Water                                             1000                          3.3428                              7.42 
PRESAGE® (Chloroform)         1045-1047                   3.4348                               6.62 
Radiochromic films                   1080-1200                       -----                                6.84 
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Figure 7-2: Radiological effective atomic number Zeff based on the photon energy absorption processes 
for water equivalent PRESAGE®, solid water (RW3) and TLDs (LiF). 
 
 
In this study we have shown that a commercially UV/Vis spectrophotometer 
(CLARIOstar microplate reader) available in most of chemistry and biology labs can read 
PRESAGE® samples in 2-D within minutes with an OD accuracy of less than 1%. 
 
7.3 Materials and Methods 
7.3.1 PRESAGE® dosimeter fabrication  
 
The PRESAGE® dosimeters used for this work were prepared with Polyurethane resin 
(Crystal Clear 200, Smooth-On, Easton, PA USA). The detailed fabrication procedure is 
stated in chapter three (section 3.2.5). The fabricated dosimeters were 6 x 85.5 x 172.7 mm 
depth, width and length which are shown in Figure (7-3 A). A PRESAGE® dosimeter with 
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the inclusion of an air cavity inhomogeneity was fabricated by cutting out a rectangle 25 x 35 
mm in the PRESAGE® dosimeter block; Figure (7-3 B). The PRESAGE® dosimeters, pre- 
and post-irradiation, were stored in a dark and cold (-18O C) environment to avoid colour 
fading and or accidental exposure to external UV light [164]. 
 
7.3.2 PRESAGE® irradiation  
 
The PRESAGE® dosimeters were irradiated with 6 MV and 18 MV energy beams 
using a Varian 21EX medical linear accelerator (Clinic 21EX, Varian Associates Inc., Palo 
Alto, CA, U.S.A.) at Alfred Health Radiation Oncology, Melbourne, Australia. The 
PRESAGE® dosimeters were placed in a mini water tank to provide a full scatter condition 
and positioned centrally on the cross-plane axis of the X-ray beam. The field size was set to 3 
x 3 cm for the beam profile experiments and 10 x 10 cm for the percentage depth dose (PDD) 
experiments. The collimator and gantry angles were set to 00 and a SSD of 100cm to the 
water surface was used as displayed in Figure (7-3 C). A dose of 15 Gy was delivered to the 
dosimeters at a dose rate of 600 MU/min. 
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Figure 7-3: A) Samples of PRESAGE® dosimeter, B) inhomogeneous PRESAGE® dosimeter, 
C) Irradiation process setup. Image is not in scale.  
 
 
7.3.3 Optical Density Measurements 
7.3.3.1 UV/VIS spectrophotometer 
 
The dose distributions in the PRESAGE® dosimeters were read out using a 
CLARIOstar microplate reader (BMG LABTECH - The Microplate Reader Company, 
Ortenberg, Germany) operating in the UV/VIS spectrophotometer mode. The microplate 
reader is an ultra-fast scanning machine capturing all wavelengths from 220 to 1000 nm with 
a selectable spectral resolution of 1–10 nm, in less than 1 second per point. A high-power 
xenon flash lamp is used as the light source and the absorbance detected with a low-noise 
photomultiplier tube. The optical density range is 0-4 with an accuracy of less than 1% at 2 
OD [227]. An optical filter was used to specify a wavelength of 633 nm for optimum 
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absorbance of the PRESAGE® dosimeter and the scanning was performed at 1 mm intervals. 
The scan direction was in the same direction as the X-ray beam for PDD measurements and 
across the beam direction for beam profiles, Figure (7-4).  
 
 
Figure 7-4: CLARIOstar microplate reader for absorbance measurement. 
 
 
The absorbance, also known as the material’s Optical Density (OD), was measured 
using equation (7-1), which is the logarithmic ratio between the intensity of monochromatic 
light  hitting the dosimeter (I) and the intensity of that very light transmitted through the 
dosimeter (I0). 
0
log
I
I
OD        …………  (7-1) 
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Using this method, the PRESAGE® dosimeter was scanned pre- and post- irradiation. 
Equation (7-2) was applied where (IB) is the pre-irradiation intensity, (Iirr) is the post-
irradiation intensity and (Iblank) is the intensity of background. The measurement of 
background and pre-irradiation intensity was conducted in order to eliminate artifacts caused 
by the plate and dosimeter non uniformity 
 
blankB
blankirr
II
II
OD


 log          ……….. (7-2) 
 
 
 7.3.3.2 Ion Chamber Measurements 
 
Ion chamber measurements were taken with an IC 13 ionisation chamber in a water 
phantom (Blue Phantom, IBA Dosimetry, Schwarzenbruck, Germany) with a 100 cm SSD. 
The chamber was aligned with the long axis of the chamber in the in-plane direction of the X-
ray beam to reduce the effect of penumbra widening due to the chamber volume. A 
percentage depth dose (PDD) profile was taken for a 10 x 10 cm field for both 6 and 18 MV. 
Cross-plane profiles were taken for a 3 x 3cm field at 2.25 cm depth for 6 MV and 5 cm 
depth for 18 MV. 
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7.4 Results 
 
The experimental results obtained from ion chamber measurements and CLARIOstar 
microplate reader measurements for the percentage depth dose (PDD) and profile irradiations 
are presented in the following sections. 
 
7.4.1 Percentage Depth Dose (PDD) measurements 
 
Figure (7-5 A and B) represent the experimental depth dose curves acquired using 
ionisation chamber and PRESAGE® dosimeters for both 6 MV and 18 MV X-ray beam 
energies respectively. Dose variation with depth was measured up to approximately 10 cm in 
the PRESAGE® dosimeter. 
 
 
Figure 7-5: PDD curves obtained using an ionisation chamber and PRESAGE®, A) at 6 MV and, B) at 18 
MV. 
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The shape of the PDD curve for both 6 and 18 MV beams in the PRESAGE® 
dosimeters is similar to the ion chamber measurements. The agreement is within 1% for 6 
MV and 2% for 18 MV. 
 
7.4.2 Beam profile measurements 
 
Figure (7-6 A and B) shows the profile across a 3 x 3 cm beam (cross-plane 
direction) using an ionisation chamber and the PRESAGE® dosimeters. The profile in Figure 
(7-6 A) was taken at 2.25 cm depth for the 6 MV beam and the profile in Figure (7-6 B) was 
taken at 5 cm depth for the 18 MV beam. The 6 MV PRESAGE® profile is within 3% 
compared with the ion chamber measurements above the 20% of the normalised Relative 
Optical Density, Figure (7-6 A). There is a discrepancy of 2% at a distance of 20 mm from 
the isocentre, Figure (7-6 B). The 18 MV PRESAGE® profile is within 2% compared with 
the ion chamber measurements with the largest discrepancy at the 60 % of the normalised 
Relative Optical Density; Figure (7-6 B). The 18 MV PRESAGE® profile also displays a 
similar feature to the 6 MV profile just beyond a distance of 20 mm from the isocentre. 
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Figure 7-6: Beam profiles acquired from an ionisation chamber and PRESAGE®, A) at 6 MV 2.5cm 
depth and, B) 18 MV at 5cm depth. 
 
 
7.4.3 PRESAGE dosimeter with air cavity 
 
The  PDD curve of the heterogeneous PRESAGE® dosimeter was measured and 
compared to the PDD curve of the ion chamber measurements for a 6 MV X-ray beam in 
water along with the PDD calculated on a TPS (Eclipse, Varian Medical Systems, Palo Atlo, 
CA) using the AAA algorithm (v11.0.31) shown in Figure (7-7).  
 
 
Chapter Seven: Two-Dimensional Scanning of PRESAGE® Dosimetry Using UV/VIS spectrophotometry and its 
Potential Application in Radiotherapy 
178 
 
 
 
Figure 7-7: PDD’s curve obtained from ionisation chamber in water and the in-homogenous PRESAGE® 
dosimeter and TPS at 6 MV. 
 
 
The agreement of PDD curves of PRESAGE® dosimeter and ion chamber 
measurements prior to the an inhomogeneity is within 1.4%, however, the curve of 
PRESAGE® dosimeter post the inhomogeneity is greater by 4% than the ionization chamber 
in water curve. This result is anticipated by the fact there is less attenuating material in the 
beam and is verified by calculation with the TPS.  
 
7.5 Discussion  
 
The PDDs and beam profiles show excellent agreement with the ion chamber 
measurements. The PDDs for 6 MV and 18 MV display minor ripples in the curve past the 
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maximum depth dose. The magnitude of these ripples is less than 1.5% and could be due to 
variations in the thickness of the PRESAGE® dosimeters or the homogeneity of the sample 
[228]. The rippling effect can be eliminated by smoothing the PRESAGE® curve and by 
ensuring complete mixing of the precursor chemicals during the fabrication process. The data 
presented in Figure (7-5) are from the central axis of the field however, the CLARIOstar 
microplate reader can also read off-axis profiles. Therefore the technique could be extended 
to measure 2-D dose distributions in PRESAGE® phantoms.  
The beam profiles in Figure (7-6) both have a similar discrepancy at the field edge at 
approximately 20 mm from the isocentre. The OD of the PRESAGE® dosimeter was 
measured in 1 mm steps by the CLARIOstar microplate reader and may be of higher spatial 
dose resolution than the reading by the IC13 chamber at the edge of the field which is a 
convolution involving the chamber volume and the edge of the field. The bulging of the 18 
MV PRESAGE® profile in Figure (7-6 B) may be due to the sample shape. Although the 
PRESAGE® dosimeter was set in a plate designed specifically for the CLARIOstar 
microplate reader the thickness of the dosimeter may not have a uniform thickness. Any 
increase or decrease in sample thickness will change the relative optical density at that point 
and care needs to be taken during fabrication. The symmetrical nature of the discrepancy 
suggests that this may be the case. Repeating the measurement with PRESAGE® dosimeters 
of uniform thickness is necessary to confirm the reliability of the PRESAGE® profile.  
The beam profile data was compared at 2.25 and 5 cm depth for 6 MV and 18 MV 
photons however; profiles at any depth in the dosimeter can be scanned to also produce 2-D 
depth profile distributions. Similarly, for the PDDs off-axis scans are also possible to produce 
off-axis PDD profiles. 
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Results presented in Figure (7-7), revealed similar behaviour as with ion chamber 
measurements before the inhomogeneity, however after the inhomogeneity there is an 
increase in the dose compared to the ion chamber with no inhomogeneity. The TPS (using 
AAA algorithm) demonstrates that the dose expected after the air cavity in the phantom will 
be greater if there was no air cavity however there is a discrepancy of 1-2% between the 
PRESAGE® and TPS curves. This result demonstrates the ability of the PRESAGE® 
dosimeter to measure dose distributions in a water equivalent phantom with air cavities.  
 
7-6 Conclusion 
 
We have shown that a UV/Vis spectrophotometry technique using a CLARIOstar 
microplate reader can be used to generate 2-D dose distributions of megavoltage X-ray beams 
with PRESAGE® dosimeters. The agreement of the PDD curves and beam profiles 
demonstrate that performance of CLARIOstar microplate reader as a valid 2-D dosimetry 
instrument.  
The PDDs, profile distributions and in-homogeneity behaviour were easily measured 
in a water equivalent dosimeter relatively quickly compared to optical CT or film dosimetry. 
This technique can potentially be extended to 3D through repeat measurements at various 
PRESAGE® angulations, in much the same way OCT works, and then reconstruct the data in 
a volume. 
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Titanium Dioxide Nanoparticles (TiO2 NPs) 
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8.1 Summary 
 
This chapter is aims to investigate the activation of TiO2 NPs by proton beams for 
imaging as gamma emitters. It covers the materials and experimental methodology used for 
TiO2 NPs activation by proton beam including the capsule preparation for holding the NPs, 
samples irradiation process with proton beam, energy spectrum measurement and the storage 
condition of the activated TiO2 NPs. Finally, it presents and discusses the experimental 
results obtained. There is potential for the activated TiO2 NPs to be used as theranostic agents 
(imaging and dose enhancer in the target) since most of this work proved the compatibility of 
these NPs for dose enhancement of the types used in radiotherapy and this chapter shows also 
their potential application as imaging source via nuclear medicine techniques. 
 
8.2 Background 
 
Nuclear medicine was established in the middle of last century that initially iodine 
was used to diagnose and treat thyroid disease [229, 230]. In the recent years, this branch of 
medicine have employed radiations involving the use of radioactive substances 
(radioisotopes) produced in a cyclotron to provide information about functioning of human 
organs and how to treat specific diseases. The stable radioisotopes are linked with different 
carrier organic chemical depending on the organ and/or purpose of the scan such as glucose 
(fluorodexoyglucose), protein (cyclo-RGDfC) or hormone (norepinephrine) and are used as a 
radioactive tracers in the nuclear medicine applications which generally are short lived (short 
half-life) isotopes [231]. These radioactive tracers after been delivered to the organs by either 
intravenous injection, direct injection into organ, oral ingesting or inhalation depending on 
the disease studied, as it decays, it emits positron which instantly combines with a nearby 
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electron (electron-positron annihilation process) resulting in the simultaneous energy release 
as two identifiable gamma rays (γ-rays) in opposite directions. The γ-rays are then detected 
outside the body by detectors from many different angels and are used to image an internal 
organs or structures tomographically. The formulated images are then utilised for diagnostic 
techniques in radiotherapy. In vivo imaging techniques, the emitted γ-rays are detected by 
special solid-state detectors. The imaging system based on this principle is known as 
positron-emission tomography i.e. (PET) another less commonly used system is single 
photon emission computerised tomography (SPECT). Now, the dual CT/PET scans are the 
more recent development techniques used for imaging enabling 30% better diagnosis than 
with traditional gamma camera [232]. The featured advantage of nuclear medicine imaging 
over X-ray imaging techniques is that the positioning of radiation source within the organs 
imaged and both soft tissue and bone can be imaged very clear  [233]. 
Currently, the commonly available positron emitter radioisotopes used as radioactive 
tracers in the nuclear medicine are carbon (11C), nitrogen (13N), oxygen (15O), fluorine (18F), 
gallium (68Ga) and rubidium (82Rb). Lately, nanoparticles have also been tested as a potential 
radioactive tracers including metal oxide NPs and particularly TiO2 NPs for in vitro and in 
vivo studies [234-237]. In literature, a very limited number of studies are conducted to 
investigate the radioisotopes generated from TiO2 NPs via proton beam activation. 
Researchers showed that TiO2 NPs have been successfully radiolabelled with stable 
vanadium (48V) post activation by cyclotron generated proton beam. In addition, 
characterisation of the activated TiO2 NPs using XRD demonstrates that there was no 
significant modification in the morphological properties of the irradiated NPs. Furthermore, 
in vitro investigation of the uptake of cold non-activated and activated TiO2 NPs with human 
cell line Calu-3 was quantified by high resolution γ-ray spectroscopy and inductively coupled 
plasma mass spectrometry (ICPMS). These indicates that there was no significant alteration 
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in the uptake quantification between both batches of NPs [238], this refers that radioisotopes 
did not hamper the uptake of NPs by cells. Others have activated 18O-enriched TiO2 NPs 
directly by proton beam to study in vivo bio-distribution of NPs via generated positron 
emitter 18F using PET. Further generated radioisotopes were investigated such as 44Sc, 47V 
and 48V. Their results demonstrate that short term studies for in vivo bio-distribution of NPs 
in the organs using labelled TiO2 NPs with radioactive 
18F atoms could be performed which 
aggregation of NPs were observed by PET after 8 h of intravenous and oral administration. 
Moreover, neither the morphology nor the size of the activated TiO2 NPs was obviously 
affected by the proton beam irradiation as demonstrated by TEM and DLS [239].      
In this study, the generation of radioisotopes via TiO2 NPs activation with a 
cyclotron-generated proton beams are investigated and then the activated TiO2 NPs are 
examined to show that it can be used as imaging agent using PET scan in order to be applied 
in future as a potential radioactive tracer for diagnostic techniques in nuclear medicine. 
Hence after proving the value of TiO2 NPs in enhancing the radiation effects at the targets 
through this research as previously stated (chapter six) renders it to be a theranostic agent 
with dual effects (i.e. imaging and dose enhancer agent) simultaneously if it is in the radiation 
targets.  
 
8.3 Materials and Methods 
 
The materials and experimental methods followed for activation of 30 nm diameter 
TiO2 NPs with proton beams are described in the following sections. 
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8.3.1 Capsule preparation 
 
The stainless-steel capsule was manufactured locally with outer diameter of 25 mm 
and the cavity diameter of 15 mm as shown in Figure (8-1). The synthesised anatase TiO2 
NPs according to the previously stated procedure in chapter 3 (Section 3.1.1) were loaded in 
the capsule prior irradiation by the proton beam. The total weight of TiO2 NPs loaded in the 
capsule was about 21 mg. The capsule window was sealed with titanium foil of 0.1 mm 
thickness.  
 
 
Figure 8-1: Digital image of the special designed capsule for holding TiO2 NPs in the cyclotron.  
 
 
 
8.3.2 TiO2 NPs irradiation with proton beam 
 
The irradiations were performed using high current (HC) cyclotron (IBA Inc., 
Louvain-La-Neuve, Belgium) located at the basement of the nuclear medicine department, 
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Austin Health, Melbourne, Australia, which it can be used to accelerate positive ions 
including both proton and deuterium ion source. Briefly, a cyclotron consists of two hollow 
cylindrical metal electrodes shaped like the letter “D” hence; these electrodes are called 
“dees”. The dees are placed face to face and separated slightly along the diameter with a 
narrow gap and then creating a cylindrical space within them for the charged particles to 
move and these dees are enclosed in an evacuated chamber. A very high frequency and a high 
voltage oscillator is connected to these dees. A source of positive ions is placed in the centre 
of the cylindrical space. The dees and the positive ion source are placed between two poles of 
a large electromagnet as shown in Figure (8-2). The positive ions are accelerated in to the 
negatively charged D1 due to the electrostatic attraction and when the alternating current 
shifts the positive terminal to the negative terminal, the positive ions moves in to D2 and 
continuous this process with the presence of magnetic field perpendicular to the electrode 
plane, the positive ions follow circular path as a result of Lorentz force. As the positively 
charged particle gain energy from electric field during each time crossing the gap between 
dees; therefore, their rotational radius increases and the ions spiral out from the dees through 
a small gap and bombard the target located at the exit point of the chamber arm and result in 
a nuclei reaction [240-242]. 
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Figure 8-2: Schematic diagram showing the components of cyclotron. The image is not in scale.  
 
 
In this work, the capsule loaded with TiO2 NPs was inserted in a cyclotron holder 
(Figure 8-3) that allowed direct cooling system from both front and rear side, which this is 
essential for limiting the generated heat on the TiO2 NPs in order to preserve the properties of 
the NPs during the proton bombardment. The cyclotron proton energy was set to 13 MeV 
where this energy covers the maximum reaction cross section of the proposed radioisotopes 
produced from TiO2 NPs post proton activated such as reaction cross-section of 
48Ti(p,n)48V. 
The target, collimator and stripper current were set to 5, 0.2 and 5 µA respectively. The beam 
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time of 10 mins was applied. Finally, the D-voltage was set on 34.5 kV as this voltage makes 
the beam less diffusive and with less noise.  
 
 
Figure 8-3: Cyclone 18/9 –HC cyclotron system showing the capsule holder and the cooling system. Inset: 
digital image of capsule in the top right.   
 
 
8.3.3 Energy Spectrum by Germanium (Ge) γ-ray detector 
 
The energy spectrum of the activated TiO2 NPs was acquired using gamma 
spectrometer. The high resolution GC4020 GE Co-Axial hyper pure-germanium (Ge) γ-ray 
detector (CANBERRA, USA) as shown in Figure (8-4) was utilized to quantify and identify 
the γ-ray emitting radionuclides in an activated TiO2 NPs. The Ge-detector was calibrated at 
efficiency and energy by using certified radioactive standard sources. A model 747 series 
lead shield was used to prevent any effects of the background counts. The measurements 
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were conducted directly after irradiation at times (0, 20, 40) min and then post 72 h. The 
acquired γ-ray spectra’s were analyzed using the Genie 200 software package (CANBERRA, 
USA).  
 
 
Figure 8-4: Image showing germanium γ-ray detector, activated TiO2 NPs and the lead shield.  
 
 
8.3.4 Imaging using positron emission tomography (PET) scanner 
 
The positron emission tomography imaging was performed on Mediso nanoScan 
PET/MRI small animal testing system (Mediso Medical Equipment Developing and Service 
Ltd., Budapest, Hungary) at Molecular Imaging and Therapy/Nuclear Medicine department, 
Austin Health, Melbourne, Australia, and was used for imaging the radiolabeled anatase TiO2 
NPs with proton beam. The working principle of PET scan is when the radiotracers are 
injected into the patient bloodstream, after one hour they accumulates in body tissues with a 
high energy demand, especially tumours. These radiotracers decays within the tumour cells, 
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emitting positrons, and these positrons interact with nearby electrons in an annihilation 
reaction, producing a pair of gamma rays in opposite directions. These pairs of gamma rays 
are detected by the gamma camera in the PET scanner (Figure 8-5 A), hence are used to 
create a 3D image of the body showing the area of tumour tissue [243]. In this study the 
anatase TiO2 NPs activated with proton beam were allowed to decay for few days before 
performing PET imaging. The NPs were placed in uniform prospects and then scanned with 
PET scanner as shown in Figure (8-5 B). The duration of the scanning was 10 min resulting 
in capturing a total of 235 images by PET scanner. The 3D image was then reconstructed and 
the total activity produced was measured.   
 
 
Figure 8-5: PET scanner, A) Basic principle of electron-positron annihilation and releasing two-gamma 
photons useg for PET imaging. B) Image of Mediso nanoScan PET/MRI small animal testing system 
performing imaging of activated TiO2 NPs. 
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8.3.5 Risk & Safety control 
 
The hazard associated with radiations and/MRI radioisotopes during the experiments 
were controlled by following the general safety guidelines described by engineers at 
cyclotron facility, Austin Health, Melbourne, Australia and these include the safe use of 
radioactive materials, handling and storage. Prior to the conduction of the experiments, a 
training session was conducted aimed at understanding how to work with the radiations 
around cyclotron and control the risk associated with handling of radioactive materials. The 
typical instructions followed were wearing a laboratory coat, disposable gloves and personal 
radiation monitoring device at all times during the experiment. In addition, monitor clothing, 
hands and shoes before leaving the facility area at a spot of low contamination background. 
Furthermore, controlling the radiation hazard during irradiation, handling and spectrum 
measurement were by utilising shielding materials such as concrete and lead in order to 
reduce the radiation effect to an acceptable low level. The activated TiO2 NPs were clearly 
labelled and stored at a special lead shielding room for radioactive material storage at the 
cyclotron facility, Austin Health.  
 
8.4 Results 
 
The high resolution γ-ray spectra of the TiO2 NPs activated by13 MeV proton beam 
were acquired after the removal of NPs from the capsule i.e. after activation. The 
measurement presented are conducted at times (15, 45, 85) min and 72 h after the end of the 
irradiation process. The energy spectrum of 15 min post irradiation is shown in Figure (8-6). 
The results demonstrate that high intensity peak was observed at 511 keV which correspond 
to the γ-ray resulted from electron-positron annihilation, while less intense signals were 
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detected at energies of 944.2, 984.55 and 1312.08 keV which all corresponds to Vanadium-
48V (T1/2 = 15.97 days). The γ-ray peaks of the radioisotope at energies of 1390, 1551 and 
1796 keV corresponds to the Vanadium-47V (T1/2 = 32.6 min). The peak at 1157 keV 
corresponds to Scandium (Sc)- 44gSc (T1/2 = 3.93 h). Figures (8-7) and (8-8) shows the γ-ray 
energy spectra acquired for the time frames of 45 and 85 min. It is observed that 44gSc (1157) 
peak diminished with time whereas two peaks of 159.27 and 271.2 keV appeared which 
corresponds to 47Sc (T1/2 = 3.35 d) and 
44mSc (T1/2 = 2.44 d), respectively. Post 72 h from 
irradiation, only the major signals corresponding to 47Sc (159.27 keV), 44mSc (271.2 keV), the 
electron-positron annihilation (511 keV) and to 48V γ-ray emission (928.3, 944.2, 984.55 and 
1312.08) keV were detected in addition to the peaks (1494.55 and 1823.08) keV resulting 
from the sum of (983.55+511) and (1312.08+511) γ-rays, while both 47V and 44gSc signals 
were vanished from the γ-ray spectrum as shown in Figure (8-9). 
 
 
Figure 8-6: Gamma ray spectrum of the proton irradiated TiO2 NPs showing the electron-positron 
annihilation peak (511 keV) in addition to γ-rays emission peaks for 48V and 47V after 15 min the end of 
irradiation process. 
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Figure 8-7: Gamma ray spectrum of the proton irradiated TiO2 NPs showing the electron-positron 
annihilation peak (511 keV) in addition to γ-rays emission peaks for 48V and 47V after 45 min the end of 
irradiation process. 
 
 
 
 
Figure 8-8: Gamma ray spectrum of the proton irradiated TiO2 NPs showing the electron-positron 
annihilation peak (511 keV) in addition to γ-rays emission peaks for 48V and 47V after 15 min the end of 
irradiation process. 
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Figure 8-9: Gamma ray spectrum of the proton irradiated TiO2 NPs showing the electron-positron 
annihilation peak (511 keV) in addition to γ-rays emission peaks for 47Sc (159.27 keV), 44mSc (271.2 keV) 
and 48V (928.3, 944.2, 983.55 and 1312.08 keV) after 72 h the end of irradiation process. 
 
 
Figure (8-10) is an example of images acquired as a rotating 3D maximum intensity 
projection (MIP) of the image volume obtained from PET scanning the proton activated 
anatase TiO2 NPs. The black spot represent the signal of radiolabeled anatase TiO2 NPs. The 
activity of 48V was measured from images obtained with acquisition of PET scans performed 
on small sample of irradiated TiO2 NPs. The image reports activity of 404 kBq based on 
18F. 
Once correcting for the 18F branching ratio (0.9686) and the system Decay Correction 
Correction Factor (DCCF) (0.9692) as calculated by specific software for the start of the 10-
minutes acquisition, the activity was lowered by about 6% for 48V to be 380 kBq as measured 
at the imaging time. In nuclear physics, the branching fraction or ratio for decay is the 
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fraction of particles that decay by an individual decay mode with respect to the total number 
of particles, which decay.  
 
 
Figure 8-10: Maximum intensity projection (MIP) PET image of 18F-labeled TiO2 NPs.  
 
 
8.5 Discussion 
 
In discussion, TiO2 NPs can be proposed as a potential candidate for producing 
nuclear medical radioisotopes via proton activation since only limited radioisotopes for the 
nuclear medicine applications are currently available. It is obvious from the results that the 
main radionuclides generated from TiO2 NPs activation are 
47Sc, 44mSc, 44Sc, 48V as shown in 
Figures (8-6) and (8-9). The radionuclide 47Sc is produced via direct nuclear reaction of 
either 48Ti(p,γ)47Sc or 47Ti(p,n)47Sc [244]. Recently, β− and α emitters are potentially 
suggested by several innovators for new radiopharmaceutical applications. Therefore, 47Sc 
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radionuclide is a promising therapeutic agent for preparing radiolabeled antibodies due to its 
favorable β- emission energy (162 keV) which decays to stable 47Ti (100% β− emission ), and 
to its moderate half-life (T1/2 = 3.35 d) [245]. On the other hand, 
47Sc (β−) is accompanied to 
γ-ray (159.2 keV) that can be used for in vivo imaging; therefore, the simultaneously presence 
of β− and γ could make 47Sc an alternative to the currently employed radionuclides (67Cu or 
177Lu) for targeted radionuclide therapy [245, 246]. The other generated radioisotopes is 44Sc 
which has a long-lived isomeric state radionuclide 44mSc (T1/2 = 2.44 d) formed from the 
nuclear reaction of 47Ti(p,α)44mSc and 48Ti(p,nα)44mSc and a short-lived ground state  of 44gSc 
(T1/2 = 3.93 h) resulted from the reaction of 
47Ti(p,α)44gSc and 48Ti(p,nα)44gSc via TiO2 NPs-
proton activation [239, 247 and 248]. The presence of 47V in the energy spectrum could be 
due to the 47Ti(p,n)47V and (less probably) 46Ti(p, γ)47V nuclear reactions resulting from the 
low energy incident protons [247, 249]. The 47V and 44gSc are short-lived isotopes (32.6 min, 
3.93 h) respectively; therefore, both were decayed (compare Figures (8-7, 8-8) to (8-6)) and 
almost quantitatively eliminated from the spectrum after 72 h of irradiation shown in Figure 
(8-9). Also, the energy spectra taken at 15 min post irradiation has a very low signal to noise 
level ratio, which resulted in hiding the peaks of 47Sc (195.2 keV) and 44mSc (271.2 keV). 
After 72 h the target activity dies down and the noise count rate dropped significantly making 
these two peaks became more obvious (Figure 8-9). The γ-ray peak produced at 511 keV in 
the energy spectrum corresponds to the positron annihilation and are the most important 
radioisotopes for potential nuclear medicine imaging applications particularly for PET. 
Whereas the long-lived radioisotope 48V (T1/2 = 15.9 d) can effectively be formed by the 
direct nuclear reaction 48Ti(p,n)48V and completely decays to stable 48Ti nuclide by 100% 
electron capture process. The half-live of 48V made it suitable for biological tracer tests [238]. 
The radioladeled anatase TiO2 NPs show its feasibility to be employed as radioactive tracer 
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for PET imaging as clearly can be seen in Figure (8-10). This has potential to be used for 
nuclear medicine applications. 
 
8.6 Conclusion 
 
In this study, the direct proton irradiation of anatase TiO2 NPs can be successfully 
activated through generation of the positron emitters (0.511 MeV) that potentially can be 
employed for in vivo imaging application using PET. Simultaneously to the formation of 
positrons, other radionuclides, such as 47V, 44gSc, and 48V, are generated by the irradiation as 
demonstrated using high-resolution Germanium detector. The generated radionuclides with a 
certain activity level especially 48V can be used for radiotracing applications. Therefore, 
anatase TiO2 NPs can be considered as a potential radiologic imaging agent for nuclear 
medicine applications. 
In the previous chapters (5 and 6) it was shown that TiO2 NPs can be used for 
enhancing radiation doses especially for radiotherapy. Combining the outcome of this chapter 
with those of chapters five and six clearly demonstrates that TiO2 NPs can act as therapeutic 
and imaging agents, i.e. theranostic agents.      
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9. Conclusions and future directions 
 
This chapter presents the general conclusions of the experimental results around thesis 
whole and then it is followed by suggestions for further studies to answer the research 
questions raised during the process of answering the main ones. 
 
9.1 Conclusions 
 
This thesis is based on novel and original work and innovative methods and 
techniques of employing nanotechnology in medical radiations in general and radiotherapy in 
particular. The inspiration behind this research is that anatase TiO2 NPs nanoparticles can 
effectively radiosensitise the target via biochemical effects beside the physical effects. In 
addition, the nanoparticles can be successfully activated by the proton beam, hence used as a 
potential radioactive tracer for diagnostic imaging techniques in the nuclear medicine 
applications rendering it to be a theranostic agent (i.e. imaging and enhance radiotherapeutic 
ratio). 
The main findings of this thesis were, firstly, explore and discuss the characterisations 
of synthesised TiO2 NPs. Secondly, the influence of TiO2 NPs on radiation dose enhancement 
at low and high energy X-ray beams have been comprehensively analysed through in vitro 
and phantom based studies. Finally, the feasibility of employing the activated TiO2 NPs by 
proton beam as a radioactive isotope for imaging purposes in nuclear medicine was 
investigated. Over the preceding eight chapters of this thesis, we have addressed the main 
achievements of this work that includes the following: 
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1. This thesis comprised investigation and discussions of the results for several 
characteristics of TiO2 NPs which make them potentially suited for applications in 
radiotherapy. The TiO2 NPs were typically synthesised to achieve highly pure anatase 
nanocrystalline structures. This selected form creates more free radicals and effectively 
generates more ROSs since it has larger surface to volume ratio. These features have a high 
impact in damaging DNA molecule of biological systems during irradiations. The XPS 
analysis reveals that the binding energy of the synthesised NPs are referred to titanium and 
oxygen signals in the TiO2 lattice, whereas the XRD analysis indicates that anatase crystal 
structure was with negligible levels of impurities. Furthermore, the synthesised anatase TiO2 
NPs were surface modified with either 3-aminopropyl trimethoxysilane (APTS) or poly 
(ethylene glycol) propyl trimethoxysilane (PEGTS) to afford amino- and PEG-functionalised 
NPs that could be easily dispersed in aqueous and organic solutions, respectively. The surface 
coatings were analysed using FTIR and TGA. The results show that amino and PEG surface 
coatings were successfully grafted on the TiO2 NPs as analysed by FTIR while coating mass 
was only ~ 6-7 % of the total NPs mass as analysed by TGA which is an indicator that the 
observed dose enhancement is mainly due to the TiO2 NPs itself. 
 
2. In phantom studies, the influence of radical initiators including chloroform and 
iodoform employed in this study on the physical and radiological characteristics of the 
PRESAGE® dosimeter was investigated. The results obtained refers that physical density of 
PRESAGE® dosimeter with iodoform radical initiator was higher than PRESAGE® dosimeter 
with chloroform radical initiator, this is because of high density and atomic number (Z) of 
iodine (Z=53) compared to the chlorine (Z=17). With regards to the radiological properties, it 
is noted that the incorporation of these radical initiators in the PRESAGE® dosimeter 
composition resulted in variations of the dosimeter sensitivity to the radiation doses. The 
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change in sensitivity mainly depends on the type and concentration of the radical initiator 
used. The results indicate that the slope of the dose response curve for iodoform-based 
PRESAGE® formulation showed significantly higher sensitivity than chloroform-based 
PRESAGE® formulation which proves that iodoform radical initiator enhances the sensitivity 
of the PRESAGE® dosimeter to radiation doses more than chloroform at the same 
halocarbons molar concentration and applied radiation dose. This enhancement in sensitivity 
is believed to be linked directly to the carbon-halogen bond dissociation energy. Furthermore, 
the post-response photostability of the PRESAGE® dosimeter with both radical initiators 
were stable over the period of 10 days. Finally, the phantom’s water-equivalency 
characteristic was evaluated experimentally. The PDD results showed that the PRESAGE® 
dosimeters are water-equivalent; hence, there is no need to apply dosimetric correction 
factors in order to determine doses to tissue. 
The radiation-modifying effects of anatase PEGS functionalised TiO2 NPs in the 
formulation of the PRESAGE® dosimeter were explored. The 3D PRESAGE® dosimeters 
were utilized to quantify the DEF produced by the inclusion of the PEG functionalised TiO2 
NPs and then validated these results with the biological studies. The results clearly 
demonstrates that the sensitivity of the dosimeter increases to the radiation doses with the 
concentration of the TiO2 NPs incorporated into the composition of the PRESAGE
® 
dosimeter. Furthermore, the measured dose enhancements were significant at 80 kV 
compared to the negligible dose enhancement detected at 6 MV X-ray energy beams which is 
mainly due to contribution of PE as the energy spectrum of the MV beam shows some 
residual low energy and PEs. 
 
3. The PRESAGE® dosimeter was used for the first time to simulate the tissue 
inhomogeneity behavior using CLARIOstar microplate reader (UV/Vis spectrophotometry). 
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This UV/Vis spectrophotometry technique was used to measure the 2D dose distribution prior 
and after the inhomogeneous section. The PDD results measured by this technique reveals 
similar trend as with ion chamber measurements before the inhomogeneity. However, an 
increase in dose was measured post inhomogeneity compared to the ion chamber 
measurement with no inhomogeneity. A discrepancy of 1-2% was noted between the 
Treatment Planning System and actual PRESAGE® dosimeter curves post inhomogeneity. 
This technique can potentially be extended to 3D by obtaining measurements at 360 angels as 
similar way OCT works, and then reconstruct the data in a volume. This will lead to many 
clinical applications such as determining the 3D dose distributions around and inside an 
inhomogeneity and then validate treatments for sophisticated techniques such as tomotherapy 
and IMRT.  
 
4. In vitro studies; the localisation of amino functionalised anatase TiO2 NPs inside the 
cells was observed in this research to determine whether the NPs are taken-up inside the cells. 
HaCaT and DU145 cells were incubated with TiO2 NPs for 24 h to include the NPs into both 
types of cell lines. Various techniques were employed to investigate cellular association 
and/or uptake of NPs such as FCM and immunohistochemistry cell staining technique using 
light microscopy. The results of FCM conforms an increase of the scattered visible light in 
the case of NPs presence which the forward scatter were slightly changed suggesting no 
change in object size while the side scatter was increased with the increase of TiO2 NPs 
concentrations and suggesting a high association between cells and the NPs. The distribution 
of TiO2 NPs inside the cells was studied by light microscopy and the results reveals that TiO2 
NPs were clustered as a black dot in the cell’s cytoplasm and did not enter its nucleus. 
 
 
Chapter Nine: General Conclusions and Future Directions  
203 
 
 
5. Assessments of cytotoxicity of amine functionalised TiO2 NPs on HaCaT and DU145 
were explored with different concentrations of NPs and incubation times. The toxicity 
induced by anatase TiO2 NPs was tested by measuring the cell viability which is a percentage 
of treated cultures (with TiO2 NPs treatment) to untreated controls (without TiO2 NPs 
treatment) [250]. The results of cytotoxicity investigations for both types of cells shows that 
the anatase amine functionalised TiO2 NPs does not alter the biological system for the 
concentrations of up to 4 mM post 72 h of treatment as the cell viability for these 
concentrations of TiO2 NPs did not show any statistically significant changes (p > 0.05) in 
the cells’ viability. These results are in agreement with findings of other researchers [32, 
149]. Therefore, in this study, the TiO2 NPs concentrations (maximum of 4 mM) used in vitro 
were suitable for studying radiosensitisation effects without any health concern. Contrary to 
other NPs such as gold and bismuth NPs which it is not possible to exceed a 1 mM 
concentration.  
 
6. In this thesis, the radiosensitisation produced  by inclusion of anatase amino 
functionalised TiO2 NPs using HaCaT and DU145 cell lines irradiated with 1-8 Gy ranges of 
radiation doses at 0.5, 1 and 4 mM TiO2 NPs concentrations was quantified for low 
(kilovoltage) and high (megavoltage) energies external X-ray radiation sources by two 
methods: MTS and clonogenic assays. The DEFs were deduced from the data analysed in the 
form of cell survival curve. The results indicate that radiosensitisation induced by TiO2 NPs 
was significant at kilovoltage range of energy where the maximal dose enhancement was 
observed at 80 kV. Furthermore, significant radiosensitisation was observed for in vitro study 
at megavoltage energy beam. In addition, the slight variations in regards of DEF observed 
between HaCaT and DU145 cell lines could be due to the difference in their response to the 
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radiations and to the inclusion of the TiO2 NPs as it is known that cells have different 
response to the same radiations [16]. With the inclusion of TiO2 NPs in the target, same 
fraction of cells were destroyed with lower radiation doses compared to the case of absence 
of TiO2 NPs which these nanoparticles result in the observable effect on the measured DEF 
values and the DEF was increased with the TiO2 NPs concentration increase. This means if 
the TiO2 NPs are added to the biological target, a reduction of external dose of an order of 
magnitude can be achieved to deliver the same local control as without the inclusion of TiO2 
NPs for treatments with kilovoltage and megavoltage X-rays beams. This is because of ROSs 
and further secondary electron generation with the presence of NPs in the target which makes 
cells more sensitive to the radiations. This reduction of delivered radiation dose to the target 
will lead to reducing the dose to the surrounding normal tissues during treatment which is the 
primary concern in all radiotherapy treatment procedures. Hence, TiO2 NPs are considered to 
be an efficient dose enhancer agent and have a great potential value for future clinical 
radiotherapy applications. 
The interesting point of the dose enhancement results is the observed differences and 
disagreement in the level of produced DEF between in vitro and phantom based studies, 
especially at high energies (6 MV). The PRESAGE® dosimeters showed lower enhancements 
in radiosensitivity than cells in culture studies. The main reason behind this is that 
PRESAGE® dosimeters being only sensitive to the directly generated free electron due to the 
methods of interactions of radiations with matter such as photoelectric effect, Compton 
scatter and/or Auger effect not being suited to detect the generated ROS (Biochemical 
effects) due to a lack of free water molecules in its structure. Contrariwise, cells can be 
affected by many other biochemical factors, such as the generated ROS which is added to the 
physical effect including the stress caused by generated electron free radicals, and this result 
in higher radiosensitivity. 
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7. Ranges of kV radiotherapy X-ray beams (80, 100 and 150 kV) in combination with 
different concentrations (0.5, 1 and 4 mM) of anatase TiO2 NPs were employed to investigate 
the DEF dependence on beam energies at this ranges. The results for both in vitro and 
phantom based studies predict that the optimal kV energy that create highest DEF was 
obtained at 80 kV which later was selected to be applied for both studies (in vitro and 
phantom) of this thesis.  
 
8. The radiobiological effects of amino functionalised anatase TiO2 NPs on HaCaT and 
DU145 cell lines were analysed and the experimental data plotted as cell survival curves were 
fitted with linear quadratic model. The linear (α) and the quadratic (β) parameters were 
extracted from these data in order to describe the DNA damage by radiations. The results 
clearly demonstrate that α value significantly increases with the inclusion of TiO2 NPs while 
β value insignificantly changes. This increase in α value indicates that the probability of 
double strand DNA breakage by different secondary electrons increases with the presence of 
NPs in the target. This is expected as the presence of TiO2 NPs will enhance production of 
low energy free radicals and also ROSs which would lead to increase the likelihoods of DNA 
strands breakages.  
 
9. In this work, the ROS generated from amino functionalised anatase TiO2 NPs upon 
exposed to radiotherapy X-ray energy beam was investigated. Aqueous solutions without 
(control) and with the presence of TiO2 NPs was exposed to 6 MV beam. The result clearly 
shows that ROS were detected and the level of generated ROS was proportionally dependent 
on the TiO2 NPs concentration. This explains that biochemical effects need to be considered 
as a key factor for enhancing the cellular radiosensitivity with the presence of nanoparticles 
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which would be an important consideration for in vitro and in vivo radiosensitivity 
measurements. 
 
10. In this thesis, the direct proton irradiation of anatase TiO2 NPs allowed sufficient 
activation through generation of the positron emitter which can be used to perform in vivo 
imaging using PET. However, the further radionuclides generated have an advantage to be 
employed as radiotracer agents for nuclear medicine applications. 
 
9.2 Future Direction  
 
Certainly, this work has addressed many issues which could have impact on 
radiotherapy and investigated and answered many questions for better understanding of 
resolving these issues in future. However, further theoretical and experimental investigations 
are required to be tackled in future. Currently, few investigations are in progress to 
complement the primary findings of this thesis as follows; 
 
1. This thesis focused on both low energy (kilovoltage) and high energy (megavoltage) 
radiotherapy X-ray beams for investigation of radiosensitisation. However, it will be of great 
value for radiotherapy field to extend such investigation into other radiotherapy beams such 
as electron beam, synchrotron based microbeams and more importantly proton beams which 
are increasingly becoming important and expanding. This is currently in the planning stages 
for our group.    
 
2. The dose enhancement induced by anatase TiO2 NPs were investigated for in vitro 
and phantom based studies in this work.  It will be of great value to extend these ideas into in 
vivo studies. 
Chapter Nine: General Conclusions and Future Directions  
207 
 
 
3. Only one type of the ROS generated from anatase TiO2 NPs at megavoltage X-ray 
energy beam was detected in this study which was hydroxyl radical (•OH). However, further 
investigations are in progress to detect the other types of ROS generated from TiO2 NPs and 
from other types of NPs. In addition, employing proton beam is under investigation to 
explore for any possible ROS generation from NPs. Also measuring the ROS levels generated 
with low energy X-rays. 
 
4. Employing PRESAGE® dosimeter for clinical applications is one of the challenges. 
However, for the first time a work is under investigation to validate the surface dose 
distribution for a patient been treated with radiotherapy electron beams at Barwon Health 
Andrew Love Cancer Centre (Barwon Health: Geelong Hospital, Geelong, VIC, Australia).  
 
5. Further measurements are being conducted to evaluate the importance of the 
radioisotopes generated from activated anatase TiO2 NPs via cyclotron proton beam for the 
potential nuclear medicine application.      
 
6. It will be valuable to repeat the measurements of this research using different sizes of 
anatase TiO2 NPs. This will allow for better understand the underpinning of the physical and 
radiobiological effects on radiation dose enhancement.   
 
7.   As a consequence of rapid development in the area of nano-biotechnology, testing 
different types of nano-compound structures such as mixture of anatase/rutile TiO2 NPs 
and/or silver/titanium dioxide composite nanoparticles could be of great value. 
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Appendices 
Appendix I: Permission to reproduce published materials in chapter 7.  
 
 
Appendix   
227 
 
Appendix II: Two-dimensional scanning of PRESAGE® dosimetry using UV/VIS 
spectrophotometry and its potential application in radiotherapy. 
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Appendix III: Permission to reproduce published materials in chapter 3, 4, 5 and 6. 
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Appendix IV: Titanium Dioxide Nanoparticles as Radiosensitiser: An In vitro and 
Phantom-Based Study. 
 
 
